nitroglycerin has been researched along with Heart Failure in 634 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Guidelines recommend short-acting nitrates, such as sublingual nitroglycerin, for the treatment of acute angina pectoris in patients with chronic coronary syndromes (CCSs), common comorbidities in HF." | 9.51 | Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study. ( Becker, C; Besche, N; Boettcher, M; Donath, F; Düngen, HD; Gurniak, M; Karakas, M; Koch, T; Mikus, G; Thuermann, PA; Werner, N, 2022) |
| "Vasodilators, such as nitroglycerin, have long been first-line treatments for acute heart failure syndromes (AHFS)." | 9.24 | Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial. ( Fujinaga, H; Fujisawa, K; Harada, K; Harada, T; Iima, T; Kageyama, N; Kawata, A; Okada, A; Okumura, T; Saito, A; Shigekiyo, M; Terada, N; Yamamoto, H; Yamamoto, T, 2017) |
| "Patients (>60 y) with hypertension and heart failure were randomly assigned to receive intravenous urapidil (n=89) or nitroglycerin (n=91) for 7 days." | 9.24 | Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial. ( Chen, XM; Fu, Y; Guo, JC; He, JY; Hua, Q; Li, J; Qin, J; Qin, S; Wang, Z; Yang, W; Zhan, H; Zhou, YJ, 2017) |
| "Rises in serum creatinine and efficacy have been reported as dose-related effects of nesiritide and nitroglycerin in acute decompensated heart failure (ADHF)." | 9.15 | Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure. ( Chew, E; Chow, SL; Heywood, JT; O'Barr, SA; Pak, F; Patel, P; Patterson, JH; Peng, J; Quist, R, 2011) |
| "The A-HeFT trial demonstrated incremental survival with hydralazine/isosorbide dinitrate combination in African-American patients with chronic heart failure (CHF)." | 9.14 | Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure. ( Chirkov, YY; De Sciscio, M; Horowitz, JD; Leslie, S; Sage, PR; Sverdlov, AL, 2010) |
| "To compare the therapeutic effect of recombinant human brain natriuretic peptide (rhBNP) and nitroglycerin on acute decompensated heart failure (ADHF)." | 9.13 | [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin]. ( Chen, SM; Feng, XG; Li, P; Meng, SR; Wang, W; Xie, CL, 2008) |
| "To compare the efficacy and safety of intravenous infusion recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin (NIT) in treating patients with decompensated acute heart failure." | 9.12 | [Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study]. ( , 2006) |
| "We perform a feasibility and outcome assessment of the treatment of severe decompensated heart failure with high-dose nitroglycerin." | 9.12 | Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. ( Compton, S; Delgado, G; Dunne, R; Jennett, A; Levy, P; Penugonda, N; Welch, R; Zalenski, R, 2007) |
| "The results of this study showed an advantage of nesiritide compared with high-dose nitroglycerin in the treatment of patients with decompensated heart failure." | 9.11 | Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure. ( Akhter, MW; Elkayam, U; Khan, S; Singh, H; Usman, A, 2004) |
| "Intermittent intravenous dobutamine therapy is used to treat patients with decompensated end-stage chronic heart failure (CHF), in whom the vascular endothelium is usually impaired." | 9.11 | Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure. ( Feinberg, MS; Freimark, D; Hochberg, N; Matezky, S; Shechter, M, 2004) |
| "We sought to determine the effect of aspirin on the venodilator effect of furosemide in patients with chronic heart failure (CHF) BACKGROUND: Furosemide has an acute venodilator effect preceding its diuretic action, which is blocked by nonsteroidal anti-inflammatory, drugs." | 9.09 | Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. ( Davie, AP; Jhund, PS; McMurray, JJ, 2001) |
| "This study was designed to determine the effect of oral hydralazine on the development of nitrate tolerance in patients with chronic congestive heart failure." | 9.08 | Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. ( Ajit-Uppal, J; Elkayam, U; Gogia, H; Johnson, JV; Mehra, A; Parikh, S; Raman, M, 1995) |
| " We examined the hemodynamic parameters as well as femoral arterial and venous cyclic guanosine monophosphate (cGMP) concentrations during intravenous infusion of NTG or nicorandil, a nitrate and potassium channel opener, in patients with congestive heart failure." | 9.08 | Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure. ( Fukai, D; Hisanaga, T; Kinoshita, M; Maeda, K; Maeda, Y; Tsutamoto, T; Wada, A; Yoshida, S, 1995) |
| " In order to test the immediate response of right ventricular hemodynamic parameters to nitroglycerin and dobutamine usually used to treat severe left ventricular dysfunction, we studied 17 congestive heart failure patients (15 men, two women; mean age 55 +/- 13 years) with end-stage idiopathic dilated cardiomyopathy (n = 10) or end-stage ischemic heart disease (n = 7), left ventricular ejection fraction < 35% (mean 22 +/- 8%), and sinus rhythm." | 9.08 | Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation. ( Berder, V; Cherrier, F; Danchin, N; Feldmann, L; Juillière, Y; Perrin, O, 1995) |
| "Twenty patients with congestive heart failure and pulmonary capillary wedge pressure (PCWP) > or = 18 mm Hg were randomly assigned to nitroglycerin or nicorandil in a double-blind, crossover study." | 9.08 | Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure. ( Aarsland, T; Dickstein, K; Gøransson, L; Larsen, AI; Tamby, JF, 1997) |
| "This study was designed to investigate the effect of angiotensin-converting enzyme (ACE) inhibitors with and without a sulfhydryl group on intracellular production of cGMP, forearm blood flow, and neurohormonal factors during continuous transdermal application of nitroglycerin in patients with chronic heart failure." | 9.08 | Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure. ( Kakihana, M; Ohtsuka, S; Sugishita, Y; Watanabe, H, 1998) |
| "This study was designed to evaluate the effect of carvedilol on nitrate tolerance in patients with chronic heart failure." | 9.08 | Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure. ( Kakihana, M; Ohtsuka, S; Sugishita, Y; Watanabe, H, 1998) |
| "To evaluate whether hemodynamic tolerance develops to nicorandil, a nitrate and potassium channel opener, 14 patients with chronic heart failure (CHF) were treated with nicorandil and 11 were treated with nitroglycerin (GTN)." | 9.07 | Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure. ( Horie, H; Kinoshita, M; Maeda, Y; Nakae, I; Tsutamoto, T; Wada, A; Yabe, T, 1994) |
| "We studied the hemodynamic response to intravenous nitroglycerin (NTG) in 40 patients with and without acute heart failure (hemodynamic subsets I-IV) during acute myocardial infarction." | 9.07 | Hemodynamic mechanisms of the effect of nitroglycerin in patients with acute myocardial infarction. ( Pavicić, L; Popadić, M; Popović, G; Rezaković, DE; Stalec, J, 1991) |
| "(1) Continuous intravenous infusion (2-10 micrograms/kg/min) of nitroglycerin (TNG) was administered to 20 neonates consisting of 17 with refractory congestive heart failure and 3 with PFC (Persistent Fetal Circulation)." | 9.06 | Effects of intravenous nitroglycerin on hemodynamics in neonates with refractory congestive heart failure or PFC. ( Kawano, T; Tamura, M, 1990) |
| "We have reported early attenuation of hemodynamic effects of transdermal nitroglycerin in patients with heart failure." | 9.06 | Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. ( Casebolt, P; Franciosa, J; Hayes, MJ; Jordan, RA; Seth, L; Wilen, MM, 1986) |
| "One-hundred-and-ninety-two elderly patients with symptoms of congestive cardiac failure, despite therapy with diuretics and inotropic agents, received buccal nitroglycerin as additional medication." | 9.06 | Buccal nitroglycerin in congestive cardiac failure: a multicentre study. ( Goldberg, AA; Parsons, DG; Sanghera, SS, 1986) |
| "The hemodynamic effects of intermittent and continuous treatment with transdermal nitroglycerin, 10 mg/24 hours, were compared in 10 patients with chronic congestive heart failure (CHF)." | 9.06 | Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure. ( Coxon, R; Luke, R; Sharpe, N; Webster, M, 1987) |
| "In a double-blind crossover study, the haemodynamic effects of nitroglycerin discs were compared with placebo in 9 patients with severe chronic congestive heart failure." | 9.06 | Increase of cardiac output by afterload reduction in patients with severe congestive heart failure using nitroglycerin discs. A double-blind placebo-controlled haemodynamic study. ( Blake, P; Heikkilä, J; McAllister, A; Pellinen, TJ; Yardley, J, 1987) |
| "In an attempt to resolve some of the controversies concerning the dose requirements and duration of effects of transdermal nitroglycerin (NTG) in patients with heart failure (CHF), the short-term hemodynamic responses to transdermal NTG, in a 20 cm2 self-adhesive patch (10 mg/24 h), were evaluated in 10 patients with severe chronic CHF using a randomized, within-patient, double-blind, placebo-controlled cross-over trial." | 9.06 | Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure. ( Bolognese, L; Fornaro, G; Makmur, J; Perucca, A; Rognoni, G; Rossi, P; Sarasso, G, 1988) |
| "The efficacy of transdermal nitroglycerin was investigated in 18 patients with moderate to severe congestive heart failure in a placebo-controlled, double-blind, crossover study." | 9.06 | Efficacy and tolerability of transdermal nitroglycerin in heart failure. A noninvasive placebo controlled double-blind cross over study. ( Eriksson, SV; Lagerstrand, L; Lindvall, K; Sjögren, A, 1988) |
| "Vasodilators, such as nitroglycerin, have been widely used in the treatment of acute and chronic heart failure for therapeutic manipulation of the venous and arterial circulations to improve left ventricular function." | 9.05 | Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure. ( Crawley, JC; Lahiri, A; Raftery, EB; Sonecha, TN, 1984) |
| "Nitroglycerin ointment (NTGO) was applied to the precordial area in 88 patients with heart failure arising from acute myocardial infarction (AMI) or other types of heart disease, and its effects on hemodynamic parameters were determined." | 9.05 | Multicenter studies of 2% nitroglycerin ointment in patients with heart failure. ( Hirota, Y; Kagoshima, T; Kambara, H; Kawai, C; Nakano, T; Nobuyoshi, M; Saito, M; Tsuruha, Y, 1984) |
| "The haemodynamic effects of a 2% nitroglycerin ointment and of sublingual nitroglycerin in patients with left ventricular heart failure were investigated." | 9.05 | [Haemodynamic effects after application of nitroglycerin sublingually or as ointment in patients with left ventricular heart failure (author's transl)]. ( Bonelli, J; Gassner, A; Kleinberger, G; Lenzhofer, R; Magometschnigg, D; Pall, H; Pichler, M, 1980) |
| "The dose requirements and duration of effect of transdermal nitroglycerin in patients with heart failure are not clearly established." | 9.05 | Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure. ( Franciosa, JA; Henry, DA; Jordan, RA; Seith, L; Wilen, MM, 1985) |
| "7 consecutive patients with congestive heart failure refractory to standard therapy were treated with nitroglycerin ointment (GTNO)." | 9.04 | Use of nitroglycerin ointment in congestive heart failure. Results of acute and chronic therapy. ( Chandraratna, PA; Langevin, E; O'Dell, R; Rubenstein, C; San Pedro, S, 1978) |
| "PubMed, EMBASE, the Cochrane Library and China National Knowledge Infrastructure were searched for randomized studies that compared urapidil treatment with nitroglycerin treatment for hypertensive patients with acute heart failure." | 9.01 | Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis. ( Ding, H; Feng, S; Li, Y; Ning, G; Peng, P; Shi, H; Shi, J; Xing, C; Zheng, P, 2019) |
| "This study was the first to evaluate the therapeutic outcomes of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin (NIT) in patients with heart failure (HF)." | 8.93 | Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis. ( Wang, Z; Zhang, S, 2016) |
| "Intravenous nitroglycerin is a well-known, but underused, treatment for acute decompensated heart failure." | 8.91 | Impact of intravenous nitroglycerin in the management of acute decompensated heart failure. ( Brugts, JJ; den Uil, CA, 2015) |
| " In order to evaluate the relationship between the mode of action of nitrates at cellular level and their vasodilatory effectiveness, we studied the circulatory response of the forearm to isosorbide dinitrate and the influence of nitroglycerin on free calcium concentration in the platelets in 10 patients with chronic heart failure." | 8.78 | Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. ( Baldenkov, GN; Mazaev, AV; Mukharliamov, NM; Negrescu, EV; Sazonova, LN; Tkachuk, VA, 1990) |
| "Organic nitrates were the first peripherally-active vasodilators to be used for the treatment of heart failure." | 8.78 | [Nitrates in the treatment of heart failure]. ( Dirschinger, J; Hall, D; Rudolph, W, 1990) |
| "Nitroglycerin and its derivatives have become widely used agents in the treatment of severe forms of heart failure." | 8.77 | [Use of nitroglycerin in the treatment of congestive heart failure]. ( Curyło, AM, 1989) |
| "Nitroglycerin (NTG) is commonly used for the management of pulmonary edema in acute heart failure presentations." | 8.31 | Low- versus high-dose nitroglycerin infusion in the management of acute pulmonary edema. ( Branstetter, LA; Cooper, CD; Hanzelka, N; Kelly, GS; Moran, TP, 2023) |
| "We investigated if the phenotypic classification of acute heart failure (AHF) based on the number of signs/symptoms of congestion and hypoperfusion at emergency department (ED) arrival identifies subgroups in which intravenous (IV) nitroglycerine (NTG) use improves short-term survival." | 8.12 | Evaluation of the effect of intravenous nitroglycerine on short-term survival of patients with acute heart failure according to congestion and perfusion status at emergency department arrival. ( Alquézar-Arbé, A; Andueza, JA; Chioncel, O; Cotter, G; Espinosa, B; Garrido, JM; Gil, V; Jacob, J; Llauger, L; Llorens, P; Masip, J; Miró, Ò; Mojarro, EM; Mullens, W; Núñez, J; Tost, J; Urbano, CA, 2022) |
| "Although recommended for the treatment of acute heart failure (AHF), the use of intravenous (IV) nitroglycerin (NTG) is supported by scarce and contradicting evidence." | 8.02 | Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry. ( Alquézar-Arbé, A; Cotter, G; Davison, B; Freund, Y; Gil, V; Herrero-Puente, P; Jacob, J; Jiménez-Fábrega, FX; Llorens, P; Martín-Sánchez, FJ; Masip, J; Mebazaa, A; Miró, Ò; Rosselló, X; Takagi, K, 2021) |
| "Cardiac output (CO) change with sublingual nitroglycerin (NTG) could be helpful in the diagnosis of HF in patients with acute undifferentiated dyspnea." | 8.02 | Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea. ( Asma, Z; Bel Haj Ali, K; Beltaief, K; Ben Brahim, N; Ben Soltane, H; Boubaker, H; Bouida, W; Bzeouich, N; Gannoun, I; Grissa, MH; Jeddi, C; Laouiti, K; Lotfi, B; Mariem, K; Msolli, MA; Nouira, S; Riadh, B; Rym, Y; Sekma, A; Trabelssi, I; Zied, M; Zohra, D, 2021) |
| "The study describes the implementation of a prehospital treatment algorithm that included intravenous (IV) bolus (IVB) nitroglycerin (NTG) followed by maintenance infusion for the treatment of acute pulmonary edema (APE) in a single, high-volume Emergency Medical Services (EMS) system." | 7.96 | Prehospital Treatment of Acute Pulmonary Edema with Intravenous Bolus and Infusion Nitroglycerin. ( Cohen, MW; Conterato, M; Perlmutter, MC; Stratton, NS, 2020) |
| " These studies resulting in the discovery of once daily sGC stimulator vericiguat (compound 24, BAY 1021189), currently in phase 3 trials for chronic heart failure, are now reported." | 7.85 | Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure. ( Ackerstaff, J; Becker-Pelster, EM; Fey, P; Follmann, M; Geiss, V; Gerisch, M; Griebenow, N; Jautelat, R; Kern, A; Knorr, A; Kretschmer, A; Kroh, W; Lang, D; Li, V; Lustig, K; Mittendorf, J; Mondritzki, T; Redlich, G; Sandner, P; Schirok, H; Schlemmer, KH; Stasch, JP; Straub, A; Tinel, H; Trübel, H; Wunder, F, 2017) |
| "The purpose of this study was to compare health care resource utilization among patients who were given intravenous nitroglycerin for acute heart failure (AHF) in the emergency department (ED) by intermittent bolus, continuous infusion, or a combination of both." | 7.85 | Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure. ( Kwiatkowski, GM; Levy, PD; Mahajan, AP; Millis, SR; Purakal, JD; Wilson, SS, 2017) |
| " On day 11, hypertension was induced by continuous angiotensin II infusion." | 7.80 | M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics. ( Burnett, JC; Cataliotti, A; Chen, HH; Ichiki, T; McKie, PM; Sangaralingham, SJ, 2014) |
| "High-dose intravenous nitroglycerin is a common in-hospital treatment for respiratory distress due to congestive heart failure (CHF) with hypertension." | 7.79 | Prehospital high-dose sublingual nitroglycerin rarely causes hypotension. ( Clemency, BM; Lindstrom, HA; Thompson, JJ; Tundo, GN, 2013) |
| "A retrospective cohort study of patients hospitalized with acute congestive heart failure who received intravenous nesiritide or nitroglycerin for ≥6 hours." | 7.78 | Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure. ( Ackerbauer, KA; Elkayam, U; Hshieh, S; Hyderi, AF; Ng, TM, 2012) |
| "The aim of this study was to investigate whether the neuropeptide calcitonin gene related peptide (CGRP) contributes to nitroglycerin (GTN) response in patients with chronic heart failure (CHF) and the association with the mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys (ALDH2*2) polymorphism." | 7.78 | Influence of ALDH2 Glu504Lys polymorphism on nitroglycerin response in chronic heart failure and involvement of Calcitonin Gene Related Peptide (CGRP). ( Chen, XP; Guo, YJ; Li, CC; Li, L; Li, YJ; Mo, L; Peng, LM; Sun, J; Xie, W; Yang, TL, 2012) |
| "Nitroglycerin dose-dependently increases tissue perfusion in patients with severe heart failure, as observed by a decrease in central-peripheral temperature gradient and an increase in sublingual perfused capillary density." | 7.75 | Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure. ( Caliskan, K; den Uil, CA; Jewbali, LS; Lagrand, WK; Simoons, ML; Spronk, PE; van der Ent, M; van Kuijk, JP, 2009) |
| "Patients with chronic heart failure (CHF) often require higher doses of nitroglycerin (glyceryl trinitrate, GTN) than patients with normal cardiac function to achieve a given haemodynamic goal." | 7.74 | Impaired nitroglycerin biotransformation in patients with chronic heart failure. ( Adams, MA; Bennett, BM; Friberg, P; Petersson, M; Rundqvist, B, 2008) |
| "To examine changes in renal sympathetic outflow in response to cardiac unloading with nitroglycerin (GTN) in patients with chronic heart failure (CHF) and healthy subjects (HS)." | 7.73 | Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure. ( Friberg, P; Lambert, G; Petersson, M; Rundqvist, B, 2005) |
| "To investigate the plasma calcitonin gene-related peptide (CGRP) and endothelin (ET) levels and the effects of nitroglycerin on CGRP and ET in congestive heart failure (CHF), and to make clear the mechanism of nitroglycerin in vasodilation and cardiac protection." | 7.72 | [Effects of nitroglycerin on plasma calcitonin gene-related peptide and endothelin in congestive heart failure]. ( Lü, YZ; Ou, SQ; Yu, ZX, 2003) |
| "This study examined the effects of chronic bradykinin infusion on hemodynamics and myocardial and endothelial functions during the development of heart failure." | 7.72 | Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilation in conscious dogs. ( Badoual, T; Berdeaux, A; Champagne, S; Crozatier, B; Ghaleh, B; Hittinger, L; Le Corvoisier, P; Sambin, L; Su, JB; Tonduangu, D; Vincent, F, 2004) |
| "Dobutamine-based therapy is an attractive approach for the treatment of decompensated advanced heart failure, achieving comparable clinical efficacy to milrinone with a significantly reduced economic cost." | 7.71 | Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact. ( Albert, N; Haji, SA; Kelly, L; Knack, DL; Starling, RC; Yamani, MH; Young, JB, 2001) |
| "Cardiovascular effects of nicardipine hydrochloride (NIC, CAS 54527-84-3, Perdipine), a calcium channel blocker, were investigated in anesthetized normal dogs and dogs with acute heart failure (AHF), and compared with those of nitroglycerin (NTG)." | 7.70 | Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure. ( Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S, 1998) |
| "Comparative hemodynamic effects of nicorandil (NCR), nitroglycerin (NTG) and cromakalim (CRM) were examined in a canine model of acute congestive heart failure (CHF)." | 7.70 | Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim. ( Koyama, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M, 1998) |
| " Data were collected at baseline, after induction of heart failure (microsphere embolization into the left coronary artery), and then after toborinone boluses of 0." | 7.70 | Acute effects of toborinone on vascular capacitance and conductance in experimental heart failure. ( Belenkie, I; Semeniuk, LM; Tyberg, JV, 1998) |
| "In 29 patients with advanced heart failure, therapy tailored to hemodynamic goals was attempted using an initial infusion of dobutamine and nitroglycerin (the latter in those with pulmonary hypertension) followed by escalating doses of oral vasodilators." | 7.70 | Tailored therapy using dobutamine and nitroglycerin in advanced heart failure. ( Drazner, MH; Solomon, MA; Thompson, B; Yancy, CW, 1999) |
| "To understand the effect of intravenous nitroglycerin (NTG) on hemodynamics in infants and small children with congestive heart failure secondary to congenital cardiac defect of left to right shunt." | 7.70 | Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure. ( Du, J; Li, W; Sun, L; Zeng, H, 2000) |
| "A new experimental model of acute congestive heart failure was established in open-chest dogs, and it was employed to examine the effects of dobutamine, propranolol and nitroglycerin." | 7.69 | The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure. ( Kamijo, T; Kido, H; Miwa, AY; Nakamura, F; Sugimoto, T; Tomaru, T; Uchida, Y, 1994) |
| " We assessed the effect of acute heart failure and the subsequent administration of hydralazine, enalaprilat, and nitroglycerin on the splanchnic venous pressure-volume relation in intact dogs." | 7.69 | Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin. ( Manyari, DE; Scott-Douglas, N; Smiseth, OA; Smith, ER; Tyberg, JV; Wang, SY, 1995) |
| "It is shown in a prospective study that the initial beneficial hemodynamic effect of nitroglycerine (NTG) significantly decreased after continuous 3-day infusion of this drug (10-50 micrograms/min) in acute myocardial infarction (AMI) patients associated with acute left heart failure." | 7.69 | [A study of captopril enhancement of nitrate effect coronary arterial disease patients associated with heart failure]. ( Han, YL; Jing, QM; Tong, M, 1994) |
| "Since organic nitroesters and endothelium-derived nitric oxide mediate vasodilation through a final common pathway, that is, by activation of soluble guanylate cyclase in vascular smooth muscle, nitroglycerin (NTG) could specifically enhance the endothelium-dependent vasodilatory response to acetylcholine (Ach) in patients with congestive heart failure (CHF) and endothelial cell dysfunction." | 7.69 | Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure. ( Demopoulos, L; Hirsch, H; Jondeau, G; Katz, SD; LeJemtel, TH; Schwarz, M; Yuen, JL, 1994) |
| "Development of nitrate tolerance was observed during intravenous nitroglycerin treatment (10 mg/h) in 16 of 19 patients (7 women, 12 men; mean age 56 +/- 8 years) with coronary heart disease [stenosis > or = 75%, New York Heart Association (NYHA) classes II-III)." | 7.69 | Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin. ( Bodemann, T; Eichstädt, H; Gareis, R; Möckel, M; Müller, R; Störk, T, 1997) |
| "The acute haemodynamic and neurohumoral effects of flosequinan, a new direct-acting vasodilator, were studied in 12 patients with severe (eight in New York Heart Association grade 3, four in grade 4) cardiac failure." | 7.68 | Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy. ( Dakak, N; Halon, DA; Kahana, L; Lewis, BS; Makhoul, N; Merdler, A; Schneeweiss, A; Yechiely, H, 1993) |
| " In 13 out of 16 patients (5 women, 11 men, 62 [53/71] years [median, 25%/75%-percentiles]) with chronic heart failure (NYHA stage II-III; median angiographic ejection fraction (EF) 55%) and coronary artery disease (stenosis of at least 75%) the development of tolerance under the continuous infusion of high doses of nitroglycerin (10 mg/h) was observed." | 7.68 | [Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance]. ( Bodemann, T; Danne, O; Eichstädt, H; Hochrein, H; Möckel, M; Müller, R; Piske, G; Störk, S; Störk, T, 1993) |
| "The effect of sublingual and intravenous nitroglycerin (SLNTG and IVNTG) on left ventricular global and segmental systolic function was quantitatively assessed with two-dimensional echocardiography (2DE) in 28 cases of myocardial infarction (MI), including a group without heart failure of 13 and another group with heart failure of 15." | 7.68 | [Quantitative assessment of the effect of nitroglycerin on left ventricular function with two-dimensional echocardiography in patients with myocardial infarction]. ( Chen, ZJ; Xu, YS; Yang, YJ, 1993) |
| "The impact of intravenous infusion of nifedipine and nitroglycerin on invasive central hemodynamic parameters and microcirculation was compared in 94 patients with acute myocardial infarction complicated by heart failure." | 7.68 | [Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin]. ( Gruzdev, AK; Kosminskiĭ, PG; Lazarev, IA; Magnitskiĭ, AV; Sidorenko, BA; Vaniev, SB; Vasechkin, SS, 1992) |
| "Atrial natriuretic peptide (ANP) levels were measured in 17 patients with severe congestive heart failure (New York Heart Association functional class IV), and the response of the peptide was studied during changes in cardiac filling pressures induced by a 24-hour infusion of nitroglycerin." | 7.68 | Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy. ( Dakak, N; Flugelman, MY; Halon, DA; Kahana, L; Lewis, BS; Makhoul, N; Yechiely, H, 1992) |
| " In this study, we compared the effects of S-nitroso N-acetyl penicillamine (SNAP) and nitroglycerin (NTG) on left ventricular (LV) hemodynamics in congestive heart failure rats." | 7.68 | Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. ( Bauer, JA; Fung, HL, 1991) |
| "Organic nitrates such as nitroglycerin and isosorbide dinitrate are useful in the treatment of congestive heart failure (CHF), but tolerance develops rapidly during continuous administration." | 7.68 | Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure. ( Bauer, JA; Fung, HL, 1991) |
| "To better understand the mechanism of nitrate tolerance in patients with congestive heart failure, 13 patients received a 24 h infusion of nitroglycerin (1." | 7.68 | Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. ( Dupuis, J; Lalonde, G; Lemieux, R; Rouleau, JL, 1990) |
| "The load-reducing effect of nitroglycerin (NTG), a vasodilator, was studied in dogs with heart failure." | 7.68 | Experimental studies of the load reducing effects of nitroglycerin in heart failure. ( Ichikawa, S; Muto, M; Takahashi, M; Wakao, Y, 1990) |
| "To determine whether a 72-hour infusion of nitroglycerin produces hemodynamic improvement in patients with severe congestive heart failure and to assess the contributing role of various possible causes of hemodynamic tolerance to nitroglycerin, 19 patients received an infusion of nitroglycerin 1." | 7.68 | Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. ( Bichet, D; Dupuis, J; Lalonde, G; Lebeau, R; Rouleau, JL, 1990) |
| "The possible role of angiotensin-converting enzyme inhibition in preventing or minimizing tolerance to intravenous nitroglycerin in severe congestive heart failure (CHF) was studied by quantitating the degree of tolerance in 12 patients receiving nitroglycerin (group 1) and in 9 patients (group 2) receiving nitroglycerin and concurrent treatment with captopril (60 +/- 29 mg/day)." | 7.68 | Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. ( Dakak, N; Flugelman, MY; Halon, DA; Lewis, BS; Makhoul, N; Merdler, A; Schneeweiss, A; Shehadeh, H, 1990) |
| " The relaxant actions of nitroglycerin (previously considered to be an endothelium-independent relaxing agent) and acetylcholine (an endothelium-dependent relaxing agent) were compared on 4 vascular preparations (dorsal pedal artery, saphenous vein, left anterior descending coronary artery and circumflex coronary artery) from dogs with and without pacing-induced congestive heart failure (CHF)." | 7.68 | Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure. ( Armstrong, PW; Forster, C; Main, JS, 1990) |
| "The hemodynamic effects of a new transdermal preparation of nitroglycerin were evaluated in 9 patients with chronic congestive heart failure (CHF)." | 7.67 | Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin. ( Demma, FJ; Goldberg, LI; Rajfer, SI, 1984) |
| "The study of the cerebral and central hemodynamics by tetrapolar and chest rheography in 53 patients with various stages of chronic heart failure has shown that the intravenous injection of nitroglycerin exerts a marked vasodilating peripheral effect in patients with pronounced cardiac failure while having no significant influence on cardiac output." | 7.67 | [Effect of nitroglycerine on cerebral blood flow and central hemodynamics in patients with chronic heart failure]. ( Bobylev, VV; Galiautdinov, GS; Gusev, AT; Lebedeva, OI, 1984) |
| " Its acute haemodynamic effects were compared in a cross-over study with those of dobutamine, captopril, and glyceryl trinitrate (GTN) in eight adult patients with chronic heart failure." | 7.67 | Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate. ( Bayliss, J; Poole-Wilson, P; Thomas, L, 1987) |
| "To determine whether captopril alters peripheral venous tone in patients with congestive cardiac failure." | 7.67 | Acute and chronic arterial and venous effects of captopril in congestive cardiac failure. ( Capewell, S; Hannan, WJ; Muir, AL; Taverner, D, 1989) |
| "The effect of an acute and sustained reduction in atrial pressure on atrial natriuretic factor (ANF) and vasoactive hormone secretion was studied in 9 patients with congestive heart failure (CHF)." | 7.67 | Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy. ( Coxon, R; Espiner, EA; Hannan, S; Murphy, J; Nicholls, MG; Sharpe, DN; Webster, MW, 1989) |
| " To determine whether ANF reduces cardiac preload through venodilation in congestive heart failure (CHF), we compared the hemodynamic effects of ANF-(99-126) with those of the venodilator nitroglycerin in conscious rats with CHF induced by coronary artery ligation previously." | 7.67 | Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure. ( Chien, YW; Frohlich, ED; Trippodo, NC, 1989) |
| "To clarify the continuing controversy concerning the use of transdermal nitroglycerin (TDN), the shortterm hemodynamic responses to sublingual, oral and transcutaneous nitrates were evaluated and compared in 22 patients with severe chronic congestive heart failure." | 7.67 | Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure. ( Lee, WH; Medina, N; Packer, M; Yushak, M, 1986) |
| "Ten patients with chronic congestive heart failure were studied to assess the hemodynamic effects and bioavailability of a transdermal nitroglycerin delivery system." | 7.67 | Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure. ( Armstrong, PW, 1987) |
| "Nitroglycerin and nifedipine have been suggested as useful agents in the therapy of congestive heart failure." | 7.67 | A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure. ( Armstrong, PW; Lefkowitz, CA; Moe, GW, 1987) |
| "The effectiveness of nitroglycerin in the treatment of acute heart failure was investigated in 100 patients with myocardial infarction." | 7.67 | Use of nitroglycerin in the treatment of acute heart failure and cardiogenic shock in patients with myocardial infarction. ( Belskii, NE; Gilmar, IS; Pilipenko, VA; Roshchin, SI; Shira, AI, 1987) |
| "The immediate haemodynamic effects of prenalterol and nitroglycerine were examined in 15 patients, with severe chronic heart failure." | 7.67 | Prenalterol in severe congestive heart failure. I. The immediate haemodynamic effects as compared to nitroglycerine. ( Jespersen, C; Lyngborg, K; Rehling, M; Tangø, M; Trap-Jensen, J, 1988) |
| "The hemodynamic effects of isosorbide-5-mononitrate (IS-5-MN) and nitroglycerin were compared in 10 patients with chronic congestive heart failure (CHF)." | 7.67 | Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure. ( Schneeweiss, A, 1988) |
| "The resting and exertional haemodynamic effects of acute and chronic discontinuous (one tablet every 6 h) treatment with 5 mg of buccal nitroglycerin (BN) have been assessed in nine postinfarction heart failure patients." | 7.67 | Resting and exertional haemodynamic effects of buccal nitroglycerin: acute and chronic discontinuous treatment in post-myocardial infarction patients with heart failure. ( Cobelli, F; Febo, O; Lepore, AM; Luca, C; Opasich, C; Riccardi, G; Specchia, G; Tramarin, R, 1988) |
| "This study examined the effects of sublingually administered nitroglycerin on forearm resistance vessels in normal subjects (n = 9) and in patients with congestive heart failure (n = 8)." | 7.67 | The effects of sublingually administered nitroglycerin on forearm vascular resistance in patients with heart failure and in normal subjects. ( Ashihara, T; Imaizumi, T; Nakamura, M; Takeshita, A, 1985) |
| "The hemodynamic effect of a large dose of nitroglycerin (NTG) (90 mg) given transdermally using a reservoir system was studied in 10 patients with severe, long-standing congestive heart failure." | 7.67 | Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure. ( Elkayam, U; Henriquez, B; Rahimtoola, SH; Roth, A; Tonnemacher, D; Weber, L, 1985) |
| "To determine if the addition of preload reduction with nitrates would potentiate the acute vasodilator actions of nifedipine, we titered intravenous nitroglycerin in seven patients with severe congestive heart failure after they received a single oral dose of nifedipine." | 7.67 | Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. ( Cody, RJ; Fox, SC; Kubo, SH; Prida, XE, 1985) |
| "The hemodynamic and hormonal responses to nitroglycerin administered transdermally in a gel-like matrix were evaluated in nine patients with severe congestive heart failure and in nine normal subjects." | 7.66 | Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure. ( Carlyle, PF; Cohn, JN; Levine, TB; Olivari, MT, 1983) |
| "The use of nitroglycerin as a vasodilator in the treatment of congestive heart failure has demonstrated that the hemodynamic response is related to the degree of left ventricular dysfunction." | 7.66 | The altered baroreceptor response to nitroglycerin in congestive heart failure. ( Faxon, DP; Gross, S; Ryan, TJ; Tilney, C, 1980) |
| " Hemodynamic effects o high doses of oral isosorbide dinitrate in patients with chronic heart failure (N - 13)." | 7.66 | Hemodynamic effects of nitrates in chronic heart failure and myocardial infarction. ( Chatterjee, K, 1980) |
| "The combined and separate hemodynamic effects of dobutamine and IV nitroglycerin were compared in 12 patients with chronic congestive heart failure (nine with ischemic heart disease, two with idiopathic congestive cardiomyopathy, and one with valvular heart disease)." | 7.66 | Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure. ( Boucher, R; David, A; Fortin, L; Gagnon, RM; Gilbert, S; Lemire, J; Morrisette, M; Present, S, 1980) |
| "The radioactive microsphere technique was used to trace regional blood flow and total cardiac output distribution in rats in heart failure secondary to biventricular volume overload during acute intravenous infusion of nitroglycerin." | 7.66 | Mechanism of action of nitroglycerin during exercise in a rat model of heart failure. Improvement of blood flow to the renal, splanchnic, and cutaneous beds. ( Flaim, SF; Weitzel, RL; Zelis, R, 1981) |
| "In 21 patients with acute coronary artery disease the influence of cardiac failure on the elimination of lidocaine (L) was evaluated by repeated serum level measurements during and after a therapeutic L-infusion." | 7.66 | [Slower lidocaine elimination and dose adjustment in patients with heart failure]. ( Follath, F; Ritz, R; Vozeh, S; Wenk, M, 1982) |
| "The effect of nitroglycerin intravenously injected in 23 patients with heart failure (stage A and stage B), on the regional blood circulation (the chest, abdominal cavity, crus and finger) was studied by the method of impedansplethysmography." | 7.66 | [Regional circulatory changes in heart failure as affected by intravenous nitroglycerin administration]. ( Bitar, S; Elizarova, NA; Samiev, UB, 1982) |
| "The effects of intravenous nitroglycerin (NG; 2, 8, 32 micrograms/kg) on cardiocirculatory dynamics were evaluated in control normal (C) and chronically volume-overloaded [high-output heart failure (aortocaval fistula), HCO] conscious rats." | 7.66 | Peripheral vascular effects of nitroglycerin in a conscious rat model of heart failure. ( Flaim, SF, 1982) |
| "Intravenous trinitroglycerine was administered in 68 patients in cardiac failure during the acute phase of myocardial infarction." | 7.66 | [Intravenous trinitroglycerin during acute myocardial infarction with cardiac failure. Cooperative study of 68 patients (author's transl)]. ( Le Pailleur, C, 1979) |
| "In 15 patients with left ventricular failure, ten with recent myocardial infarction and five with old infarct a highly significant fall in pulmonary-artery pressure occurred within 3-5 minutes of sublingual administration of nitroglycerine, 0." | 7.65 | [Effect of nitroglycerine in acute myocardial infarction: I: Sublingual nitroglycerine in the treatment of left-heart failure and pulmonary oedema (author's transl)]. ( Bussmann, WD; Kaltenbach, M; Vachalowa, J, 1975) |
| "Nitroglycerin reduces ischemic injury during acute myocardial infarction (AMI) in dogs--an effect that is potentiated when drug-induced hypotension and tachycardia are prevented with phenylephrine." | 7.65 | Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction. ( Bianchi, C; Borer, JS; Cagin, N; Epstein, SE; Levitt, B; Redwood, DR; Vallin, H, 1975) |
| "Sixty-three patients with stable, severe typical angina pectoris (New York Heart Association functional class III or IV) were treated with propranolol and studied prospectively with a follow-up period of 5 to 8 years to assess the rate of complications and long-term effectiveness after an initial control period." | 7.65 | Long-term propranolol therapy for angina pectoris. ( Brewer, DL; Orgain, ES; Warren, SG, 1976) |
| "In the treatment of angina pectoris nitroglycerin is still the most important drug." | 7.65 | [Nitroglycerin in the therapy of coronary insufficiency and heart failure]. ( Bussmann, WD; Kaltenbach, M; Kober, G, 1976) |
| "The hemodynamic effects of nitroglycerin absorbed transcutaneously from an ointment base were determined in 10 patients with chronic congestive heart failure (9 with ischemic heart disease and 1 with cardiomyopathy)." | 7.65 | Hemodynamic effects of nitroglycerin ointment in congestive heart failure. ( Chatterjee, K; Forrester, JS; Magnusson, P; Swan, HJ; Takano, T; Taylor, WR, 1976) |
| "Urapidil is a therapeutic option for the multifactor heart failure patients complicated with hypertension and DM." | 6.80 | A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly. ( Chen, XM; Fu, Y; Guo, JC; Hua, Q; Qin, J; Qin, S; Yang, W; Zhou, YJ, 2015) |
| "Milrinone was also significantly more effective in decreasing systemic vascular resistance (P =." | 6.70 | A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure. ( Bristow, M; Cody, R; Colucci, WS; Elkayam, U; Jaski, B; Loh, E, 2001) |
| "Decompensated congestive heart failure (CHF) is the leading hospital discharge diagnosis in patients older than 65 years." | 6.70 | Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. ( , 2002) |
| "Eight patients with congestive heart failure and 10 age- and sex-matched healthy volunteers were studied." | 6.69 | Impaired vasodilatation response to amrinone in the forearm of patients with congestive heart failure: role of endothelium-derived nitric oxide. ( Hirano, Y; Inoue, SI; Ishibashi, Y; Murakami, Y; Nakamura, K; Ohata, S; Sakane, T; Shimada, T; Sugamori, T; Takahashi, N, 2000) |
| "Nineteen patients with congestive heart failure received nitroglycerin (1." | 6.67 | Captopril does not prevent nitroglycerin tolerance in heart failure. ( Bichet, D; Dupuis, J; Lalonde, G; Rouleau, JL, 1990) |
| "During exercise in subjects with congestive heart failure and mitral regurgitation the rise in systemic arterial pressure is usually accompanied by increase in systemic vascular resistance." | 6.67 | [Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency]. ( Korewicki, J; Madeja, G; Pogorzelska, H; Rajecka, A, 1990) |
| "5 to 50 mg) was administered in randomized fashion to three skin sites, arm, chest, or thigh, to compare the hemodynamic effects and bioavailability in nine patients with severe congestive heart failure." | 6.66 | Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure. ( Armstrong, PW; Moe, G, 1986) |
| "Nitrates have been used as vasodilators in AHFS for many years and have been shown to improve some aspects of AHFS in some small studies." | 6.49 | Nitrates for acute heart failure syndromes. ( Brooks, SC; Diercks, DB; Fermann, GJ; Kidney, R; McCabe, A; Pospisil, C; Salter, N; Seupaul, RA; Wakai, A, 2013) |
| "The emphasis on treating pulmonary edema has shifted from diuretics to vasodilators, especially high-dose nitrates, combined with non-invasive positive pressure ventilation." | 5.91 | Taming the Tiger: Ultra high dose nitroglycerin in managing sympathetic crashing acute pulmonary edema patient. ( Bhaskararayuni, J; Kumar, A; Nayer, J; Sahu, AK; Siddiqua, N, 2023) |
| "Sympathetic crashing acute pulmonary edema (SCAPE) describes the most severe presentation of acute heart failure (AHF)." | 5.62 | High-dose nitroglycerin infusion for the management of sympathetic crashing acute pulmonary edema (SCAPE): A case series. ( Bisanzo, M; Blohm, E; DeWitt, KM; Porter, BA; Sheeser, M; Stemple, K, 2021) |
| "Sympathetic crashing acute pulmonary edema (SCAPE) is a severe form of hypertensive acute heart failure with a dramatic presentation." | 5.62 | High-Dose Nitroglycerin Bolus for Sympathetic Crashing Acute Pulmonary Edema: A Prospective Observational Pilot Study. ( Aggarwal, P; Kumar, A; Mathew, R; Sahu, A; Wali, S, 2021) |
| "Sublingual nitroglycerin (SL NTG) is useful for treating acute decompensated heart failure, possibly by increasing splanchnic capacitance and reducing left ventricular (LV) preload." | 5.51 | Effect of nitroglycerin on splanchnic and pulmonary blood volume. ( Biaggioni, I; Dupont, WD; Kronenberg, MW; Okamoto, LE, 2022) |
| " Guidelines recommend short-acting nitrates, such as sublingual nitroglycerin, for the treatment of acute angina pectoris in patients with chronic coronary syndromes (CCSs), common comorbidities in HF." | 5.51 | Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study. ( Becker, C; Besche, N; Boettcher, M; Donath, F; Düngen, HD; Gurniak, M; Karakas, M; Koch, T; Mikus, G; Thuermann, PA; Werner, N, 2022) |
| "Hydralazine has been shown to prevent tolerance in experimental and clinical studies, all of which may be at least in part secondary to antioxidant properties of this compound." | 5.33 | Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. ( Bachschmid, M; Coldewey, M; Daiber, A; Huth, C; Kaiser, K; Mülsch, A; Münzel, T; Nazirisadeh, Y; Oelze, M; Schildknecht, S; Tsilimingas, N; Ullrich, V, 2005) |
| " The administration of iloprost after bypass (T3) at a dosage of 1." | 5.33 | Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery. ( Baysal, A; Bilsel, S; Bulbul, OG; Idiz, M; Kayacioglu, I; Yekeler, I, 2006) |
| " We used a previously developed pharmacokinetic-pharmacodynamic (PK/PD) model of NTG tolerance in experimental heart failure to test whether dosage regimens, designed from this model, may allow avoidance of tolerance development upon continuous NTG infusion." | 5.30 | Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure. ( Balthasar, JP; Bauer, JA; Fung, HL, 1997) |
| "Continuous nitroglycerin (NTG) administration causes pharmacologic tolerance in humans and animals, whereas intermittent dosing is capable of avoiding or reducing tolerance development." | 5.29 | Continuous versus intermittent nitroglycerin administration in experimental heart failure: vascular relaxation and radioligand binding to adrenoceptors and ion channels. ( Bauer, JA; Fung, HL; Gopalakrishnan, M; Kwon, YW; Triggle, DJ; Zheng, W, 1993) |
| " We have obtained pharmacodynamic data on NTG-induced hemodynamic tolerance in a rat model of congestive heart failure (CHF), which we have shown to mimic human behavior toward NTG in vivo." | 5.29 | Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure. ( Bauer, JA; Fung, HL, 1994) |
| "Nitroglycerin was given by intravenous infusion for 5-7 days." | 5.28 | [The effects of nitroglycerin on refractory congestive heart failure by intravenous infusion]. ( Ma, S, 1992) |
| "Nitroglycerin was detected in plasma 2 min after commencement of the infusion, the concentration rose to a peak of approximately 4 ng/ml at 30 min and was maintained throughout the balance of the infusion period." | 5.27 | Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. ( Armstrong, PW; Moffat, JA; Watts, DG, 1983) |
| "In four patients with severe anemia and cardiac failure, IV nitroglycerin permitted rapid and large-volume blood transfusion without compromising cardiac function." | 5.27 | Intravenous nitroglycerin in transfusion therapy for severe anemia. Association with congestive heart failure. ( Kwa, RP; Varriale, P; Vyas, P, 1984) |
| "Captopril is a mixed vasodilator and is effective from the first hour of administration." | 5.27 | [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine]. ( Baubion, N; Di Matteo, J; Heulin, A; Le Pailleur, C; Metzger, JP; Vacheron, A, 1984) |
| "Nine patients with congestive heart failure, New York Heart Association class II-III, were evaluated with right heart catheterization." | 5.27 | Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure. ( Keller, N; Larsen, J; Storm, T; Sykulski, R; Thamsborg, G, 1988) |
| "Nitroglycerin has long been a mainstay of the treatment of ischemic cardiac pain." | 5.27 | The role of transdermal nitroglycerin in the treatment of coronary heart disease. ( Taylor, SH, 1986) |
| " The long-term use of the peripheral vasodilator molsidomin effectively prevents heart failure in myocardial infarction survivors." | 5.27 | [Comparative efficacy of the long-term use of long-acting nitroglycerin (sustak) and molsidomine after myocardial infarct complicated by heart failure]. ( Dormidontov, EN; Petrov, DV, 1986) |
| " Taking into consideration that the range of the effective doses was very wide (15-150 micrograms/min), the authors believe that intravenous NTG infusion is indicated mainly in cases of manifest heart failure and should be administered under strict control of the dosage and with careful monitoring of the therapeutic effects." | 5.27 | Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure. ( Korewicki, J; Kraska, T; Opolski, G; Ostrzycki, A, 1985) |
| "Therefore, in 7 patients with congestive heart failure due to congestive cardiomyopathy, hemodynamic measurements were made using a Swan Ganz thermodilution catheter and cardiac output computer." | 5.26 | Enhancement of phentolamine by nitrates in patients with congestive heart failure. ( Gould, L; Reddy, CV; Singh, BK; Zen, B, 1981) |
| "In 6 patients with pulmonary edema, clinically an impressive improvement was observed within 5-15 min after administration of the drug." | 5.26 | Sublingual nitroglycerin in the treatment of left ventricular failure and pulmonary edema. ( Bussmann, WD; Kaltenbach, M, 1976) |
| "Vasodilators, such as nitroglycerin, have long been first-line treatments for acute heart failure syndromes (AHFS)." | 5.24 | Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial. ( Fujinaga, H; Fujisawa, K; Harada, K; Harada, T; Iima, T; Kageyama, N; Kawata, A; Okada, A; Okumura, T; Saito, A; Shigekiyo, M; Terada, N; Yamamoto, H; Yamamoto, T, 2017) |
| "Patients (>60 y) with hypertension and heart failure were randomly assigned to receive intravenous urapidil (n=89) or nitroglycerin (n=91) for 7 days." | 5.24 | Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial. ( Chen, XM; Fu, Y; Guo, JC; He, JY; Hua, Q; Li, J; Qin, J; Qin, S; Wang, Z; Yang, W; Zhan, H; Zhou, YJ, 2017) |
| "Rises in serum creatinine and efficacy have been reported as dose-related effects of nesiritide and nitroglycerin in acute decompensated heart failure (ADHF)." | 5.15 | Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure. ( Chew, E; Chow, SL; Heywood, JT; O'Barr, SA; Pak, F; Patel, P; Patterson, JH; Peng, J; Quist, R, 2011) |
| "The A-HeFT trial demonstrated incremental survival with hydralazine/isosorbide dinitrate combination in African-American patients with chronic heart failure (CHF)." | 5.14 | Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure. ( Chirkov, YY; De Sciscio, M; Horowitz, JD; Leslie, S; Sage, PR; Sverdlov, AL, 2010) |
| "Seventy-five patients admitted to our hospital with decompensated heart failure were randomised (1:2) to nitroglycerin (group I: n = 23) or carperitide infusion (group II: n = 52)." | 5.13 | Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. ( Fujii, M; Horie, M; Nishiyama, K; Sakai, H; Tanaka, T; Tsutamoto, T; Yamamoto, T, 2008) |
| "To compare the therapeutic effect of recombinant human brain natriuretic peptide (rhBNP) and nitroglycerin on acute decompensated heart failure (ADHF)." | 5.13 | [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin]. ( Chen, SM; Feng, XG; Li, P; Meng, SR; Wang, W; Xie, CL, 2008) |
| "To compare the efficacy and safety of intravenous infusion recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin (NIT) in treating patients with decompensated acute heart failure." | 5.12 | [Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study]. ( , 2006) |
| "We perform a feasibility and outcome assessment of the treatment of severe decompensated heart failure with high-dose nitroglycerin." | 5.12 | Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. ( Compton, S; Delgado, G; Dunne, R; Jennett, A; Levy, P; Penugonda, N; Welch, R; Zalenski, R, 2007) |
| "The results of this study showed an advantage of nesiritide compared with high-dose nitroglycerin in the treatment of patients with decompensated heart failure." | 5.11 | Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure. ( Akhter, MW; Elkayam, U; Khan, S; Singh, H; Usman, A, 2004) |
| "To compare the safety and efficacy of nesiritide versus intravenous nitroglycerin (NTG) in patients with acute coronary syndromes enrolled in the Vasodilation in the Management of Acute Congestive heart failure trial." | 5.11 | Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy. ( Emerman, CL; Peacock, WF; Young, J, 2004) |
| "Intermittent intravenous dobutamine therapy is used to treat patients with decompensated end-stage chronic heart failure (CHF), in whom the vascular endothelium is usually impaired." | 5.11 | Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure. ( Feinberg, MS; Freimark, D; Hochberg, N; Matezky, S; Shechter, M, 2004) |
| "Chronic heart failure (CHF) is associated with impaired endothelium-dependent vasodilation and increased basal vascular tone due, in part, to elevated endothelin-1 plasma levels." | 5.09 | Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure. ( Berger, R; Frey, B; Heher, S; Hülsmann, M; Neunteufl, T; Pacher, R; Stanek, B, 2001) |
| "We sought to determine the effect of aspirin on the venodilator effect of furosemide in patients with chronic heart failure (CHF) BACKGROUND: Furosemide has an acute venodilator effect preceding its diuretic action, which is blocked by nonsteroidal anti-inflammatory, drugs." | 5.09 | Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. ( Davie, AP; Jhund, PS; McMurray, JJ, 2001) |
| "This study was designed to determine the effect of oral hydralazine on the development of nitrate tolerance in patients with chronic congestive heart failure." | 5.08 | Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. ( Ajit-Uppal, J; Elkayam, U; Gogia, H; Johnson, JV; Mehra, A; Parikh, S; Raman, M, 1995) |
| " We examined the hemodynamic parameters as well as femoral arterial and venous cyclic guanosine monophosphate (cGMP) concentrations during intravenous infusion of NTG or nicorandil, a nitrate and potassium channel opener, in patients with congestive heart failure." | 5.08 | Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure. ( Fukai, D; Hisanaga, T; Kinoshita, M; Maeda, K; Maeda, Y; Tsutamoto, T; Wada, A; Yoshida, S, 1995) |
| " In order to test the immediate response of right ventricular hemodynamic parameters to nitroglycerin and dobutamine usually used to treat severe left ventricular dysfunction, we studied 17 congestive heart failure patients (15 men, two women; mean age 55 +/- 13 years) with end-stage idiopathic dilated cardiomyopathy (n = 10) or end-stage ischemic heart disease (n = 7), left ventricular ejection fraction < 35% (mean 22 +/- 8%), and sinus rhythm." | 5.08 | Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation. ( Berder, V; Cherrier, F; Danchin, N; Feldmann, L; Juillière, Y; Perrin, O, 1995) |
| "Nitrates dilate coronary arteries, ameliorate myocardial ischemia, minimize left ventricular remodeling, and reduce mortality in patients with acute myocardial infarction." | 5.08 | Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. ( Arai, M; Aso, N; Hama, J; Ishikawa, K; Kamata, N; Kanamasa, K; Katori, Y; Kimura, A; Naito, T; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yabushita, H; Yamamoto, K; Yamamoto, T, 1996) |
| "Twenty patients with congestive heart failure and pulmonary capillary wedge pressure (PCWP) > or = 18 mm Hg were randomly assigned to nitroglycerin or nicorandil in a double-blind, crossover study." | 5.08 | Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure. ( Aarsland, T; Dickstein, K; Gøransson, L; Larsen, AI; Tamby, JF, 1997) |
| "Twenty patients with congestive heart failure were randomized to receive intravenous infusion of nitroglycerin concomitantly with placebo (placebo group, n=10) or intravenous ascorbate (vitamin C group, n=10)." | 5.08 | Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure. ( Kakihana, M; Ohtsuka, S; Sugishita, Y; Watanabe, H, 1998) |
| "This study was designed to investigate the effect of angiotensin-converting enzyme (ACE) inhibitors with and without a sulfhydryl group on intracellular production of cGMP, forearm blood flow, and neurohormonal factors during continuous transdermal application of nitroglycerin in patients with chronic heart failure." | 5.08 | Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure. ( Kakihana, M; Ohtsuka, S; Sugishita, Y; Watanabe, H, 1998) |
| "This study was designed to evaluate the effect of carvedilol on nitrate tolerance in patients with chronic heart failure." | 5.08 | Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure. ( Kakihana, M; Ohtsuka, S; Sugishita, Y; Watanabe, H, 1998) |
| "To evaluate whether hemodynamic tolerance develops to nicorandil, a nitrate and potassium channel opener, 14 patients with chronic heart failure (CHF) were treated with nicorandil and 11 were treated with nitroglycerin (GTN)." | 5.07 | Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure. ( Horie, H; Kinoshita, M; Maeda, Y; Nakae, I; Tsutamoto, T; Wada, A; Yabe, T, 1994) |
| "We studied the hemodynamic response to intravenous nitroglycerin (NTG) in 40 patients with and without acute heart failure (hemodynamic subsets I-IV) during acute myocardial infarction." | 5.07 | Hemodynamic mechanisms of the effect of nitroglycerin in patients with acute myocardial infarction. ( Pavicić, L; Popadić, M; Popović, G; Rezaković, DE; Stalec, J, 1991) |
| "The magnitude and time course of the hemodynamic effect of a new formulation of an aqueous solution of isosorbide dinitrate (ISDN) spray were compared with those of sublingual nitroglycerin (NTG) tablets in 12 patients with chronic congestive heart failure." | 5.06 | Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets. ( Marmor, A, 1990) |
| "(1) Continuous intravenous infusion (2-10 micrograms/kg/min) of nitroglycerin (TNG) was administered to 20 neonates consisting of 17 with refractory congestive heart failure and 3 with PFC (Persistent Fetal Circulation)." | 5.06 | Effects of intravenous nitroglycerin on hemodynamics in neonates with refractory congestive heart failure or PFC. ( Kawano, T; Tamura, M, 1990) |
| "The haemodynamic effects of a transdermal nitroglycerin delivery system (NTG-TTS) were investigated in 67 patients with a recent myocardial infarction." | 5.06 | Haemodynamic dose-response effects of a transdermal nitrate delivery system in acute myocardial infarction with and without left heart failure. ( Hafizullah, M; Jackson, NC; Nelson, GI; Reynolds, GW; Silke, B; Taylor, SH; Verma, SP, 1988) |
| "We have reported early attenuation of hemodynamic effects of transdermal nitroglycerin in patients with heart failure." | 5.06 | Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. ( Casebolt, P; Franciosa, J; Hayes, MJ; Jordan, RA; Seth, L; Wilen, MM, 1986) |
| "One-hundred-and-ninety-two elderly patients with symptoms of congestive cardiac failure, despite therapy with diuretics and inotropic agents, received buccal nitroglycerin as additional medication." | 5.06 | Buccal nitroglycerin in congestive cardiac failure: a multicentre study. ( Goldberg, AA; Parsons, DG; Sanghera, SS, 1986) |
| "The hemodynamic effects of intermittent and continuous treatment with transdermal nitroglycerin, 10 mg/24 hours, were compared in 10 patients with chronic congestive heart failure (CHF)." | 5.06 | Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure. ( Coxon, R; Luke, R; Sharpe, N; Webster, M, 1987) |
| "In a double-blind crossover study, the haemodynamic effects of nitroglycerin discs were compared with placebo in 9 patients with severe chronic congestive heart failure." | 5.06 | Increase of cardiac output by afterload reduction in patients with severe congestive heart failure using nitroglycerin discs. A double-blind placebo-controlled haemodynamic study. ( Blake, P; Heikkilä, J; McAllister, A; Pellinen, TJ; Yardley, J, 1987) |
| "In an attempt to resolve some of the controversies concerning the dose requirements and duration of effects of transdermal nitroglycerin (NTG) in patients with heart failure (CHF), the short-term hemodynamic responses to transdermal NTG, in a 20 cm2 self-adhesive patch (10 mg/24 h), were evaluated in 10 patients with severe chronic CHF using a randomized, within-patient, double-blind, placebo-controlled cross-over trial." | 5.06 | Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure. ( Bolognese, L; Fornaro, G; Makmur, J; Perucca, A; Rognoni, G; Rossi, P; Sarasso, G, 1988) |
| "The efficacy of transdermal nitroglycerin was investigated in 18 patients with moderate to severe congestive heart failure in a placebo-controlled, double-blind, crossover study." | 5.06 | Efficacy and tolerability of transdermal nitroglycerin in heart failure. A noninvasive placebo controlled double-blind cross over study. ( Eriksson, SV; Lagerstrand, L; Lindvall, K; Sjögren, A, 1988) |
| "Patients with hypertensive acute heart failure (H-AHF) can decompensate rapidly and require immediate medical attention; the use of high-dose nitroglycerin is a topic of growing interest in this patient population." | 5.05 | Role of high-dose intravenous nitrates in hypertensive acute heart failure. ( Samai, K; Wang, K, 2020) |
| "Vasodilators, such as nitroglycerin, have been widely used in the treatment of acute and chronic heart failure for therapeutic manipulation of the venous and arterial circulations to improve left ventricular function." | 5.05 | Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure. ( Crawley, JC; Lahiri, A; Raftery, EB; Sonecha, TN, 1984) |
| "Nitroglycerin ointment (NTGO) was applied to the precordial area in 88 patients with heart failure arising from acute myocardial infarction (AMI) or other types of heart disease, and its effects on hemodynamic parameters were determined." | 5.05 | Multicenter studies of 2% nitroglycerin ointment in patients with heart failure. ( Hirota, Y; Kagoshima, T; Kambara, H; Kawai, C; Nakano, T; Nobuyoshi, M; Saito, M; Tsuruha, Y, 1984) |
| "The haemodynamic effects of a 2% nitroglycerin ointment and of sublingual nitroglycerin in patients with left ventricular heart failure were investigated." | 5.05 | [Haemodynamic effects after application of nitroglycerin sublingually or as ointment in patients with left ventricular heart failure (author's transl)]. ( Bonelli, J; Gassner, A; Kleinberger, G; Lenzhofer, R; Magometschnigg, D; Pall, H; Pichler, M, 1980) |
| "The dose requirements and duration of effect of transdermal nitroglycerin in patients with heart failure are not clearly established." | 5.05 | Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure. ( Franciosa, JA; Henry, DA; Jordan, RA; Seith, L; Wilen, MM, 1985) |
| "7 consecutive patients with congestive heart failure refractory to standard therapy were treated with nitroglycerin ointment (GTNO)." | 5.04 | Use of nitroglycerin ointment in congestive heart failure. Results of acute and chronic therapy. ( Chandraratna, PA; Langevin, E; O'Dell, R; Rubenstein, C; San Pedro, S, 1978) |
| "PubMed, EMBASE, the Cochrane Library and China National Knowledge Infrastructure were searched for randomized studies that compared urapidil treatment with nitroglycerin treatment for hypertensive patients with acute heart failure." | 5.01 | Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis. ( Ding, H; Feng, S; Li, Y; Ning, G; Peng, P; Shi, H; Shi, J; Xing, C; Zheng, P, 2019) |
| "This study was the first to evaluate the therapeutic outcomes of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin (NIT) in patients with heart failure (HF)." | 4.93 | Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis. ( Wang, Z; Zhang, S, 2016) |
| "Intravenous nitroglycerin is a well-known, but underused, treatment for acute decompensated heart failure." | 4.91 | Impact of intravenous nitroglycerin in the management of acute decompensated heart failure. ( Brugts, JJ; den Uil, CA, 2015) |
| "Organic nitrates still are one of the most important drug classes used in the treatment of an acute coronary syndrome and stable coronary artery disease as well as acute and chronic congestive heart failure." | 4.84 | [Recent findings on nitrates: their action, bioactivation and development of tolerance]. ( Münzel, T, 2008) |
| "Glyceryl trinitrate, isosorbide dinitrate, and isosorbide-5-mononitrate are organic nitrate esters commonly used in the treatment of angina pectoris, myocardial infarction, and congestive heart failure." | 4.79 | Mechanisms of action of nitrates. ( Ahlner, J; Torfgård, KE, 1994) |
| "There is now little dispute that clinical tolerance of organic nitrates occurs, particularly when these drugs are used by themselves to treat patients with stable angina pectoris and congestive heart failure." | 4.79 | Mechanisms of nitrate tolerance. ( Bauer, JA; Fung, HL, 1994) |
| " Acute pulmonary edema can be successfully treated with single or repeated doses of sublingual nitroglycerin." | 4.78 | Nitrate therapy in heart failure. ( Bussmann, WD; Hartmann, A; Kaltenbach, M; Schneider, W, 1991) |
| " In order to evaluate the relationship between the mode of action of nitrates at cellular level and their vasodilatory effectiveness, we studied the circulatory response of the forearm to isosorbide dinitrate and the influence of nitroglycerin on free calcium concentration in the platelets in 10 patients with chronic heart failure." | 4.78 | Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. ( Baldenkov, GN; Mazaev, AV; Mukharliamov, NM; Negrescu, EV; Sazonova, LN; Tkachuk, VA, 1990) |
| "Organic nitrates were the first peripherally-active vasodilators to be used for the treatment of heart failure." | 4.78 | [Nitrates in the treatment of heart failure]. ( Dirschinger, J; Hall, D; Rudolph, W, 1990) |
| "Nitroglycerin and its derivatives have become widely used agents in the treatment of severe forms of heart failure." | 4.77 | [Use of nitroglycerin in the treatment of congestive heart failure]. ( Curyło, AM, 1989) |
| "The role of transdermal nitroglycerin (TNTG) in the treatment of ischemic heart disease and congestive heart failure (CHF) is reviewed, with an emphasis on controversies concerning efficacy, hemodynamics, and dosing." | 4.77 | Controversies in the use of transdermal nitroglycerin systems. ( Klamerus, KJ; Zeller, FP, 1987) |
| "Nitroglycerin and other organic nitrates exert a number of favorable effects on the circulation of patients with severe congestive heart failure, and these effects mediate the short- and long-term hemodynamic and clinical improvement that follows treatment with these drugs." | 4.77 | Mechanisms of nitrate action in patients with severe left ventricular failure: conceptual problems with the theory of venosequestration. ( Packer, M, 1985) |
| "Nitroglycerin has been the mainstay of the medical management of angina pectoris for over 100 years." | 4.76 | The transdermal administration of nitrates: an overview. ( Demma, FJ; Wilson, RR, 1983) |
| " Nitrates are routinely used for the treatment of stable and unstable angina and also play a role in therapy for complications of myocardial infarction." | 4.76 | Nitrate delivery systems in perspective. A decade of progress. ( Abrams, J, 1984) |
| "The expanding applications of nitroglycerin and nitrate esters--in congestive heart failure, in the reduction of infarct size in myocardial infarction and in the long-term prophylaxis of angina--have enhanced the clinical importance of these drugs." | 4.75 | Nitroglycerin and nitrate esters. ( Francis, GS; Warren, SE, 1978) |
| "Cardiovascular diseases and their treatment in the aged are discussed under the headings of ischemic heart disease, hypertension, cardiac failure (with special reference to the use of diuretics and digoxin), infective carditis and thyroid disorders." | 4.75 | Drug therapy for cardiovascular disease in the aged. ( Kennedy, RD, 1975) |
| "Nitroglycerin (NTG) is commonly used for the management of pulmonary edema in acute heart failure presentations." | 4.31 | Low- versus high-dose nitroglycerin infusion in the management of acute pulmonary edema. ( Branstetter, LA; Cooper, CD; Hanzelka, N; Kelly, GS; Moran, TP, 2023) |
| "We investigated if the phenotypic classification of acute heart failure (AHF) based on the number of signs/symptoms of congestion and hypoperfusion at emergency department (ED) arrival identifies subgroups in which intravenous (IV) nitroglycerine (NTG) use improves short-term survival." | 4.12 | Evaluation of the effect of intravenous nitroglycerine on short-term survival of patients with acute heart failure according to congestion and perfusion status at emergency department arrival. ( Alquézar-Arbé, A; Andueza, JA; Chioncel, O; Cotter, G; Espinosa, B; Garrido, JM; Gil, V; Jacob, J; Llauger, L; Llorens, P; Masip, J; Miró, Ò; Mojarro, EM; Mullens, W; Núñez, J; Tost, J; Urbano, CA, 2022) |
| "Although recommended for the treatment of acute heart failure (AHF), the use of intravenous (IV) nitroglycerin (NTG) is supported by scarce and contradicting evidence." | 4.02 | Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry. ( Alquézar-Arbé, A; Cotter, G; Davison, B; Freund, Y; Gil, V; Herrero-Puente, P; Jacob, J; Jiménez-Fábrega, FX; Llorens, P; Martín-Sánchez, FJ; Masip, J; Mebazaa, A; Miró, Ò; Rosselló, X; Takagi, K, 2021) |
| "Cardiac output (CO) change with sublingual nitroglycerin (NTG) could be helpful in the diagnosis of HF in patients with acute undifferentiated dyspnea." | 4.02 | Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea. ( Asma, Z; Bel Haj Ali, K; Beltaief, K; Ben Brahim, N; Ben Soltane, H; Boubaker, H; Bouida, W; Bzeouich, N; Gannoun, I; Grissa, MH; Jeddi, C; Laouiti, K; Lotfi, B; Mariem, K; Msolli, MA; Nouira, S; Riadh, B; Rym, Y; Sekma, A; Trabelssi, I; Zied, M; Zohra, D, 2021) |
| "The study describes the implementation of a prehospital treatment algorithm that included intravenous (IV) bolus (IVB) nitroglycerin (NTG) followed by maintenance infusion for the treatment of acute pulmonary edema (APE) in a single, high-volume Emergency Medical Services (EMS) system." | 3.96 | Prehospital Treatment of Acute Pulmonary Edema with Intravenous Bolus and Infusion Nitroglycerin. ( Cohen, MW; Conterato, M; Perlmutter, MC; Stratton, NS, 2020) |
| " These studies resulting in the discovery of once daily sGC stimulator vericiguat (compound 24, BAY 1021189), currently in phase 3 trials for chronic heart failure, are now reported." | 3.85 | Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure. ( Ackerstaff, J; Becker-Pelster, EM; Fey, P; Follmann, M; Geiss, V; Gerisch, M; Griebenow, N; Jautelat, R; Kern, A; Knorr, A; Kretschmer, A; Kroh, W; Lang, D; Li, V; Lustig, K; Mittendorf, J; Mondritzki, T; Redlich, G; Sandner, P; Schirok, H; Schlemmer, KH; Stasch, JP; Straub, A; Tinel, H; Trübel, H; Wunder, F, 2017) |
| "The purpose of this study was to compare health care resource utilization among patients who were given intravenous nitroglycerin for acute heart failure (AHF) in the emergency department (ED) by intermittent bolus, continuous infusion, or a combination of both." | 3.85 | Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure. ( Kwiatkowski, GM; Levy, PD; Mahajan, AP; Millis, SR; Purakal, JD; Wilson, SS, 2017) |
| "There is little evidence on the prognostic influence of intravenous nitrates in patients with acute heart failure." | 3.81 | Influence of Intravenous Nitrate Treatment on Early Mortality Among Patients With Acute Heart Failure. NITRO-EAHFE Study. ( Herrero-Puente, P; Jacob, J; Llorens, P; Lucas-Imbernón, FJ; Martín-Sánchez, FJ; Martínez-Camblor, P; Martínez-Zapico, A; Miró, Ò; Vázquez-Álvarez, J, 2015) |
| " On day 11, hypertension was induced by continuous angiotensin II infusion." | 3.80 | M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics. ( Burnett, JC; Cataliotti, A; Chen, HH; Ichiki, T; McKie, PM; Sangaralingham, SJ, 2014) |
| "Nitroglycerin ointment is commonly used in the treatment of emergency department (ED) patients with suspected acute heart failure (AHF) or suspected acute coronary syndrome (ACS), but its hemodynamic effects in this population are not well described." | 3.80 | Hemodynamic effects of nitroglycerin ointment in emergency department patients. ( Dhingra, KR; Diercks, DB; Kurlinkus, C; Mumma, BE, 2014) |
| "High-dose intravenous nitroglycerin is a common in-hospital treatment for respiratory distress due to congestive heart failure (CHF) with hypertension." | 3.79 | Prehospital high-dose sublingual nitroglycerin rarely causes hypotension. ( Clemency, BM; Lindstrom, HA; Thompson, JJ; Tundo, GN, 2013) |
| "A retrospective cohort study of patients hospitalized with acute congestive heart failure who received intravenous nesiritide or nitroglycerin for ≥6 hours." | 3.78 | Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure. ( Ackerbauer, KA; Elkayam, U; Hshieh, S; Hyderi, AF; Ng, TM, 2012) |
| "The aim of this study was to investigate whether the neuropeptide calcitonin gene related peptide (CGRP) contributes to nitroglycerin (GTN) response in patients with chronic heart failure (CHF) and the association with the mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys (ALDH2*2) polymorphism." | 3.78 | Influence of ALDH2 Glu504Lys polymorphism on nitroglycerin response in chronic heart failure and involvement of Calcitonin Gene Related Peptide (CGRP). ( Chen, XP; Guo, YJ; Li, CC; Li, L; Li, YJ; Mo, L; Peng, LM; Sun, J; Xie, W; Yang, TL, 2012) |
| " Endothelium-dependent and -independent vasodilation (EDV and EIDV) was studied in the reactive hyperemia (RH) test and nitroglycerin (NTG) test." | 3.78 | [Vascular remodeling indicators and their impact on prognosis in patients with chronic heart failure]. ( Kosheleva, NA; Rebrov, AP, 2012) |
| "Nitroglycerin dose-dependently increases tissue perfusion in patients with severe heart failure, as observed by a decrease in central-peripheral temperature gradient and an increase in sublingual perfused capillary density." | 3.75 | Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure. ( Caliskan, K; den Uil, CA; Jewbali, LS; Lagrand, WK; Simoons, ML; Spronk, PE; van der Ent, M; van Kuijk, JP, 2009) |
| " Careful titration of dosage is required (beginning at 5 micrograms/min), and if the infusion sets contain polyvinylchloride, the delivered dose is lower than that calculated, because of adsorption of glyceryl trinitrate onto the plastic tubing." | 3.75 | Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy. ( Brogden, RN; Romankiewicz, JA; Sorkin, EM, 1984) |
| "Patients with chronic heart failure (CHF) often require higher doses of nitroglycerin (glyceryl trinitrate, GTN) than patients with normal cardiac function to achieve a given haemodynamic goal." | 3.74 | Impaired nitroglycerin biotransformation in patients with chronic heart failure. ( Adams, MA; Bennett, BM; Friberg, P; Petersson, M; Rundqvist, B, 2008) |
| "To examine changes in renal sympathetic outflow in response to cardiac unloading with nitroglycerin (GTN) in patients with chronic heart failure (CHF) and healthy subjects (HS)." | 3.73 | Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure. ( Friberg, P; Lambert, G; Petersson, M; Rundqvist, B, 2005) |
| "To investigate the plasma calcitonin gene-related peptide (CGRP) and endothelin (ET) levels and the effects of nitroglycerin on CGRP and ET in congestive heart failure (CHF), and to make clear the mechanism of nitroglycerin in vasodilation and cardiac protection." | 3.72 | [Effects of nitroglycerin on plasma calcitonin gene-related peptide and endothelin in congestive heart failure]. ( Lü, YZ; Ou, SQ; Yu, ZX, 2003) |
| "This study examined the effects of chronic bradykinin infusion on hemodynamics and myocardial and endothelial functions during the development of heart failure." | 3.72 | Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilation in conscious dogs. ( Badoual, T; Berdeaux, A; Champagne, S; Crozatier, B; Ghaleh, B; Hittinger, L; Le Corvoisier, P; Sambin, L; Su, JB; Tonduangu, D; Vincent, F, 2004) |
| "Dobutamine-based therapy is an attractive approach for the treatment of decompensated advanced heart failure, achieving comparable clinical efficacy to milrinone with a significantly reduced economic cost." | 3.71 | Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact. ( Albert, N; Haji, SA; Kelly, L; Knack, DL; Starling, RC; Yamani, MH; Young, JB, 2001) |
| "Cardiovascular effects of nicardipine hydrochloride (NIC, CAS 54527-84-3, Perdipine), a calcium channel blocker, were investigated in anesthetized normal dogs and dogs with acute heart failure (AHF), and compared with those of nitroglycerin (NTG)." | 3.70 | Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure. ( Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S, 1998) |
| "Comparative hemodynamic effects of nicorandil (NCR), nitroglycerin (NTG) and cromakalim (CRM) were examined in a canine model of acute congestive heart failure (CHF)." | 3.70 | Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim. ( Koyama, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M, 1998) |
| " Data were collected at baseline, after induction of heart failure (microsphere embolization into the left coronary artery), and then after toborinone boluses of 0." | 3.70 | Acute effects of toborinone on vascular capacitance and conductance in experimental heart failure. ( Belenkie, I; Semeniuk, LM; Tyberg, JV, 1998) |
| "In 29 patients with advanced heart failure, therapy tailored to hemodynamic goals was attempted using an initial infusion of dobutamine and nitroglycerin (the latter in those with pulmonary hypertension) followed by escalating doses of oral vasodilators." | 3.70 | Tailored therapy using dobutamine and nitroglycerin in advanced heart failure. ( Drazner, MH; Solomon, MA; Thompson, B; Yancy, CW, 1999) |
| "To understand the effect of intravenous nitroglycerin (NTG) on hemodynamics in infants and small children with congestive heart failure secondary to congenital cardiac defect of left to right shunt." | 3.70 | Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure. ( Du, J; Li, W; Sun, L; Zeng, H, 2000) |
| "A new experimental model of acute congestive heart failure was established in open-chest dogs, and it was employed to examine the effects of dobutamine, propranolol and nitroglycerin." | 3.69 | The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure. ( Kamijo, T; Kido, H; Miwa, AY; Nakamura, F; Sugimoto, T; Tomaru, T; Uchida, Y, 1994) |
| " We assessed the effect of acute heart failure and the subsequent administration of hydralazine, enalaprilat, and nitroglycerin on the splanchnic venous pressure-volume relation in intact dogs." | 3.69 | Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin. ( Manyari, DE; Scott-Douglas, N; Smiseth, OA; Smith, ER; Tyberg, JV; Wang, SY, 1995) |
| "It is shown in a prospective study that the initial beneficial hemodynamic effect of nitroglycerine (NTG) significantly decreased after continuous 3-day infusion of this drug (10-50 micrograms/min) in acute myocardial infarction (AMI) patients associated with acute left heart failure." | 3.69 | [A study of captopril enhancement of nitrate effect coronary arterial disease patients associated with heart failure]. ( Han, YL; Jing, QM; Tong, M, 1994) |
| "Twenty patients with heart failure underwent a continuous infusion of glyceryl trinitrate over 24 hours followed by administration of N-acetylcysteine (5 g intravenously) in a bolus." | 3.69 | Haemodynamic effects of glyceryl trinitrate during continuous 24 hour infusion in patients with heart failure. ( Campana, C; Diotallevi, P; Eleuteri, E; Ferrario, M; Ghio, S; Montemartini, C; Mussini, A; Poli, A; Specchia, G, 1994) |
| "The present study was performed to evaluate the effects of nitroglycerin (GTN) on plasma arteriovenous cGMP production and to compare its hemodynamic effects in patients with congestive heart failure (CHF)." | 3.69 | Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure. ( Adachi, T; Kinoshita, M; Maeda, Y; Ohbayashi, Y; Tsutamoto, T; Wada, A, 1994) |
| "Since organic nitroesters and endothelium-derived nitric oxide mediate vasodilation through a final common pathway, that is, by activation of soluble guanylate cyclase in vascular smooth muscle, nitroglycerin (NTG) could specifically enhance the endothelium-dependent vasodilatory response to acetylcholine (Ach) in patients with congestive heart failure (CHF) and endothelial cell dysfunction." | 3.69 | Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure. ( Demopoulos, L; Hirsch, H; Jondeau, G; Katz, SD; LeJemtel, TH; Schwarz, M; Yuen, JL, 1994) |
| "Three hundred prehospital patients who were given nitroglycerin by advanced life support personnel for presumed myocardial ischemia or congestive heart failure; excluded were those without repeat vital signs or ECG monitoring and those given additional medications." | 3.69 | Safety of prehospital nitroglycerin. ( Holliman, CJ; Meador, S; Roth, GS; Swope, G; Wuerz, R, 1994) |
| "Hydralazine has been shown to reduce mortality in patients with congestive heart failure when given concomitantly with isosorbide dinitrate." | 3.69 | Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. ( Berrington, WR; Freeman, BA; Harrison, DG; Kurz, S; Münzel, T; Rajagopalan, S; Thoenes, M; Thompson, JA, 1996) |
| "To characterize vasodilator capacity of small coronary arteries (200-350 microm diameter) in the setting of congestive heart failure, we examined relaxation responses to acetylcholine (10(-9)-10(-4) M) and nitroglycerin (10(-9)-10(-4) M), in the absence and presence of the nitric oxide precursor, L-arginine (10(-4) M)." | 3.69 | Altered vasodilator response of coronary microvasculature in pacing-induced congestive heart failure. ( Forster, C; Larosa, G, 1996) |
| "Development of nitrate tolerance was observed during intravenous nitroglycerin treatment (10 mg/h) in 16 of 19 patients (7 women, 12 men; mean age 56 +/- 8 years) with coronary heart disease [stenosis > or = 75%, New York Heart Association (NYHA) classes II-III)." | 3.69 | Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin. ( Bodemann, T; Eichstädt, H; Gareis, R; Möckel, M; Müller, R; Störk, T, 1997) |
| "The acute haemodynamic and neurohumoral effects of flosequinan, a new direct-acting vasodilator, were studied in 12 patients with severe (eight in New York Heart Association grade 3, four in grade 4) cardiac failure." | 3.68 | Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy. ( Dakak, N; Halon, DA; Kahana, L; Lewis, BS; Makhoul, N; Merdler, A; Schneeweiss, A; Yechiely, H, 1993) |
| " In 13 out of 16 patients (5 women, 11 men, 62 [53/71] years [median, 25%/75%-percentiles]) with chronic heart failure (NYHA stage II-III; median angiographic ejection fraction (EF) 55%) and coronary artery disease (stenosis of at least 75%) the development of tolerance under the continuous infusion of high doses of nitroglycerin (10 mg/h) was observed." | 3.68 | [Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance]. ( Bodemann, T; Danne, O; Eichstädt, H; Hochrein, H; Möckel, M; Müller, R; Piske, G; Störk, S; Störk, T, 1993) |
| "The effect of sublingual and intravenous nitroglycerin (SLNTG and IVNTG) on left ventricular global and segmental systolic function was quantitatively assessed with two-dimensional echocardiography (2DE) in 28 cases of myocardial infarction (MI), including a group without heart failure of 13 and another group with heart failure of 15." | 3.68 | [Quantitative assessment of the effect of nitroglycerin on left ventricular function with two-dimensional echocardiography in patients with myocardial infarction]. ( Chen, ZJ; Xu, YS; Yang, YJ, 1993) |
| "Left ventricular pressure-volume relations were recorded with micromanometer and conductance catheters during bolus injection of intravenous nitroglycerin in 27 patients with both normal left ventricular systolic function and varying degrees of congestive heart failure." | 3.68 | Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance. ( Bergin, JD; Feldman, MD; Gimple, LW; Haber, HL; Powers, ER; Sadun, A; Simek, CL, 1993) |
| "The impact of intravenous infusion of nifedipine and nitroglycerin on invasive central hemodynamic parameters and microcirculation was compared in 94 patients with acute myocardial infarction complicated by heart failure." | 3.68 | [Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin]. ( Gruzdev, AK; Kosminskiĭ, PG; Lazarev, IA; Magnitskiĭ, AV; Sidorenko, BA; Vaniev, SB; Vasechkin, SS, 1992) |
| "Atrial natriuretic peptide (ANP) levels were measured in 17 patients with severe congestive heart failure (New York Heart Association functional class IV), and the response of the peptide was studied during changes in cardiac filling pressures induced by a 24-hour infusion of nitroglycerin." | 3.68 | Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy. ( Dakak, N; Flugelman, MY; Halon, DA; Kahana, L; Lewis, BS; Makhoul, N; Yechiely, H, 1992) |
| "The efficacy of a controlled-release topical dosage form of glyceryl trinitrate (Nitroglycerin Transdermal Therapeutic System, Nitroderm TTS, NTG-TTS; CAS 55-63-0) was studied in the experimental model of congestive heart failure in beagles." | 3.68 | Efficacy of the glyceryl trinitrate transdermal therapeutic system in a dog model of heart failure. ( Inukai, T; Katahira, J; Nakao, K; Tanaka, M, 1991) |
| " In this study, we compared the effects of S-nitroso N-acetyl penicillamine (SNAP) and nitroglycerin (NTG) on left ventricular (LV) hemodynamics in congestive heart failure rats." | 3.68 | Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. ( Bauer, JA; Fung, HL, 1991) |
| "Organic nitrates such as nitroglycerin and isosorbide dinitrate are useful in the treatment of congestive heart failure (CHF), but tolerance develops rapidly during continuous administration." | 3.68 | Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure. ( Bauer, JA; Fung, HL, 1991) |
| "To better understand the mechanism of nitrate tolerance in patients with congestive heart failure, 13 patients received a 24 h infusion of nitroglycerin (1." | 3.68 | Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. ( Dupuis, J; Lalonde, G; Lemieux, R; Rouleau, JL, 1990) |
| "The load-reducing effect of nitroglycerin (NTG), a vasodilator, was studied in dogs with heart failure." | 3.68 | Experimental studies of the load reducing effects of nitroglycerin in heart failure. ( Ichikawa, S; Muto, M; Takahashi, M; Wakao, Y, 1990) |
| "The hemodynamic profile of tolerance to intravenous nitroglycerin was studied in 9 patients with New York Heart Association Class III to IV congestive heart failure." | 3.68 | Nitrate tolerance in heart failure: differential venous, pulmonary and systemic arterial effects. ( Dakak, N; Flugelman, MY; Halon, DA; Lewis, BS; Makhoul, N; Merdler, A; Schneeweiss, A; Shefer, A, 1990) |
| "To determine whether a 72-hour infusion of nitroglycerin produces hemodynamic improvement in patients with severe congestive heart failure and to assess the contributing role of various possible causes of hemodynamic tolerance to nitroglycerin, 19 patients received an infusion of nitroglycerin 1." | 3.68 | Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. ( Bichet, D; Dupuis, J; Lalonde, G; Lebeau, R; Rouleau, JL, 1990) |
| "The possible role of angiotensin-converting enzyme inhibition in preventing or minimizing tolerance to intravenous nitroglycerin in severe congestive heart failure (CHF) was studied by quantitating the degree of tolerance in 12 patients receiving nitroglycerin (group 1) and in 9 patients (group 2) receiving nitroglycerin and concurrent treatment with captopril (60 +/- 29 mg/day)." | 3.68 | Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. ( Dakak, N; Flugelman, MY; Halon, DA; Lewis, BS; Makhoul, N; Merdler, A; Schneeweiss, A; Shehadeh, H, 1990) |
| " The relaxant actions of nitroglycerin (previously considered to be an endothelium-independent relaxing agent) and acetylcholine (an endothelium-dependent relaxing agent) were compared on 4 vascular preparations (dorsal pedal artery, saphenous vein, left anterior descending coronary artery and circumflex coronary artery) from dogs with and without pacing-induced congestive heart failure (CHF)." | 3.68 | Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure. ( Armstrong, PW; Forster, C; Main, JS, 1990) |
| "Plasma levels of nitroglycerin were measured 13 to 24 hours after the application of nitroglycerin stamps in 7 children aged from 1 month to 7 years and suffering from heart failure." | 3.68 | [Transcutaneous transport of trinitrin in children after application of nitroglycerin patches]. ( Dupuis, C; Francart, C; Olive, G; Rey, E; Vaksmann, G, 1990) |
| " Univariate analysis of baseline clinical and electrocardiographic characteristics indicates that a history of congestive heart failure, cardiomegaly, angina pectoris, multiple myocardial infarctions and therapy with digitalis and nitroglycerin were more common in those who died than in survivors, regardless of the timing of death." | 3.67 | Timing, mechanism and clinical setting of witnessed deaths in postmyocardial infarction patients. ( Canner, P; Friedman, L; Goldstein, S; Hutchinson, R; Romhilt, D; Schlant, R; Sobrino, R; Verter, J; Wasserman, A, 1984) |
| "Hemodynamic effects of vasodilator agents (molsidomine, nitroglycerin, isosorbide dinitrate or prostaglandin I2) were studied in 53 patients with acute myocardial infarction." | 3.67 | Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction. ( Kodama, K; Koretsune, Y; Nanto, S; Taniura, K, 1984) |
| "It would appear that nitroglycerin, which has been the time-honored therapy for angina pectoris, has a much broader therapeutic scope." | 3.67 | Parenteral nitroglycerin: clinical usefulness and limitations. ( Flaherty, JT, 1984) |
| "The hemodynamic effects of a new transdermal preparation of nitroglycerin were evaluated in 9 patients with chronic congestive heart failure (CHF)." | 3.67 | Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin. ( Demma, FJ; Goldberg, LI; Rajfer, SI, 1984) |
| "Nitroglycerin, when administered to patients with heart failure, causes a marked reduction in left ventricular filling pressure but often an increase in stroke volume and stroke work; based on the Frank-Starling principle, such a reduction in "preload" would be expected to result in a decrease in left ventricular end-diastolic volume and, therefore, a decline in stroke volume." | 3.67 | Mechanism of action of nitrates. Role of changes in venous capacitance and in the left ventricular diastolic pressure-volume relation. ( Belenkie, I; Kingma, I; Manyari, D; Smiseth, OA; Smith, ER; Tyberg, JV, 1984) |
| "The study of the cerebral and central hemodynamics by tetrapolar and chest rheography in 53 patients with various stages of chronic heart failure has shown that the intravenous injection of nitroglycerin exerts a marked vasodilating peripheral effect in patients with pronounced cardiac failure while having no significant influence on cardiac output." | 3.67 | [Effect of nitroglycerine on cerebral blood flow and central hemodynamics in patients with chronic heart failure]. ( Bobylev, VV; Galiautdinov, GS; Gusev, AT; Lebedeva, OI, 1984) |
| " Its acute haemodynamic effects were compared in a cross-over study with those of dobutamine, captopril, and glyceryl trinitrate (GTN) in eight adult patients with chronic heart failure." | 3.67 | Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate. ( Bayliss, J; Poole-Wilson, P; Thomas, L, 1987) |
| ") isosorbide dinitrate (ISDN) and buccal and transdermal nitroglycerin (NTG)] were evaluated in 36 patients with acute left ventricular failure due to a recent myocardial infarction." | 3.67 | Nitrate therapy for left ventricular failure complicating acute myocardial infarction: a haemodynamic comparison of intravenous, buccal, and transdermal delivery systems. ( Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP, 1989) |
| "Cardiac performance and mitral regurgitation were measured by Doppler echocardiography and right heart catheterization in 12 patients with severe congestive heart failure who performed isometric exercise during control and intravenous administration of dobutamine and nitroglycerin." | 3.67 | Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. ( Katz, S; Keren, G; LeJemtel, TH; Sonnenblick, EH; Strom, J, 1989) |
| "To determine whether captopril alters peripheral venous tone in patients with congestive cardiac failure." | 3.67 | Acute and chronic arterial and venous effects of captopril in congestive cardiac failure. ( Capewell, S; Hannan, WJ; Muir, AL; Taverner, D, 1989) |
| " Haemodynamic responses to exercise, posture and nitrates were measured before and after 8 weeks of therapy with an arteriolar smooth muscle specific calcium antagonist, nicardipine, in eight patients with congestive heart failure (New York Heart Association class II or III)." | 3.67 | Changes in the haemodynamic responses to exercise, posture and nitrates after treatment of congestive heart failure with an arteriolar vasodilator. ( Culling, W; Dixon, MS; Sheridan, DJ; Thomas, P, 1989) |
| "Nirmin, a novel dosage form of nitroglycerin, was used to treat heart failure in 47 patients on days 1-3 after acute myocardial infarction." | 3.67 | [Effects of nirmin on central hemodynamics in patients with heart failure in the acute period of myocardial infarct]. ( Gorin, VV; Ioseliani, DG; Koval', AN; Liusov, VA; Slavutskiĭ, SIa; Volov, NA, 1989) |
| "The effect of an acute and sustained reduction in atrial pressure on atrial natriuretic factor (ANF) and vasoactive hormone secretion was studied in 9 patients with congestive heart failure (CHF)." | 3.67 | Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy. ( Coxon, R; Espiner, EA; Hannan, S; Murphy, J; Nicholls, MG; Sharpe, DN; Webster, MW, 1989) |
| " To determine whether ANF reduces cardiac preload through venodilation in congestive heart failure (CHF), we compared the hemodynamic effects of ANF-(99-126) with those of the venodilator nitroglycerin in conscious rats with CHF induced by coronary artery ligation previously." | 3.67 | Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure. ( Chien, YW; Frohlich, ED; Trippodo, NC, 1989) |
| "To clarify the continuing controversy concerning the use of transdermal nitroglycerin (TDN), the shortterm hemodynamic responses to sublingual, oral and transcutaneous nitrates were evaluated and compared in 22 patients with severe chronic congestive heart failure." | 3.67 | Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure. ( Lee, WH; Medina, N; Packer, M; Yushak, M, 1986) |
| "Seven patients with decompensated chronic heart failure and functional mitral regurgitation were studied before and during administration of nitroglycerin at a mean dose of 42 micrograms/min (range 20 to 90 micrograms/min)." | 3.67 | Dynamics of mitral regurgitation during nitroglycerin therapy: a Doppler echocardiographic study. ( Bier, A; Keren, G; Laniado, S; LeJemtel, TH; Sonnenblick, EH; Strom, JA, 1986) |
| "The haemodynamic effect of transdermal nitroglycerin treatment with Deponit 10 was investigated in 10 patients with chronic cardiac failure due to coronary artery disease (8 patients) or congestive cardiomyopathy (2 patients)." | 3.67 | [Hemodynamic effect and duration of action of Deponit 10 in patients with congestive heart insufficiency]. ( Kreuzer, H; Vogt, A, 1986) |
| "Ten patients with chronic congestive heart failure were studied to assess the hemodynamic effects and bioavailability of a transdermal nitroglycerin delivery system." | 3.67 | Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure. ( Armstrong, PW, 1987) |
| "Nitroglycerin and nifedipine have been suggested as useful agents in the therapy of congestive heart failure." | 3.67 | A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure. ( Armstrong, PW; Lefkowitz, CA; Moe, GW, 1987) |
| "Intravenous isosorbide dinitrate and nitroglycerin administered within early hours of myocardial infarction have a marked antianginal effect, stabilize the size of necrotic focus and promptly control acute left-ventricular insufficiency." | 3.67 | [Comparative evaluation of the efficacy of nitrosorbide and nitroglycerin in acute myocardial infarct patients]. ( Sal'nikov, SN; Vertkin, AL; Zharov, EI, 1987) |
| "The effectiveness of nitroglycerin in the treatment of acute heart failure was investigated in 100 patients with myocardial infarction." | 3.67 | Use of nitroglycerin in the treatment of acute heart failure and cardiogenic shock in patients with myocardial infarction. ( Belskii, NE; Gilmar, IS; Pilipenko, VA; Roshchin, SI; Shira, AI, 1987) |
| " To evaluate this relationship in chronic congestive heart failure (CHF), we studied eight patients with chronic CHF at baseline and during treatment with nitroglycerin." | 3.67 | Dependence of oxygen consumption on oxygen delivery in patients with chronic congestive heart failure. ( Amin, D; Jasper, AC; Koerner, SK; Mohsenifar, Z; Shah, PK, 1987) |
| "To evaluate possible mechanisms underlying the development of nitrate tolerance, we treated 35 patients who had severe chronic heart failure with a prolonged (48-hour) intravenous infusion of nitroglycerin (6." | 3.67 | Prevention and reversal of nitrate tolerance in patients with congestive heart failure. ( Gottlieb, SS; Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M, 1987) |
| "The immediate haemodynamic effects of prenalterol and nitroglycerine were examined in 15 patients, with severe chronic heart failure." | 3.67 | Prenalterol in severe congestive heart failure. I. The immediate haemodynamic effects as compared to nitroglycerine. ( Jespersen, C; Lyngborg, K; Rehling, M; Tangø, M; Trap-Jensen, J, 1988) |
| "The hemodynamic effects of isosorbide-5-mononitrate (IS-5-MN) and nitroglycerin were compared in 10 patients with chronic congestive heart failure (CHF)." | 3.67 | Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure. ( Schneeweiss, A, 1988) |
| "The resting and exertional haemodynamic effects of acute and chronic discontinuous (one tablet every 6 h) treatment with 5 mg of buccal nitroglycerin (BN) have been assessed in nine postinfarction heart failure patients." | 3.67 | Resting and exertional haemodynamic effects of buccal nitroglycerin: acute and chronic discontinuous treatment in post-myocardial infarction patients with heart failure. ( Cobelli, F; Febo, O; Lepore, AM; Luca, C; Opasich, C; Riccardi, G; Specchia, G; Tramarin, R, 1988) |
| "This study examined the effects of sublingually administered nitroglycerin on forearm resistance vessels in normal subjects (n = 9) and in patients with congestive heart failure (n = 8)." | 3.67 | The effects of sublingually administered nitroglycerin on forearm vascular resistance in patients with heart failure and in normal subjects. ( Ashihara, T; Imaizumi, T; Nakamura, M; Takeshita, A, 1985) |
| "The hemodynamic effect of a large dose of nitroglycerin (NTG) (90 mg) given transdermally using a reservoir system was studied in 10 patients with severe, long-standing congestive heart failure." | 3.67 | Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure. ( Elkayam, U; Henriquez, B; Rahimtoola, SH; Roth, A; Tonnemacher, D; Weber, L, 1985) |
| "To determine if the addition of preload reduction with nitrates would potentiate the acute vasodilator actions of nifedipine, we titered intravenous nitroglycerin in seven patients with severe congestive heart failure after they received a single oral dose of nifedipine." | 3.67 | Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. ( Cody, RJ; Fox, SC; Kubo, SH; Prida, XE, 1985) |
| "The effects of intravenous nitroglycerin (NTG), trimetaphan (TMP), and phentolamine (PTL) on pulmonary artery diastolic pressure (PADP), systemic arterial pressure (SAP), cardiac index (CI) and systemic vascular resistance (SVR) in patients (12 in each treated group) with chronic ischaemic heart failure are analyzed." | 3.67 | Vasodilator drugs in patients with chronic ischaemic heart failure. ( Korewicki, J; Kraska, T; Opolski, G; Ostrzycki, A, 1985) |
| " We examined the influence of nitroglycerin on the blood volume distribution in patients with coronary artery disease (n = 10) and chronic heart failure (n = 8)." | 3.66 | [Functional scintigraphic blood pool study. A radiologic technic for non-invasive study of pharmacologically induced blood volume fluctuations]. ( Felix, R; Loos, D; Schneider, R; Schörner, W, 1983) |
| "The hemodynamic effect of the skin nitroglycerin ointment was studied in 16 patients with coronary disease (12 with acute myocardial infarction, and 4 with nonstable angina pectoris)." | 3.66 | [Hemodynamic effect of skin applications of a nitroglycerin ointment in acute myocardial infarct]. ( Karpov, IuA; Noeva, EA, 1983) |
| "The hemodynamic and hormonal responses to nitroglycerin administered transdermally in a gel-like matrix were evaluated in nine patients with severe congestive heart failure and in nine normal subjects." | 3.66 | Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure. ( Carlyle, PF; Cohn, JN; Levine, TB; Olivari, MT, 1983) |
| "Using a method of in vivo labeling of erythrocytes and subsequent whole-body scanning, we investigated the effect of nitroglycerin (NTG) on regional blood pooling in patients with chronic left heart failure (six men and two women)." | 3.66 | Changes in regional body blood volume caused by nitroglycerin. ( Loos, D; Schneider, R; Schörner, W, 1983) |
| "The use of nitroglycerin as a vasodilator in the treatment of congestive heart failure has demonstrated that the hemodynamic response is related to the degree of left ventricular dysfunction." | 3.66 | The altered baroreceptor response to nitroglycerin in congestive heart failure. ( Faxon, DP; Gross, S; Ryan, TJ; Tilney, C, 1980) |
| " Hemodynamic effects o high doses of oral isosorbide dinitrate in patients with chronic heart failure (N - 13)." | 3.66 | Hemodynamic effects of nitrates in chronic heart failure and myocardial infarction. ( Chatterjee, K, 1980) |
| "The combined and separate hemodynamic effects of dobutamine and IV nitroglycerin were compared in 12 patients with chronic congestive heart failure (nine with ischemic heart disease, two with idiopathic congestive cardiomyopathy, and one with valvular heart disease)." | 3.66 | Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure. ( Boucher, R; David, A; Fortin, L; Gagnon, RM; Gilbert, S; Lemire, J; Morrisette, M; Present, S, 1980) |
| "Peripheral vasodilators nitroglycerin and sodium nitroprusside were given to 29 patients in the treatment of acute circulatory insufficiency (10 of these patients had pulmonary edema) which in most of them was caused by acute myocardial infarction." | 3.66 | [Use of vasodilator agents for treating acute cardiac insufficiency]. ( Gratsianskiĭ, NA; Karpov, IuA; Ruda, MIa, 1980) |
| "The haemodynamic effects of nitroglycerin (NG) ointment were studied in 13 patients, 6 with congestive cardiac failure." | 3.66 | [Hemodynamic effects of percutaneous trinitrin]. ( Besse, P; Gateau, P; Ledain, L; Page, A, 1981) |
| "The radioactive microsphere technique was used to trace regional blood flow and total cardiac output distribution in rats in heart failure secondary to biventricular volume overload during acute intravenous infusion of nitroglycerin." | 3.66 | Mechanism of action of nitroglycerin during exercise in a rat model of heart failure. Improvement of blood flow to the renal, splanchnic, and cutaneous beds. ( Flaim, SF; Weitzel, RL; Zelis, R, 1981) |
| "To treat the left ventricular insufficiency, complicating myocardial infarction, and to limit the area of the ischemic damage of myocardium the authors used nitroglycerin solution." | 3.66 | [Experience in using nitroglycerin in the acute period of myocardial infarct]. ( Giliarovskiĭ, AK; Lazutin, VK; Mikhaĭlov, AA; Simonov, VI; Zhelnov, VV, 1981) |
| "Sublingual nitroglycerin has been the time-honored therapy for angina pectoris for nearly a century." | 3.66 | Therapeutic scope of intravenous nitroglycerin. ( Flaherty, JT, 1982) |
| "In 21 patients with acute coronary artery disease the influence of cardiac failure on the elimination of lidocaine (L) was evaluated by repeated serum level measurements during and after a therapeutic L-infusion." | 3.66 | [Slower lidocaine elimination and dose adjustment in patients with heart failure]. ( Follath, F; Ritz, R; Vozeh, S; Wenk, M, 1982) |
| "The effect of nitroglycerin intravenously injected in 23 patients with heart failure (stage A and stage B), on the regional blood circulation (the chest, abdominal cavity, crus and finger) was studied by the method of impedansplethysmography." | 3.66 | [Regional circulatory changes in heart failure as affected by intravenous nitroglycerin administration]. ( Bitar, S; Elizarova, NA; Samiev, UB, 1982) |
| "The effects of intravenous nitroglycerin (NG; 2, 8, 32 micrograms/kg) on cardiocirculatory dynamics were evaluated in control normal (C) and chronically volume-overloaded [high-output heart failure (aortocaval fistula), HCO] conscious rats." | 3.66 | Peripheral vascular effects of nitroglycerin in a conscious rat model of heart failure. ( Flaim, SF, 1982) |
| "Ten patients with severe congestive heart failure after acute myocardial infarction were treated with 40 mg isosorbiddinitrate-retard every 4 hours and additional sublingual nitroglycerine." | 3.66 | [Peroral nitrate therapy in severe cardiac insufficiency following acute myocardial infarct]. ( Baitsch, G; Bertel, O; Burkart, F; Elsässer, S; Ritz, R, 1978) |
| "It has been shown that hydralazine is beneficial in chronic heart failure by virtue of its afterload reducing effect." | 3.66 | Non-parenteral combined afterload and preload reduction therapy in congestive heart failure. ( Conti, CR; Mehta, J; Pepine, CJ, 1978) |
| "Intravenous trinitroglycerine was administered in 68 patients in cardiac failure during the acute phase of myocardial infarction." | 3.66 | [Intravenous trinitroglycerin during acute myocardial infarction with cardiac failure. Cooperative study of 68 patients (author's transl)]. ( Le Pailleur, C, 1979) |
| "In 15 patients with left ventricular failure, ten with recent myocardial infarction and five with old infarct a highly significant fall in pulmonary-artery pressure occurred within 3-5 minutes of sublingual administration of nitroglycerine, 0." | 3.65 | [Effect of nitroglycerine in acute myocardial infarction: I: Sublingual nitroglycerine in the treatment of left-heart failure and pulmonary oedema (author's transl)]. ( Bussmann, WD; Kaltenbach, M; Vachalowa, J, 1975) |
| "Nitroglycerin reduces ischemic injury during acute myocardial infarction (AMI) in dogs--an effect that is potentiated when drug-induced hypotension and tachycardia are prevented with phenylephrine." | 3.65 | Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction. ( Bianchi, C; Borer, JS; Cagin, N; Epstein, SE; Levitt, B; Redwood, DR; Vallin, H, 1975) |
| "Sixty-three patients with stable, severe typical angina pectoris (New York Heart Association functional class III or IV) were treated with propranolol and studied prospectively with a follow-up period of 5 to 8 years to assess the rate of complications and long-term effectiveness after an initial control period." | 3.65 | Long-term propranolol therapy for angina pectoris. ( Brewer, DL; Orgain, ES; Warren, SG, 1976) |
| "In the treatment of angina pectoris nitroglycerin is still the most important drug." | 3.65 | [Nitroglycerin in the therapy of coronary insufficiency and heart failure]. ( Bussmann, WD; Kaltenbach, M; Kober, G, 1976) |
| "The hemodynamic effects of nitroglycerin absorbed transcutaneously from an ointment base were determined in 10 patients with chronic congestive heart failure (9 with ischemic heart disease and 1 with cardiomyopathy)." | 3.65 | Hemodynamic effects of nitroglycerin ointment in congestive heart failure. ( Chatterjee, K; Forrester, JS; Magnusson, P; Swan, HJ; Takano, T; Taylor, WR, 1976) |
| "A patient with severe, chronic congestive heart failure was unresponsive not only to conventional therapy, but also to nonparenteral nitroglycerin and isosorbide dinitrate; he became nitroprusside dependent." | 3.65 | Combination vasodilator therapy for severe chronic congestive heart failure. ( Chatterjee, K; Drew, D; Klausner, SC; Parmley, WW; Polansky, J; Zacherle, B, 1976) |
| "Twenty-one consecutive patients with CHF and CSR (apnea-hypopnea index [AHI] ≥15/h) underwent right heart catheterization with titration of intravenous (IV) glyceryltrinitrate (GTN) to a maximum tolerable dosage and inhalation of iloprost 10 μg/mL after a washout phase." | 2.82 | Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure-a randomized, controlled, double-blind, crossover trial. ( Bitter, T; Dimitriadis, Z; Fox, H; Horstkotte, D; Oldenburg, O; Schmalgemeier, H; Spiesshöfer, J; Wellmann, B; Zwenke, A, 2016) |
| "Urapidil is a therapeutic option for the multifactor heart failure patients complicated with hypertension and DM." | 2.80 | A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly. ( Chen, XM; Fu, Y; Guo, JC; Hua, Q; Qin, J; Qin, S; Yang, W; Zhou, YJ, 2015) |
| "This study was performed to investigate the risk of cardiac events by eccentric or continuous dosing of nitrates in patients with healed myocardial infarction." | 2.71 | Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction. ( Haku, R; Ishikawa, K; Kai, T; Kanamasa, K; Kitayama, K; Morii, H; Nagatani, Y; Naito, N; Nakano, K; Tanaka, Y; Yonekawa, O, 2004) |
| "Milrinone was also significantly more effective in decreasing systemic vascular resistance (P =." | 2.70 | A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure. ( Bristow, M; Cody, R; Colucci, WS; Elkayam, U; Jaski, B; Loh, E, 2001) |
| " The present study demonstrates that chronic administration of the ACE inhibitor perindopril increases the magnitude of the flow-dependent dilatation and restores the flow-dependent increase in compliance and distensibility of the radial artery evaluated at stable shear stress." | 2.70 | Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure. ( Bizet-Nafeh, C; Costentin, A; Cribier, A; Derumeaux, G; Iacob, M; Joannides, R; Thuillez, C, 2001) |
| "Decompensated congestive heart failure (CHF) is the leading hospital discharge diagnosis in patients older than 65 years." | 2.70 | Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. ( , 2002) |
| "Eight patients with congestive heart failure and 10 age- and sex-matched healthy volunteers were studied." | 2.69 | Impaired vasodilatation response to amrinone in the forearm of patients with congestive heart failure: role of endothelium-derived nitric oxide. ( Hirano, Y; Inoue, SI; Ishibashi, Y; Murakami, Y; Nakamura, K; Ohata, S; Sakane, T; Shimada, T; Sugamori, T; Takahashi, N, 2000) |
| " The data were obtained in a bioavailability study of two sprays of glyceryl trinitrate, which differed in their galenical characteristics and in the dose of GTN (0." | 2.67 | Comparison of the effects of two different galenical preparations of glyceryl trinitrate on pulmonary artery pressure and on the finger pulse curve. ( Bonn, R; Buschmann, M; Jähnchen, E; Rehe, A; Roskamm, H; Schnellbacher, K; Trenk, D; Wiegand, A, 1993) |
| "Fifteen congestive heart failure patients (NYHA: class III or IV) were enrolled in the study and were classified into two groups." | 2.67 | Hemodynamic comparison of combined therapy by nitroglycerin tape and ibopamine with combination of nitroglycerin tape and nifedipine. ( Itoh, H; Taniguchi, K; Tsujibayashi, T, 1990) |
| "Nineteen patients with congestive heart failure received nitroglycerin (1." | 2.67 | Captopril does not prevent nitroglycerin tolerance in heart failure. ( Bichet, D; Dupuis, J; Lalonde, G; Rouleau, JL, 1990) |
| "During exercise in subjects with congestive heart failure and mitral regurgitation the rise in systemic arterial pressure is usually accompanied by increase in systemic vascular resistance." | 2.67 | [Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency]. ( Korewicki, J; Madeja, G; Pogorzelska, H; Rajecka, A, 1990) |
| " In own long-term studies on 34 patients with coronary heart disease with clinical and haemodynamic evidence (pathologic increase of the end-diastolic pressure of the pulmonary arteries under ergometric load) of an exercise-induced heart insufficiency the efficacy of pentaerythril tetranitrate (PETN) and isosorbide dinitrate (ISDN) in chronic dosage titration use was tested." | 2.67 | [Long-term nitrate therapy in coronary heart disease--loss of effect by developing tolerance]. ( Dück, KD; Richard, F, 1990) |
| "5 to 50 mg) was administered in randomized fashion to three skin sites, arm, chest, or thigh, to compare the hemodynamic effects and bioavailability in nine patients with severe congestive heart failure." | 2.66 | Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure. ( Armstrong, PW; Moe, G, 1986) |
| "BACKGROUND Pulmonary edema is the accumulation of fluid in the lung secondary to increased hydrostatic pressure." | 2.61 | Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature. ( Castillo LaTorre, C; Cintrón Martínez, HR; Fonseca Ferrer, V; González Monroig, HA; López-Rivera, F; Méndez Meléndez, OF; Rivera González, A; Rodríguez Vélez, JG; Vázquez Vargas, EJ, 2019) |
| " However, it increased the risk of cardiovascular adverse events." | 2.53 | Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials. ( Gong, B; Li, Z; Wu, Z, 2016) |
| " New insight has been gained regarding volume management, including dosing strategies for intravenous loop diuretics and the role of ultrafiltration in patients with heart failure and renal dysfunction." | 2.49 | Acute decompensated heart failure: update on new and emerging evidence and directions for future research. ( Albert, NM; Butler, J; Carson, PE; Collins, SP; Colvin-Adams, M; Dimarco, JP; Ezekowitz, JA; Fang, JC; Givertz, MM; Hernandez, AF; Hershberger, RE; Katz, SD; Krishnamani, R; Rogers, JG; Spertus, JA; Starling, RC; Stevenson, WG; Stough, WG; Sweitzer, NK; Tang, WH; Teerlink, JR; Walsh, MN; Westlake Canary, CA, 2013) |
| "Nitrates have been used as vasodilators in AHFS for many years and have been shown to improve some aspects of AHFS in some small studies." | 2.49 | Nitrates for acute heart failure syndromes. ( Brooks, SC; Diercks, DB; Fermann, GJ; Kidney, R; McCabe, A; Pospisil, C; Salter, N; Seupaul, RA; Wakai, A, 2013) |
| " The clinical experience including indications for use, contraindications, dosage and monitoring has been reviewed." | 2.44 | Nesiritide: the clinical experience. ( Weeks, SG, 2008) |
| "Heart failure is a disease of epidemic proportions." | 2.43 | Critical review and recommendations for nesiritide use in the emergency department. ( Collins, SP; Hinckley, WR; Storrow, AB, 2005) |
| "The prevalence of congestive heart failure (CHF) is increasing in the US and worldwide, partly because patients are living longer." | 2.42 | Intravenous vasodilator therapy in congestive heart failure. ( Chana, JS; Kocheril, AG; Moazemi, K; Willard, AM, 2003) |
| "Cardiac failure is the principal medium-term complication of myocardial infarction." | 2.38 | [Ventricular "remodeling" after myocardial infarction]. ( Cohen-Solal, A; Gourgon, R; Guéret, P; Himbert, D, 1991) |
| " New nitrate delivery systems have recently become available which provide considerable dosing flexibility, further increasing the interest in this group of compounds." | 2.37 | Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration. ( Abrams, J, 1987) |
| " Finally, appropriate dosing strategies are suggested that should eliminate the potential problem of nitrate tolerance." | 2.37 | Nitrates. ( Abrams, J, 1988) |
| " The overall hemodynamic response to nitrate administration will be modulated by the degree of sympathetic reflex discharge, the presence or absence of congestive heart failure, the dosage of administered nitrate, and the presence or absence of nitrate tolerance." | 2.37 | Hemodynamic effects of nitroglycerin and long-acting nitrates. ( Abrams, J, 1985) |
| ", shorter duration of action, loss of intensity of effect) with long-term dosing in this clinical setting." | 2.37 | Nitrate tolerance. ( Leier, CV, 1985) |
| " It is appropriate that the patient's dosage of nitrates be administered with a formulation most likely to be both clinically effective and well tolerated." | 2.37 | Pharmacology of nitroglycerin and long-acting nitrates. ( Abrams, J, 1985) |
| "Whether the pulmonary edema is cardiogenic or noncardiogenic, optimal management is facilitated by the improvement of ventilation and gas exchange within the lungs and the restoration of oxygen transport to peripheral tissues." | 2.36 | Acute alveolar edema. ( Nowakowski, JF, 1983) |
| "The emphasis on treating pulmonary edema has shifted from diuretics to vasodilators, especially high-dose nitrates, combined with non-invasive positive pressure ventilation." | 1.91 | Taming the Tiger: Ultra high dose nitroglycerin in managing sympathetic crashing acute pulmonary edema patient. ( Bhaskararayuni, J; Kumar, A; Nayer, J; Sahu, AK; Siddiqua, N, 2023) |
| "Sympathetic crashing acute pulmonary edema (SCAPE) describes the most severe presentation of acute heart failure (AHF)." | 1.62 | High-dose nitroglycerin infusion for the management of sympathetic crashing acute pulmonary edema (SCAPE): A case series. ( Bisanzo, M; Blohm, E; DeWitt, KM; Porter, BA; Sheeser, M; Stemple, K, 2021) |
| "Sympathetic crashing acute pulmonary edema (SCAPE) is a severe form of hypertensive acute heart failure with a dramatic presentation." | 1.62 | High-Dose Nitroglycerin Bolus for Sympathetic Crashing Acute Pulmonary Edema: A Prospective Observational Pilot Study. ( Aggarwal, P; Kumar, A; Mathew, R; Sahu, A; Wali, S, 2021) |
| "74%, respectively) and rales (56% vs." | 1.48 | Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. ( Ambrosy, AP; Armstrong, PW; Butler, J; Cerbin, LP; Coles, A; DeVore, AD; Ezekowitz, JA; Greene, SJ; Hernandez, AF; Mentz, RJ; Metra, M; O'Connor, CM; Starling, RC; Tang, W; Teerlink, JR; Voors, AA; Wu, A, 2018) |
| "Donation after circulatory death (DCD) offers a potential additional source of cardiac allografts." | 1.40 | Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning. ( Dhital, KK; Doyle, A; Feneley, MP; Gao, L; Graham, RM; Harvey, RP; Hicks, M; Iyer, A; Jabbour, A; Jansz, PC; Jayewardene, D; Kumarasinghe, G; Macdonald, PS; Rao, P; Wan, B, 2014) |
| "Coronary spasm has been described in the context of carcinoid heart disease, but few information are available over perioperative coronary spasm." | 1.39 | Early diffuse coronary artery spasm after heart valve surgery in the carcinoid syndrome. ( Anselmi, A; Boulmier, D; Corbineau, H; Ruggieri, VG, 2013) |
| "Acute myocardial infarction is a rare complication of dobutamine stress echocardiography." | 1.39 | [Acute myocardial infarction complicated by acute pulmonary oedema and cardiogenic collapse during dobutamine stress echocardiography]. ( Diack, B; Diagne-Sow, D; Dioum, M; Kagambega, LJ; Kane, A; Kane, M; Mbaye, A; Yameogo, NV, 2013) |
| "Microvascular coronary dysfunction (MCD) in women with no obstructive CAD portends an adverse prognosis of a 2." | 1.38 | Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. ( Anderson, RD; Azarbal, B; Handberg, E; Johnson, BD; Kar, S; Kelsey, SF; Kothawade, K; Lerman, A; Mehta, PK; Merz, CN; Pepine, CJ; Petersen, J; Samuels, B; Sharaf, B; Shaw, L; Shufelt, C; Sopko, G; Wei, J, 2012) |
| "Rural management of acute cardiogenic pulmonary edema should be based on avoidance of adverse outcomes such as in-hospital mortality, the need for intensive care unit care, and the need for intubation and mechanical ventilation." | 1.35 | Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure. ( Bosomworth, J, 2008) |
| "Chronic left-heart failure is often associated with the development of pulmonary venous hypertension." | 1.34 | Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. ( Braun, S; Schmeisser, A; Schrötter, H; Strasser, RH, 2007) |
| "Heart failure was induced by right ventricular pacing at 240 beats/min for 3-4 wk, and cardiac recovery (CR) was allowed by the termination of cardiac pacing for 3-4 wk after the development of CHF, in which left ventricular contractile function was restored by 80-90%." | 1.34 | Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling. ( Braz, JC; Etgen, GJ; Gill, RM; Jin, N; Shen, W, 2007) |
| "Hydralazine has been shown to prevent tolerance in experimental and clinical studies, all of which may be at least in part secondary to antioxidant properties of this compound." | 1.33 | Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. ( Bachschmid, M; Coldewey, M; Daiber, A; Huth, C; Kaiser, K; Mülsch, A; Münzel, T; Nazirisadeh, Y; Oelze, M; Schildknecht, S; Tsilimingas, N; Ullrich, V, 2005) |
| " The administration of iloprost after bypass (T3) at a dosage of 1." | 1.33 | Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery. ( Baysal, A; Bilsel, S; Bulbul, OG; Idiz, M; Kayacioglu, I; Yekeler, I, 2006) |
| "To date, its therapeutic actions in congestive heart failure (CHF) remain undefined." | 1.32 | Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure. ( Boerrigter, G; Burnett, JC; Cataliotti, A; Costello-Boerrigter, LC; Harty, GJ; Lapp, H; Stasch, JP; Tsuruda, T, 2003) |
| "The subjects were receiving treatment for myocardial infarction and included 293 patients treated with nitrates (Nitrate group) and 313 patients who were not (No-nitrate group)." | 1.31 | Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events. ( Hayashi, T; Ishikawa, K; Kanamasa, K; Kimura, A; Kitayama, K; Miyataka, M; Takenaka, T; Yabushita, H; Yamamoto, T, 2000) |
| " We used a previously developed pharmacokinetic-pharmacodynamic (PK/PD) model of NTG tolerance in experimental heart failure to test whether dosage regimens, designed from this model, may allow avoidance of tolerance development upon continuous NTG infusion." | 1.30 | Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure. ( Balthasar, JP; Bauer, JA; Fung, HL, 1997) |
| "Acute pulmonary edema (APE) is a common Emergency Department (ED) presentation requiring admission to an intensive care unit (ICU)." | 1.30 | Effect of ED management on ICU use in acute pulmonary edema. ( McDermott, P; Moakes, ME; Moyer, V; Ramoska, E; Sacchetti, A, 1999) |
| "Continuous nitroglycerin (NTG) administration causes pharmacologic tolerance in humans and animals, whereas intermittent dosing is capable of avoiding or reducing tolerance development." | 1.29 | Continuous versus intermittent nitroglycerin administration in experimental heart failure: vascular relaxation and radioligand binding to adrenoceptors and ion channels. ( Bauer, JA; Fung, HL; Gopalakrishnan, M; Kwon, YW; Triggle, DJ; Zheng, W, 1993) |
| " A combination of slow-release nitroglycerin (Nitro-Mack retard) as venodilator in the dosage of 20 mg/day and Dihydralazin SPOFA as arteriodilator in dosage of 100-200 mg/day under continuing cardiotonic and diuretic treatment were used." | 1.29 | Long-term vasodilator therapy for heart failure: noninvasive evaluation and noninvasive predictors of survival. ( Riecansky, I, 1995) |
| " We have obtained pharmacodynamic data on NTG-induced hemodynamic tolerance in a rat model of congestive heart failure (CHF), which we have shown to mimic human behavior toward NTG in vivo." | 1.29 | Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure. ( Bauer, JA; Fung, HL, 1994) |
| " NITRO-MACK retard (venodilator) in the dosage of 20 mg per day and DIHYDRALAZIN (arteriodilator) in the dosage of 100-200 mg per day were combined simultaneously with continuous administration of cardiotonics and diuretics." | 1.29 | [Non-invasive assessment of the efficacy of long-term vasodilator therapy of cardiac decompensation in patients with dilated cardiomyopathy]. ( Bzdúchová, O; Havlínová, K; Plachá, L; Riecanský, I; Schreinerová, Z; Zelenay, J, 1993) |
| "Ten patients with low cardiac output syndrome (LCOS, cardiac index [CI] = 1." | 1.29 | [Enoximone in the postoperative phase of heart surgery]. ( Hachenberg, T, 1994) |
| "Thirty-one patients with congestive heart failure (New York Heart Association functional class II-III) and five age-matched normal subjects were studied." | 1.29 | Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. ( Katz, SD; LeJemtel, TH; Schwarz, M; Yuen, J, 1993) |
| " The beneficial nitrate effect can be preserved by appropriate dosing which provides a period of many hours of nitrate washout during each 24 h period." | 1.29 | Nitrate tolerance--problems both new and old. ( Parker, JO, 1996) |
| "Thirty-nine patients with congestive heart failure (ejection fraction = 28 +/- 2%) were compared to age- and sex-matched healthy controls." | 1.29 | Investigations of the peripheral vascular mechanisms implicated in congestive heart failure by the non-invasive evaluation of radial artery compliance and reactivity. ( Aliot, E; Boscs, LB; el Ghawi, R; Khder, Y; Zannad, F, 1996) |
| "Nitroglycerin was given by intravenous infusion for 5-7 days." | 1.28 | [The effects of nitroglycerin on refractory congestive heart failure by intravenous infusion]. ( Ma, S, 1992) |
| "Nitroglycerin, 10(-5) M, was administered to 10 patients; all 10 demonstrated a pattern characteristic of vasodilation." | 1.28 | Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. ( Biasucci, L; Forman, R; Galvao, M; Jondeau, G; Katz, SD; LeJemtel, TH; Nikolic, SD; Sabba, C; Solomon, S; Strom, JA, 1992) |
| "Prehospital medications for congestive heart failure should affect hospital outcomes (survival and length of stay)." | 1.28 | Effects of prehospital medications on mortality and length of stay in congestive heart failure. ( Meador, SA; Wuerz, RC, 1992) |
| "Heart failure is known to impair arterial baroreceptor control of heart rate." | 1.28 | Arterial baroreceptor control of peripheral vascular resistance in experimental heart failure. ( Ferraro, N; Frey, MJ; Lanoce, V; Wilson, JR, 1990) |
| " The long duration of action (at least 8 hours) allows prolonged dosage intervals." | 1.27 | [Prolonged hemodynamic effects of pentaerythrityl tetranitrate combined with piridoxylate]. ( Baudet, M; Hericotte, P, 1983) |
| "Nitroglycerin was used to treat systemic or pulmonary hypertension, myocardial ischaemia and ventricular failure." | 1.27 | A profile of intravenous nitroglycerin use in cardiopulmonary bypass surgery. ( Bessette, MC; Cohen, AY; Townsend, GE; Whalley, DG; Wynands, JE, 1983) |
| "Patients with advanced congestive heart failure are high cost users of medical care, are limited by severe symptoms and have a poor prognosis." | 1.27 | [Current aspects of drug treatment of patients with congestive heart failure]. ( Bertel, O, 1983) |
| "Nitroglycerin was detected in plasma 2 min after commencement of the infusion, the concentration rose to a peak of approximately 4 ng/ml at 30 min and was maintained throughout the balance of the infusion period." | 1.27 | Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. ( Armstrong, PW; Moffat, JA; Watts, DG, 1983) |
| "In four patients with severe anemia and cardiac failure, IV nitroglycerin permitted rapid and large-volume blood transfusion without compromising cardiac function." | 1.27 | Intravenous nitroglycerin in transfusion therapy for severe anemia. Association with congestive heart failure. ( Kwa, RP; Varriale, P; Vyas, P, 1984) |
| "Captopril is a mixed vasodilator and is effective from the first hour of administration." | 1.27 | [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine]. ( Baubion, N; Di Matteo, J; Heulin, A; Le Pailleur, C; Metzger, JP; Vacheron, A, 1984) |
| "Nine patients with congestive heart failure, New York Heart Association class II-III, were evaluated with right heart catheterization." | 1.27 | Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure. ( Keller, N; Larsen, J; Storm, T; Sykulski, R; Thamsborg, G, 1988) |
| "Even though cardiac hypertrophy is viewed as a beneficial compensatory process that normalizes wall stress, the increased muscle mass carries with it the need of increased blood supply." | 1.27 | Effects of vasodilators on the coronary circulation in congestive heart failure. ( Burkart, F; Kiowski, W, 1988) |
| "Nitroglycerin has long been a mainstay of the treatment of ischemic cardiac pain." | 1.27 | The role of transdermal nitroglycerin in the treatment of coronary heart disease. ( Taylor, SH, 1986) |
| " The terminal half-life is 2-6 minutes, and clearance about 30 l/min." | 1.27 | [Pharmacokinetics of glycerol trinitrate]. ( Menke, G; Rietbrock, N; Woodcock, BG, 1986) |
| " The long-term use of the peripheral vasodilator molsidomin effectively prevents heart failure in myocardial infarction survivors." | 1.27 | [Comparative efficacy of the long-term use of long-acting nitroglycerin (sustak) and molsidomine after myocardial infarct complicated by heart failure]. ( Dormidontov, EN; Petrov, DV, 1986) |
| "Postoperatively 38 patients (26%) had cardiac failure." | 1.27 | Determinants of cardiac failure after coronary bypass surgery within 30 days of acute myocardial infarction. ( Ahmed, SW; Green, CE; Katz, NM; Kubanick, TE; Pearle, DL; Rackley, CE; Satler, LF; Wallace, RB, 1986) |
| "Isosorbide dinitrate was used in 16 patients, nitroglycerin in 36, pratsiol in 24, and captopryl in 20 patients." | 1.27 | [Comparative evaluation of the effectiveness of various peripheral vasodilators in the treatment of cardiac insufficiency]. ( Ageev, FT; Evdokimova, NKh; Mareev, VIu; Mukharliamov, NM; Novikov, SV, 1985) |
| " Trinitrin and its derivatives occupy an intermediate position because of their relatively low bioavailability after oral administration: long-term administration is not always easy and may require special modes of administration (i." | 1.27 | [Classification and principles of the use of vasodilators in the treatment of left ventricular insufficiency]. ( Cattan, S; Degeorges, M; Guérin, F; Pailleret, JJ; Weber, S, 1985) |
| " Taking into consideration that the range of the effective doses was very wide (15-150 micrograms/min), the authors believe that intravenous NTG infusion is indicated mainly in cases of manifest heart failure and should be administered under strict control of the dosage and with careful monitoring of the therapeutic effects." | 1.27 | Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure. ( Korewicki, J; Kraska, T; Opolski, G; Ostrzycki, A, 1985) |
| " Comparisons, however, are difficult owing to different methods and dosage regimens and to the isolated character of too many case-reports." | 1.26 | [Long-acting nitrate compounds (author's transl)]. ( Lhoste, F, 1980) |
| " The 15 mg initial dose of PCNG was progressively increased until optimal dosage was reached." | 1.26 | [Treatment of left ventricular failure with percutaneous nitroglycerin (author's transl)]. ( Bonin, M; Guermonprez, JL; Lancelin, B; Maurice, P, 1980) |
| "Vasodilator treatment of congestive heart failure has provided an important new role for long-acting nitrates." | 1.26 | Nitrate tolerance and dependence. A critical assessment. ( Abrams, J, 1980) |
| "Therefore, in 7 patients with congestive heart failure due to congestive cardiomyopathy, hemodynamic measurements were made using a Swan Ganz thermodilution catheter and cardiac output computer." | 1.26 | Enhancement of phentolamine by nitrates in patients with congestive heart failure. ( Gould, L; Reddy, CV; Singh, BK; Zen, B, 1981) |
| "Twenty patients with chronic congestive cardiac failure underwent hemodynamic monitoring during i." | 1.26 | Arterial-venous nitroglycerin gradient during intravenous infusion in man. ( Armstrong, PW; Marks, GS; Moffat, JA, 1982) |
| "In 6 patients with pulmonary edema, clinically an impressive improvement was observed within 5-15 min after administration of the drug." | 1.26 | Sublingual nitroglycerin in the treatment of left ventricular failure and pulmonary edema. ( Bussmann, WD; Kaltenbach, M, 1976) |
| " However, neither intravenous nor sublingual preparations are suitable for chronic administration or use in ambulatory patients." | 1.26 | Sustained haemodynamic action of nitroglycerin ointment. ( Engel, TR; Feitosa, GS; Frankl, WS; Furr, CM; Guiha, N; Hart, K; Meister, SG, 1976) |
| "Isosorbide dinitrate would produce a shift from A to D in a patient not on digitalis and from C to D in a patient already receiving digitalis." | 1.26 | Treatment of congestive heart failure. ( Mantle, JA; Moraski, RE; Rackley, CE; Rogers, WJ; Russel, RO, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 362 (57.10) | 18.7374 |
| 1990's | 128 (20.19) | 18.2507 |
| 2000's | 82 (12.93) | 29.6817 |
| 2010's | 47 (7.41) | 24.3611 |
| 2020's | 15 (2.37) | 2.80 |
| Authors | Studies |
|---|---|
| Follmann, M | 1 |
| Ackerstaff, J | 1 |
| Redlich, G | 1 |
| Wunder, F | 1 |
| Lang, D | 1 |
| Kern, A | 1 |
| Fey, P | 1 |
| Griebenow, N | 1 |
| Kroh, W | 1 |
| Becker-Pelster, EM | 1 |
| Kretschmer, A | 1 |
| Geiss, V | 1 |
| Li, V | 1 |
| Straub, A | 1 |
| Mittendorf, J | 1 |
| Jautelat, R | 1 |
| Schirok, H | 1 |
| Schlemmer, KH | 1 |
| Lustig, K | 1 |
| Gerisch, M | 1 |
| Knorr, A | 1 |
| Tinel, H | 1 |
| Mondritzki, T | 1 |
| Trübel, H | 1 |
| Sandner, P | 1 |
| Stasch, JP | 2 |
| Bel Haj Ali, K | 2 |
| Sekma, A | 2 |
| Nouira, S | 2 |
| Miró, Ò | 3 |
| Llorens, P | 3 |
| Freund, Y | 1 |
| Davison, B | 1 |
| Takagi, K | 1 |
| Herrero-Puente, P | 2 |
| Jacob, J | 3 |
| Martín-Sánchez, FJ | 2 |
| Gil, V | 2 |
| Rosselló, X | 1 |
| Alquézar-Arbé, A | 2 |
| Jiménez-Fábrega, FX | 1 |
| Masip, J | 2 |
| Mebazaa, A | 2 |
| Cotter, G | 2 |
| Okamoto, LE | 1 |
| Dupont, WD | 1 |
| Biaggioni, I | 1 |
| Kronenberg, MW | 1 |
| Boettcher, M | 1 |
| Düngen, HD | 1 |
| Donath, F | 1 |
| Mikus, G | 1 |
| Werner, N | 1 |
| Thuermann, PA | 1 |
| Karakas, M | 1 |
| Besche, N | 1 |
| Koch, T | 1 |
| Gurniak, M | 1 |
| Becker, C | 1 |
| Espinosa, B | 1 |
| Llauger, L | 1 |
| Tost, J | 1 |
| Andueza, JA | 1 |
| Garrido, JM | 1 |
| Mojarro, EM | 1 |
| Urbano, CA | 1 |
| Núñez, J | 1 |
| Chioncel, O | 1 |
| Mullens, W | 1 |
| Morawiec, R | 1 |
| Matuszewska-Brycht, O | 1 |
| Ryk, A | 1 |
| Drożdż, J | 1 |
| Kelly, GS | 1 |
| Branstetter, LA | 1 |
| Moran, TP | 1 |
| Hanzelka, N | 1 |
| Cooper, CD | 1 |
| Siddiqua, N | 1 |
| Bhaskararayuni, J | 1 |
| Sahu, AK | 1 |
| Kumar, A | 2 |
| Nayer, J | 1 |
| Stemple, K | 1 |
| DeWitt, KM | 1 |
| Porter, BA | 1 |
| Sheeser, M | 1 |
| Blohm, E | 1 |
| Bisanzo, M | 1 |
| Perlmutter, MC | 1 |
| Cohen, MW | 1 |
| Stratton, NS | 1 |
| Conterato, M | 1 |
| Kaesemeyer, W | 1 |
| Suvorava, T | 1 |
| Jeddi, C | 1 |
| Ben Brahim, N | 1 |
| Bzeouich, N | 1 |
| Gannoun, I | 1 |
| Trabelssi, I | 1 |
| Laouiti, K | 1 |
| Grissa, MH | 1 |
| Beltaief, K | 1 |
| Zohra, D | 1 |
| Asma, Z | 1 |
| Lotfi, B | 1 |
| Rym, Y | 1 |
| Ben Soltane, H | 1 |
| Zied, M | 1 |
| Mariem, K | 1 |
| Msolli, MA | 1 |
| Riadh, B | 1 |
| Bouida, W | 1 |
| Boubaker, H | 1 |
| Mathew, R | 1 |
| Sahu, A | 1 |
| Wali, S | 1 |
| Aggarwal, P | 1 |
| Hiroi, S | 1 |
| Izumida, T | 1 |
| Imamura, T | 1 |
| Ghio, S | 3 |
| Crimi, G | 1 |
| Temporelli, PL | 1 |
| Traversi, E | 1 |
| La Rovere, MT | 1 |
| Cannito, A | 1 |
| Vizza, D | 1 |
| Scelsi, L | 2 |
| Raineri, C | 2 |
| Guazzi, M | 1 |
| Oltrona Visconti, L | 1 |
| Cerbin, LP | 1 |
| Ambrosy, AP | 1 |
| Greene, SJ | 1 |
| Armstrong, PW | 10 |
| Butler, J | 2 |
| Coles, A | 1 |
| DeVore, AD | 1 |
| Ezekowitz, JA | 2 |
| Hernandez, AF | 2 |
| Metra, M | 2 |
| Starling, RC | 3 |
| Tang, W | 1 |
| Teerlink, JR | 2 |
| Voors, AA | 1 |
| Wu, A | 1 |
| O'Connor, CM | 2 |
| Mentz, RJ | 1 |
| Shi, J | 1 |
| Li, Y | 1 |
| Xing, C | 1 |
| Peng, P | 1 |
| Shi, H | 1 |
| Ding, H | 1 |
| Zheng, P | 1 |
| Ning, G | 1 |
| Feng, S | 1 |
| López-Rivera, F | 1 |
| Cintrón Martínez, HR | 1 |
| Castillo LaTorre, C | 1 |
| Rivera González, A | 1 |
| Rodríguez Vélez, JG | 1 |
| Fonseca Ferrer, V | 1 |
| Méndez Meléndez, OF | 1 |
| Vázquez Vargas, EJ | 1 |
| González Monroig, HA | 1 |
| Wang, K | 1 |
| Samai, K | 1 |
| Maher, AR | 1 |
| Arif, S | 2 |
| Madhani, M | 2 |
| Abozguia, K | 1 |
| Ahmed, I | 1 |
| Fernandez, BO | 1 |
| Feelisch, M | 2 |
| O'Sullivan, AG | 2 |
| Christopoulos, A | 1 |
| Sverdlov, AL | 2 |
| Ngo, D | 1 |
| Dautov, R | 1 |
| James, PE | 1 |
| Horowitz, JD | 4 |
| Frenneaux, MP | 3 |
| Anselmi, A | 1 |
| Corbineau, H | 1 |
| Boulmier, D | 1 |
| Ruggieri, VG | 1 |
| Givertz, MM | 1 |
| Albert, NM | 1 |
| Westlake Canary, CA | 1 |
| Collins, SP | 3 |
| Colvin-Adams, M | 1 |
| Fang, JC | 1 |
| Katz, SD | 6 |
| Krishnamani, R | 1 |
| Stough, WG | 2 |
| Walsh, MN | 1 |
| Carson, PE | 1 |
| Dimarco, JP | 1 |
| Hershberger, RE | 1 |
| Rogers, JG | 1 |
| Spertus, JA | 1 |
| Stevenson, WG | 1 |
| Sweitzer, NK | 1 |
| Tang, WH | 1 |
| Wakai, A | 1 |
| McCabe, A | 1 |
| Kidney, R | 1 |
| Brooks, SC | 1 |
| Seupaul, RA | 1 |
| Diercks, DB | 2 |
| Salter, N | 1 |
| Fermann, GJ | 1 |
| Pospisil, C | 1 |
| Clemency, BM | 1 |
| Thompson, JJ | 1 |
| Tundo, GN | 1 |
| Lindstrom, HA | 1 |
| Yameogo, NV | 1 |
| Mbaye, A | 1 |
| Kagambega, LJ | 1 |
| Dioum, M | 1 |
| Diagne-Sow, D | 1 |
| Kane, M | 1 |
| Diack, B | 1 |
| Kane, A | 1 |
| McKie, PM | 1 |
| Cataliotti, A | 2 |
| Ichiki, T | 1 |
| Sangaralingham, SJ | 1 |
| Chen, HH | 1 |
| Burnett, JC | 2 |
| Mumma, BE | 1 |
| Dhingra, KR | 1 |
| Kurlinkus, C | 1 |
| Iyer, A | 1 |
| Gao, L | 1 |
| Doyle, A | 1 |
| Rao, P | 1 |
| Jayewardene, D | 1 |
| Wan, B | 1 |
| Kumarasinghe, G | 1 |
| Jabbour, A | 1 |
| Hicks, M | 1 |
| Jansz, PC | 1 |
| Feneley, MP | 1 |
| Harvey, RP | 1 |
| Graham, RM | 1 |
| Dhital, KK | 1 |
| Macdonald, PS | 1 |
| den Uil, CA | 3 |
| Brugts, JJ | 2 |
| Moretti, M | 1 |
| Fabris, E | 1 |
| Morosin, M | 1 |
| Merlo, M | 1 |
| Barbati, G | 1 |
| Pinamonti, B | 1 |
| Gatti, G | 1 |
| Pappalardo, A | 1 |
| Sinagra, G | 1 |
| Chan, YH | 1 |
| Yiu, KH | 1 |
| Lau, KK | 1 |
| Yiu, YF | 1 |
| Li, SW | 1 |
| Lam, TH | 1 |
| Lau, CP | 1 |
| Siu, CW | 1 |
| Tse, HF | 1 |
| Borgognone, A | 1 |
| Lin, EL | 1 |
| Sharma, V | 1 |
| Drury, NE | 1 |
| Menon, A | 1 |
| Nightingale, P | 1 |
| Mascaro, J | 1 |
| Bonser, RS | 1 |
| Vázquez-Álvarez, J | 1 |
| Martínez-Camblor, P | 1 |
| Lucas-Imbernón, FJ | 1 |
| Martínez-Zapico, A | 1 |
| Yang, W | 2 |
| Zhou, YJ | 2 |
| Fu, Y | 2 |
| Qin, J | 2 |
| Qin, S | 2 |
| Chen, XM | 2 |
| Guo, JC | 2 |
| Hua, Q | 2 |
| Takahashi, F | 1 |
| Goto, M | 1 |
| Wada, Y | 1 |
| Hasebe, N | 2 |
| Gong, B | 1 |
| Wu, Z | 1 |
| Li, Z | 1 |
| Bitter, T | 1 |
| Fox, H | 1 |
| Schmalgemeier, H | 1 |
| Wellmann, B | 1 |
| Zwenke, A | 1 |
| Spiesshöfer, J | 1 |
| Dimitriadis, Z | 1 |
| Horstkotte, D | 1 |
| Oldenburg, O | 1 |
| Harada, K | 1 |
| Yamamoto, T | 4 |
| Okumura, T | 1 |
| Shigekiyo, M | 1 |
| Terada, N | 1 |
| Okada, A | 1 |
| Kawata, A | 1 |
| Iima, T | 1 |
| Harada, T | 1 |
| Fujisawa, K | 1 |
| Kageyama, N | 1 |
| Saito, A | 1 |
| Yamamoto, H | 1 |
| Fujinaga, H | 1 |
| Wilson, SS | 1 |
| Kwiatkowski, GM | 1 |
| Millis, SR | 1 |
| Purakal, JD | 1 |
| Mahajan, AP | 1 |
| Levy, PD | 1 |
| Wen, S | 1 |
| Ning, J | 1 |
| Collins, S | 1 |
| Berry, D | 1 |
| Zhang, S | 1 |
| Wang, Z | 2 |
| Zhan, H | 1 |
| Li, J | 1 |
| He, JY | 1 |
| Kishimoto, S | 1 |
| Kajikawa, M | 1 |
| Maruhashi, T | 1 |
| Iwamoto, Y | 1 |
| Matsumoto, T | 1 |
| Iwamoto, A | 1 |
| Oda, N | 1 |
| Matsui, S | 1 |
| Hidaka, T | 3 |
| Kihara, Y | 1 |
| Chayama, K | 1 |
| Goto, C | 1 |
| Aibara, Y | 1 |
| Nakashima, A | 1 |
| Noma, K | 1 |
| Higashi, Y | 1 |
| Weeks, SG | 1 |
| Paul, B | 1 |
| Hewitson, CL | 1 |
| Woodman, RJ | 1 |
| Mangoni, AA | 1 |
| Bosomworth, J | 1 |
| Münzel, T | 4 |
| Ishibashi, Y | 2 |
| Takahashi, N | 2 |
| Tokumaru, A | 1 |
| Karino, K | 1 |
| Sugamori, T | 2 |
| Sakane, T | 2 |
| Kodani, N | 1 |
| Kunizawa, Y | 1 |
| Yoshitomi, H | 1 |
| Sato, H | 2 |
| Oyake, N | 1 |
| Murakami, Y | 2 |
| Shimada, T | 2 |
| Mattu, A | 1 |
| Lawner, B | 1 |
| Kirk, JD | 2 |
| Parissis, JT | 2 |
| Filippatos, G | 2 |
| Stehlik, J | 1 |
| Movsesian, MA | 1 |
| Lagrand, WK | 2 |
| Spronk, PE | 2 |
| van der Ent, M | 2 |
| Jewbali, LS | 2 |
| Ince, C | 1 |
| Simoons, ML | 2 |
| Lisi, M | 1 |
| Parker, JD | 2 |
| Gori, T | 1 |
| Caliskan, K | 1 |
| van Kuijk, JP | 1 |
| De Backer, D | 1 |
| Ortiz, JA | 1 |
| Salgado, D | 1 |
| Chirkov, YY | 2 |
| De Sciscio, M | 1 |
| Leslie, S | 1 |
| Sage, PR | 1 |
| Pang, PS | 1 |
| Lindsell, CJ | 1 |
| Kyriacou, DN | 1 |
| Storrow, AB | 2 |
| Hollander, JE | 1 |
| Miller, CD | 1 |
| Nowak, R | 1 |
| Peacock, WF | 3 |
| Tavares, M | 1 |
| Gheorghiade, M | 3 |
| Coons, JC | 1 |
| McGraw, M | 1 |
| Murali, S | 1 |
| Chow, SL | 2 |
| O'Barr, SA | 2 |
| Peng, J | 2 |
| Chew, E | 2 |
| Pak, F | 2 |
| Quist, R | 2 |
| Patel, P | 2 |
| Patterson, JH | 2 |
| Heywood, JT | 2 |
| Aziz, EF | 1 |
| Kukin, M | 1 |
| Javed, F | 1 |
| Pratap, B | 1 |
| Sabharwal, MS | 1 |
| Tormey, D | 1 |
| Frankenberger, O | 1 |
| Herzog, E | 1 |
| Bardai, GK | 1 |
| Hales, BF | 1 |
| Sunahara, GI | 1 |
| Mizutani, T | 1 |
| Inomata, T | 1 |
| Watanabe, I | 1 |
| Maekawa, E | 1 |
| Yanagisawa, T | 1 |
| Shinagawa, H | 1 |
| Koitabashi, T | 1 |
| Takeuchi, I | 1 |
| Izumi, T | 1 |
| Ng, TM | 1 |
| Ackerbauer, KA | 1 |
| Hyderi, AF | 1 |
| Hshieh, S | 1 |
| Elkayam, U | 10 |
| Valchanov, KP | 1 |
| Arrowsmith, JE | 1 |
| Sheikh-Taha, M | 1 |
| Zeitoun, A | 1 |
| Wei, J | 1 |
| Mehta, PK | 1 |
| Johnson, BD | 1 |
| Samuels, B | 1 |
| Kar, S | 1 |
| Anderson, RD | 1 |
| Azarbal, B | 1 |
| Petersen, J | 1 |
| Sharaf, B | 1 |
| Handberg, E | 1 |
| Shufelt, C | 1 |
| Kothawade, K | 1 |
| Sopko, G | 1 |
| Lerman, A | 1 |
| Shaw, L | 1 |
| Kelsey, SF | 1 |
| Pepine, CJ | 3 |
| Merz, CN | 1 |
| Grayson, S | 1 |
| Gandy, WE | 1 |
| Peng, LM | 1 |
| Chen, XP | 1 |
| Sun, J | 1 |
| Guo, YJ | 1 |
| Li, L | 1 |
| Mo, L | 1 |
| Xie, W | 1 |
| Li, YJ | 1 |
| Yang, TL | 1 |
| Li, CC | 1 |
| Ehara, S | 1 |
| Nakamura, Y | 1 |
| Matsumoto, K | 1 |
| Hasegawa, T | 1 |
| Shimada, K | 1 |
| Takagi, M | 1 |
| Hanatani, A | 1 |
| Izumi, Y | 1 |
| Terashima, M | 2 |
| Yoshiyama, M | 1 |
| Kosheleva, NA | 1 |
| Rebrov, AP | 1 |
| Dunavant, S | 1 |
| Rifkin, W | 1 |
| Natori, S | 1 |
| Jin, YT | 1 |
| Matsusaka, T | 1 |
| Ido, A | 1 |
| Matsuhashi, H | 1 |
| Ihara, T | 1 |
| Kikuchi, K | 1 |
| Boerrigter, G | 1 |
| Costello-Boerrigter, LC | 1 |
| Tsuruda, T | 1 |
| Harty, GJ | 1 |
| Lapp, H | 1 |
| Adams, KF | 2 |
| Mathur, VS | 1 |
| Gavazzi, A | 2 |
| Campana, C | 2 |
| Klersy, C | 1 |
| Serio, A | 1 |
| Tavazzi, L | 1 |
| Moazemi, K | 1 |
| Chana, JS | 1 |
| Willard, AM | 1 |
| Kocheril, AG | 1 |
| Tsurikisawa, N | 1 |
| Taniguchi, M | 1 |
| Suzuki, S | 1 |
| Akiyama, K | 1 |
| Mills, RM | 1 |
| Noviasky, JA | 1 |
| Kelberman, M | 1 |
| Whalen, KM | 1 |
| Guharoy, R | 1 |
| Darko, W | 1 |
| Thomas, P | 2 |
| O'Gorman, DJ | 1 |
| Sheridan, DJ | 2 |
| REAL, AP | 1 |
| JOHNSON, JB | 2 |
| GROSS, JF | 1 |
| HALE, E | 1 |
| FAIRLEY, A | 1 |
| CARTER, C | 1 |
| SIMONI, Y | 1 |
| PAUL, O | 1 |
| GRIEP, AH | 1 |
| LEIBERMAN, A | 1 |
| GUGLIELMELLI, S | 1 |
| CHRISTENSSON, B | 1 |
| GUSTAFSON, A | 1 |
| KARLEFORS, T | 1 |
| WESTLING, H | 1 |
| Drazner, M | 1 |
| McGuire, DK | 1 |
| de Lemos, JA | 1 |
| McGrotty, YL | 1 |
| Yu, ZX | 1 |
| Ou, SQ | 1 |
| Lü, YZ | 1 |
| Tonduangu, D | 1 |
| Hittinger, L | 1 |
| Ghaleh, B | 1 |
| Le Corvoisier, P | 1 |
| Sambin, L | 1 |
| Champagne, S | 1 |
| Badoual, T | 1 |
| Vincent, F | 1 |
| Berdeaux, A | 1 |
| Crozatier, B | 1 |
| Su, JB | 1 |
| Emerman, CL | 2 |
| Akhter, MW | 2 |
| Singh, H | 1 |
| Khan, S | 2 |
| Usman, A | 1 |
| Nakamura, M | 2 |
| Sugawara, S | 1 |
| Arakawa, N | 1 |
| Nagano, M | 1 |
| Shizuka, T | 1 |
| Shimoda, Y | 1 |
| Sakai, T | 1 |
| Hiramori, K | 1 |
| Young, J | 1 |
| Chong, AY | 1 |
| Blann, AD | 1 |
| Patel, J | 1 |
| Freestone, B | 1 |
| Hughes, E | 1 |
| Lip, GY | 2 |
| Shlipak, MG | 1 |
| Massie, BM | 1 |
| Kanamasa, K | 3 |
| Naito, N | 1 |
| Morii, H | 1 |
| Nakano, K | 1 |
| Tanaka, Y | 1 |
| Kitayama, K | 2 |
| Haku, R | 1 |
| Kai, T | 1 |
| Yonekawa, O | 1 |
| Nagatani, Y | 1 |
| Ishikawa, K | 3 |
| Takayama, T | 1 |
| Wada, A | 4 |
| Tsutamoto, T | 5 |
| Ohnishi, M | 1 |
| Fujii, M | 2 |
| Isono, T | 1 |
| Horie, M | 2 |
| Freimark, D | 1 |
| Feinberg, MS | 1 |
| Matezky, S | 1 |
| Hochberg, N | 1 |
| Shechter, M | 1 |
| Saltzberg, MT | 1 |
| Bitar, F | 1 |
| Patrus, S | 1 |
| Derakhshani, M | 1 |
| Abraham, WT | 1 |
| Fonarow, GC | 1 |
| Costanzo, MR | 1 |
| Berkowitz, RL | 1 |
| LeJemtel, TH | 7 |
| Cheng, ML | 1 |
| Wynne, J | 1 |
| Dec, GW | 1 |
| Topol, EJ | 1 |
| Burger, AJ | 1 |
| Hinckley, WR | 1 |
| Petersson, M | 2 |
| Friberg, P | 2 |
| Lambert, G | 1 |
| Rundqvist, B | 2 |
| Daiber, A | 1 |
| Oelze, M | 1 |
| Coldewey, M | 1 |
| Kaiser, K | 1 |
| Huth, C | 1 |
| Schildknecht, S | 1 |
| Bachschmid, M | 1 |
| Nazirisadeh, Y | 1 |
| Ullrich, V | 1 |
| Mülsch, A | 1 |
| Tsilimingas, N | 1 |
| Baysal, A | 1 |
| Bilsel, S | 1 |
| Bulbul, OG | 1 |
| Kayacioglu, I | 1 |
| Idiz, M | 1 |
| Yekeler, I | 1 |
| Mehra, MR | 1 |
| Braun, S | 1 |
| Schrötter, H | 1 |
| Schmeisser, A | 1 |
| Strasser, RH | 1 |
| Brazdzionyte, J | 1 |
| Macas, A | 1 |
| Mickeviciene, A | 1 |
| Gill, RM | 1 |
| Braz, JC | 1 |
| Jin, N | 1 |
| Etgen, GJ | 1 |
| Shen, W | 1 |
| Hollenberg, SM | 1 |
| De Berrazueta Fernández, JR | 1 |
| Levy, P | 1 |
| Compton, S | 1 |
| Welch, R | 1 |
| Delgado, G | 1 |
| Jennett, A | 1 |
| Penugonda, N | 1 |
| Dunne, R | 1 |
| Zalenski, R | 1 |
| Younger, CM | 1 |
| Karavidas, A | 1 |
| Bistola, V | 1 |
| Arapi, S | 1 |
| Paraskevaidis, IA | 1 |
| Farmakis, D | 1 |
| Korres, D | 1 |
| Matsakas, E | 1 |
| Kremastinos, DT | 1 |
| Sato, M | 1 |
| Kurosawa, H | 1 |
| Nemeth, J | 1 |
| Tanaka, T | 1 |
| Sakai, H | 1 |
| Nishiyama, K | 1 |
| Bennett, BM | 1 |
| Adams, MA | 1 |
| Xie, CL | 1 |
| Meng, SR | 1 |
| Wang, W | 2 |
| Chen, SM | 1 |
| Li, P | 1 |
| Feng, XG | 1 |
| Chekman, IS | 1 |
| Kazak, LI | 1 |
| Cárdenas Loaeza, M | 1 |
| Orringer, CE | 1 |
| Mathey, DG | 1 |
| Bleifeld, W | 2 |
| Kupper, W | 1 |
| Hamm, CW | 1 |
| Bart, BIa | 1 |
| Pashkova, TL | 1 |
| Stepanov, NG | 1 |
| Orlova, TV | 1 |
| Kalmanova, EN | 1 |
| Baudet, M | 2 |
| Hericotte, P | 1 |
| Schörner, W | 2 |
| Loos, D | 2 |
| Schneider, R | 2 |
| Felix, R | 1 |
| Demma, FJ | 2 |
| Wilson, RR | 1 |
| Townsend, GE | 1 |
| Wynands, JE | 1 |
| Whalley, DG | 1 |
| Cohen, AY | 1 |
| Bessette, MC | 1 |
| Blakeley, C | 1 |
| Tinker, J | 1 |
| Karpov, IuA | 2 |
| Noeva, EA | 1 |
| Pilipenko, VA | 2 |
| Roshchin, SI | 2 |
| Iaroshchak, VV | 1 |
| Abrams, J | 18 |
| Shteĭngardt, IuN | 1 |
| Tiukalova, LI | 1 |
| Markov, VA | 1 |
| Kun, VI | 1 |
| Tsymbaliuk, VP | 1 |
| Awan, NA | 2 |
| Evenson, MK | 1 |
| Needham, KE | 1 |
| Beattie, JM | 1 |
| Mason, DT | 7 |
| Flaherty, JT | 5 |
| Becker, LC | 1 |
| Bulkley, BH | 1 |
| Weiss, JL | 1 |
| Gerstenblith, G | 1 |
| Kallman, CH | 1 |
| Silverman, KJ | 1 |
| Wei, JY | 1 |
| Pitt, B | 3 |
| Weisfeldt, ML | 2 |
| You, K | 1 |
| Coma Canella, I | 2 |
| López-Sendón, J | 1 |
| Bertel, O | 4 |
| Satinsky, JD | 1 |
| Loeb, HS | 1 |
| Ostrenga, JP | 1 |
| Gaul, W | 1 |
| Witt, J | 1 |
| Freeman, G | 1 |
| Scanlon, P | 1 |
| Gunnar, RM | 1 |
| Watts, DG | 1 |
| Moffat, JA | 2 |
| Ciafone, RA | 1 |
| Olivari, MT | 1 |
| Carlyle, PF | 1 |
| Levine, TB | 2 |
| Cohn, JN | 5 |
| Pennock, JL | 1 |
| Sorkin, EM | 1 |
| Brogden, RN | 1 |
| Romankiewicz, JA | 1 |
| Lahiri, A | 3 |
| Crawley, JC | 1 |
| Sonecha, TN | 2 |
| Raftery, EB | 3 |
| Rigaud, M | 4 |
| Luwaert, R | 1 |
| Jouret, G | 1 |
| Bardet, J | 4 |
| Bourdarias, JP | 4 |
| Varriale, P | 3 |
| Kwa, RP | 2 |
| Vyas, P | 2 |
| Gould, L | 2 |
| Gopalaswamy, C | 1 |
| Goldstein, S | 1 |
| Friedman, L | 1 |
| Hutchinson, R | 1 |
| Canner, P | 1 |
| Romhilt, D | 1 |
| Schlant, R | 1 |
| Sobrino, R | 1 |
| Verter, J | 1 |
| Wasserman, A | 1 |
| Williams, ES | 1 |
| Kodama, K | 1 |
| Koretsune, Y | 1 |
| Nanto, S | 1 |
| Taniura, K | 1 |
| Saito, M | 2 |
| Gould, LA | 1 |
| Inden, M | 1 |
| Itou, M | 1 |
| Noda, E | 1 |
| Kawahira, S | 1 |
| Tanimura, H | 1 |
| Takasaki, H | 1 |
| Morimoto, Y | 1 |
| Nakano, T | 2 |
| Takezawa, H | 1 |
| Herling, IM | 1 |
| Bayley, S | 1 |
| Valentine, H | 1 |
| Bennett, ED | 1 |
| Rajfer, SI | 1 |
| Goldberg, LI | 1 |
| Konstam, MA | 2 |
| Salem, DN | 2 |
| Isner, JM | 2 |
| Zile, MR | 2 |
| Kahn, PC | 2 |
| Bonin, JD | 1 |
| Cohen, SR | 2 |
| Levine, HJ | 2 |
| Smith, ER | 2 |
| Smiseth, OA | 3 |
| Kingma, I | 1 |
| Manyari, D | 1 |
| Belenkie, I | 2 |
| Tyberg, JV | 4 |
| Le Pailleur, C | 4 |
| Baubion, N | 1 |
| Metzger, JP | 2 |
| Heulin, A | 2 |
| Vacheron, A | 1 |
| Di Matteo, J | 3 |
| Refsum, H | 1 |
| Laskey, WK | 1 |
| Sutton, MS | 1 |
| Zeevi, G | 1 |
| Hirshfeld, JW | 1 |
| Reichek, N | 1 |
| Kawai, C | 1 |
| Kambara, H | 1 |
| Hirota, Y | 1 |
| Kagoshima, T | 1 |
| Nobuyoshi, M | 1 |
| Tsuruha, Y | 1 |
| Gusev, AT | 1 |
| Lebedeva, OI | 1 |
| Galiautdinov, GS | 1 |
| Bobylev, VV | 1 |
| Volkov, VS | 1 |
| Bratoliubov, VP | 1 |
| Benjamin, GC | 1 |
| Conner, CS | 1 |
| Gelman, CJ | 1 |
| Nowakowski, JF | 1 |
| Solonovich, TG | 1 |
| Orlov, LL | 2 |
| Shilov, AM | 2 |
| Roĭtberg, GE | 1 |
| Timmis, AD | 1 |
| Richardson, PJ | 1 |
| Pachinger, O | 1 |
| Bolte, HD | 2 |
| Franciosa, JA | 6 |
| Thrall, JH | 1 |
| Brady, TJ | 1 |
| Magrini, F | 1 |
| Niarchos, AP | 1 |
| Magometschnigg, D | 1 |
| Bonelli, J | 1 |
| Gassner, A | 1 |
| Lenzhofer, R | 1 |
| Kleinberger, G | 1 |
| Pall, H | 1 |
| Pichler, M | 1 |
| Baitsch, G | 2 |
| Burkart, F | 4 |
| Armstrong, JA | 3 |
| Marks, GS | 4 |
| Faxon, DP | 1 |
| Gross, S | 1 |
| Tilney, C | 1 |
| Ryan, TJ | 1 |
| Chatterjee, K | 7 |
| Parmley, WW | 3 |
| Taylor, SH | 6 |
| Farcot, JC | 1 |
| Lhoste, F | 1 |
| Bory, M | 2 |
| Clavier, P | 1 |
| Arnoux, F | 1 |
| Djiane, P | 1 |
| Egre, A | 1 |
| Serradimigni, A | 1 |
| Guéret, P | 2 |
| Lancelin, B | 2 |
| Guermonprez, JL | 2 |
| Bonin, M | 2 |
| Maurice, P | 2 |
| Gagnon, RM | 1 |
| Fortin, L | 1 |
| Boucher, R | 1 |
| Gilbert, S | 1 |
| Morrisette, M | 1 |
| Present, S | 1 |
| Lemire, J | 1 |
| David, A | 1 |
| Gratsianskiĭ, NA | 1 |
| Ruda, MIa | 2 |
| Vahanian, A | 1 |
| Lecannelier, E | 1 |
| Dubois, C | 1 |
| Rolland, E | 1 |
| Pornin, P | 1 |
| Hill, NS | 1 |
| Antman, EM | 1 |
| Green, LH | 1 |
| Alpert, JS | 1 |
| Klein, W | 3 |
| Goebel, R | 2 |
| Martynov, AI | 1 |
| Belinskaia, TF | 1 |
| Russell, RO | 1 |
| Mantle, JA | 2 |
| Rogers, WJ | 2 |
| Rackley, CE | 3 |
| Korewicki, J | 6 |
| Kraska, T | 4 |
| Zochowski, RJ | 2 |
| Khomenko, VL | 1 |
| Pomerantsev, VP | 1 |
| Vasiuk, IuA | 1 |
| Brandt, D | 2 |
| Fluch, N | 1 |
| Maurer, E | 1 |
| Fennell, WH | 1 |
| Page, A | 1 |
| Ledain, L | 1 |
| Gateau, P | 1 |
| Besse, P | 1 |
| Flaim, SF | 2 |
| Weitzel, RL | 1 |
| Zelis, R | 3 |
| Pierpont, G | 1 |
| Kober, G | 2 |
| Grossmann, R | 1 |
| Schulz, W | 1 |
| Kaltenbach, M | 10 |
| Tarnow, J | 1 |
| López-Sendón, JL | 1 |
| Benito, F | 1 |
| Lacort, M | 1 |
| Reddy, CV | 1 |
| Zen, B | 1 |
| Singh, BK | 1 |
| Romano, E | 1 |
| Gullo, A | 1 |
| Mocavero, G | 1 |
| Mukharliamov, NM | 4 |
| Ludbrook, PA | 1 |
| Byrne, JD | 1 |
| Tiefenbrunn, AJ | 1 |
| Leier, CV | 2 |
| Bambach, D | 1 |
| Thompson, MJ | 1 |
| Cattaneo, SM | 1 |
| Goldberg, RJ | 1 |
| Unverferth, DV | 1 |
| White, CW | 1 |
| Wagner, GC | 1 |
| Robinson, PH | 1 |
| Mikhaĭlov, AA | 2 |
| Lazutin, VK | 2 |
| Zhelnov, VV | 1 |
| Simonov, VI | 1 |
| Giliarovskiĭ, AK | 1 |
| Lessem, J | 1 |
| Dipalma, JR | 1 |
| Haq, A | 1 |
| Rakowski, H | 1 |
| Baigrie, R | 1 |
| McLaughlin, P | 1 |
| Burns, R | 1 |
| Tihal, H | 1 |
| Hilton, D | 1 |
| Feiglin, D | 1 |
| Mandell, HN | 1 |
| Deglin, SM | 1 |
| Heierli, B | 1 |
| Imhof, P | 2 |
| Pitt, WA | 1 |
| Friedman, RG | 1 |
| Gross, SA | 1 |
| Glassman, J | 1 |
| Keating, EC | 1 |
| Mazur, JH | 1 |
| Cody, R | 2 |
| Follath, F | 1 |
| Ritz, R | 2 |
| Vozeh, S | 1 |
| Wenk, M | 1 |
| Mauri, F | 2 |
| Mafrici, A | 2 |
| Azzollini, M | 2 |
| Maggiulli, G | 2 |
| Domenichini, R | 2 |
| Babalis, D | 1 |
| Levy, B | 1 |
| Azancot, I | 1 |
| Georgiopoulos, G | 1 |
| Beaufils, P | 1 |
| Slama, R | 1 |
| Elizarova, NA | 1 |
| Bitar, S | 1 |
| Samiev, UB | 1 |
| Kokomina, EF | 1 |
| Aumont, MC | 1 |
| Himbert, D | 2 |
| Czitrom, D | 1 |
| Bauer, JA | 8 |
| Fung, HL | 8 |
| Zheng, W | 1 |
| Kwon, YW | 1 |
| Gopalakrishnan, M | 1 |
| Triggle, DJ | 1 |
| Ramsey, MW | 1 |
| Goodfellow, J | 1 |
| Jones, CJ | 1 |
| Luddington, LA | 1 |
| Lewis, MJ | 2 |
| Henderson, AH | 1 |
| Gogia, H | 2 |
| Mehra, A | 2 |
| Parikh, S | 1 |
| Raman, M | 1 |
| Ajit-Uppal, J | 1 |
| Johnson, JV | 2 |
| Koshlia, VI | 1 |
| Maliukova, NG | 1 |
| Singh, SP | 1 |
| Minatoguchi, S | 2 |
| Ito, H | 2 |
| Ishimura, K | 1 |
| Watanabe, H | 5 |
| Imai, Y | 2 |
| Koshiji, M | 2 |
| Asano, K | 2 |
| Hirakawa, S | 2 |
| Fujiwara, H | 1 |
| Deedwania, PC | 1 |
| Riecansky, I | 2 |
| Yacone-Morton, LA | 1 |
| Kinoshita, M | 3 |
| Hisanaga, T | 1 |
| Maeda, Y | 3 |
| Maeda, K | 1 |
| Fukai, D | 1 |
| Yoshida, S | 1 |
| Kamijo, T | 1 |
| Tomaru, T | 1 |
| Miwa, AY | 1 |
| Nakamura, F | 1 |
| Kido, H | 1 |
| Sugimoto, T | 2 |
| Uchida, Y | 1 |
| Wang, SY | 1 |
| Manyari, DE | 1 |
| Scott-Douglas, N | 1 |
| Han, YL | 1 |
| Tong, M | 1 |
| Jing, QM | 1 |
| Torfgård, KE | 1 |
| Ahlner, J | 1 |
| Poli, A | 1 |
| Ferrario, M | 1 |
| Diotallevi, P | 1 |
| Eleuteri, E | 1 |
| Mussini, A | 1 |
| Specchia, G | 3 |
| Montemartini, C | 1 |
| Ueno, M | 2 |
| Kawashima, S | 2 |
| Tsumoto, S | 1 |
| Morita, M | 1 |
| Iwasaki, T | 2 |
| Störk, T | 3 |
| Möckel, M | 3 |
| Danne, O | 2 |
| Müller, R | 3 |
| Eichstädt, H | 3 |
| Hochrein, H | 3 |
| Dobrotvorskaia, TE | 1 |
| Shchukov, AA | 1 |
| Gordina, OV | 1 |
| Suprun, EK | 1 |
| Shardanov, NA | 1 |
| Kandoeva, MM | 1 |
| Schreinerová, Z | 1 |
| Bzdúchová, O | 1 |
| Plachá, L | 1 |
| Havlínová, K | 1 |
| Zelenay, J | 1 |
| Ohbayashi, Y | 1 |
| Adachi, T | 1 |
| Hachenberg, T | 1 |
| Akatsuka, N | 1 |
| Just, H | 2 |
| Drexler, H | 2 |
| Siegrist, J | 1 |
| Schulgen, G | 1 |
| Schumacher, M | 1 |
| Schwarz, M | 2 |
| Demopoulos, L | 1 |
| Hirsch, H | 1 |
| Yuen, JL | 1 |
| Jondeau, G | 2 |
| Nakae, I | 1 |
| Yabe, T | 1 |
| Horie, H | 1 |
| Sacchetti, A | 2 |
| McCabe, J | 1 |
| Torres, M | 1 |
| Harris, RL | 1 |
| Faggiano, P | 2 |
| Lombardi, C | 1 |
| Sorgato, A | 1 |
| Ghizzoni, G | 1 |
| Spedini, C | 1 |
| Rusconi, C | 2 |
| Wuerz, R | 1 |
| Swope, G | 1 |
| Meador, S | 1 |
| Holliman, CJ | 1 |
| Roth, GS | 1 |
| Dakak, N | 4 |
| Makhoul, N | 4 |
| Merdler, A | 3 |
| Yechiely, H | 2 |
| Kahana, L | 2 |
| Halon, DA | 4 |
| Schneeweiss, A | 5 |
| Lewis, BS | 4 |
| Störk, S | 1 |
| Piske, G | 1 |
| Bodemann, T | 3 |
| Buschmann, M | 1 |
| Wiegand, A | 1 |
| Schnellbacher, K | 1 |
| Bonn, R | 1 |
| Rehe, A | 1 |
| Trenk, D | 1 |
| Jähnchen, E | 1 |
| Roskamm, H | 1 |
| Yuen, J | 2 |
| Yang, YJ | 1 |
| Chen, ZJ | 1 |
| Xu, YS | 1 |
| Derchi, G | 1 |
| Dupuis, J | 4 |
| de Champlain, J | 1 |
| Rouleau, JL | 4 |
| Haber, HL | 1 |
| Simek, CL | 1 |
| Bergin, JD | 1 |
| Sadun, A | 1 |
| Gimple, LW | 1 |
| Powers, ER | 1 |
| Feldman, MD | 1 |
| Aisaka, K | 1 |
| Ohno, T | 1 |
| Ishihara, T | 1 |
| Parker, JO | 2 |
| Juillière, Y | 1 |
| Feldmann, L | 1 |
| Perrin, O | 1 |
| Berder, V | 1 |
| Danchin, N | 1 |
| Cherrier, F | 1 |
| Cohen, G | 1 |
| Chandraratna, PA | 3 |
| Alliluev, IG | 1 |
| Pecherskaia, MB | 1 |
| Poltavskaia, MG | 1 |
| Syrkin, AL | 1 |
| Lazebnik, LB | 1 |
| Kurz, S | 1 |
| Rajagopalan, S | 1 |
| Thoenes, M | 1 |
| Berrington, WR | 1 |
| Thompson, JA | 1 |
| Freeman, BA | 1 |
| Harrison, DG | 1 |
| Khder, Y | 1 |
| el Ghawi, R | 1 |
| Boscs, LB | 1 |
| Aliot, E | 1 |
| Zannad, F | 1 |
| Ogawa, I | 1 |
| Takenaka, T | 2 |
| Naito, T | 1 |
| Kamata, N | 1 |
| Nakai, S | 1 |
| Hama, J | 1 |
| Oyaizu, M | 1 |
| Kimura, A | 2 |
| Yamamoto, K | 1 |
| Aso, N | 1 |
| Arai, M | 1 |
| Yabushita, H | 2 |
| Katori, Y | 1 |
| Ando, S | 1 |
| Dajani, HR | 1 |
| Senn, BL | 1 |
| Newton, GE | 1 |
| Floras, JS | 1 |
| Larosa, G | 1 |
| Forster, C | 2 |
| Parker, AB | 1 |
| Farrell, B | 1 |
| Mazzotta, G | 1 |
| Baggia, S | 1 |
| Perkins, K | 1 |
| Greenberg, B | 2 |
| Bijou, R | 1 |
| Pohar, B | 1 |
| Horvat, M | 1 |
| Jørgensen, LH | 1 |
| Thaulow, E | 1 |
| Refsum, HE | 1 |
| Balthasar, JP | 1 |
| Larsen, AI | 1 |
| Gøransson, L | 1 |
| Aarsland, T | 1 |
| Tamby, JF | 1 |
| Dickstein, K | 1 |
| Ikeoka, K | 1 |
| Gareis, R | 1 |
| Bundgaard, H | 1 |
| Boesgaard, S | 1 |
| Mortensen, SA | 1 |
| Arendrup, H | 1 |
| Aldershvile, J | 1 |
| Kulbertus, H | 1 |
| Kakihana, M | 3 |
| Ohtsuka, S | 3 |
| Sugishita, Y | 3 |
| Saitoh, C | 1 |
| Momose, K | 1 |
| Tanaka, H | 1 |
| Sato, S | 1 |
| Taguchi, K | 1 |
| Saitoh, M | 1 |
| Maehara, J | 1 |
| Asano, M | 1 |
| Usuda, S | 1 |
| Noguchi, K | 1 |
| Matsuzaki, T | 1 |
| Ojiri, Y | 1 |
| Koyama, T | 1 |
| Nakasone, J | 1 |
| Sakanashi, M | 1 |
| Semeniuk, LM | 1 |
| Ito, K | 1 |
| Akita, H | 1 |
| Kanazawa, K | 1 |
| Yamada, S | 1 |
| Matsuda, Y | 1 |
| Yokoyama, M | 1 |
| Maguire, SM | 1 |
| Nugent, AG | 1 |
| McGurk, C | 1 |
| Johnston, GD | 1 |
| Nicholls, DP | 1 |
| Ramoska, E | 1 |
| Moakes, ME | 1 |
| McDermott, P | 1 |
| Moyer, V | 1 |
| Drazner, MH | 1 |
| Solomon, MA | 1 |
| Thompson, B | 1 |
| Yancy, CW | 1 |
| Werdan, K | 1 |
| Hambrecht, R | 1 |
| Hilbrich, L | 1 |
| Erbs, S | 1 |
| Gielen, S | 1 |
| Fiehn, E | 1 |
| Schoene, N | 1 |
| Schuler, G | 1 |
| Yi, GH | 1 |
| Zwas, D | 1 |
| Wang, J | 1 |
| Levine, AB | 1 |
| Bolenbaugh, J | 1 |
| Stomel, RJ | 1 |
| Gardtman, M | 1 |
| Waagstein, L | 1 |
| Karlsson, T | 1 |
| Herlitz, J | 1 |
| Hirano, Y | 1 |
| Ohata, S | 1 |
| Inoue, SI | 1 |
| Nakamura, K | 1 |
| Berger, R | 1 |
| Stanek, B | 1 |
| Hülsmann, M | 1 |
| Frey, B | 1 |
| Heher, S | 1 |
| Pacher, R | 1 |
| Neunteufl, T | 1 |
| Hayashi, T | 1 |
| Miyataka, M | 1 |
| Shinohara, T | 1 |
| Yanai, H | 1 |
| Suzuki, K | 1 |
| Ohsuzu, F | 1 |
| Jhund, PS | 1 |
| Davie, AP | 1 |
| McMurray, JJ | 1 |
| Ellis, GR | 1 |
| Anderson, RA | 1 |
| Morris-Thurgood, J | 1 |
| Jackson, SK | 1 |
| Krum, H | 1 |
| Loh, E | 1 |
| Bristow, M | 1 |
| Jaski, B | 1 |
| Colucci, WS | 1 |
| Bussmann, WD | 12 |
| Herholz, C | 1 |
| Yamani, MH | 1 |
| Haji, SA | 1 |
| Kelly, L | 1 |
| Albert, N | 1 |
| Knack, DL | 1 |
| Young, JB | 1 |
| Kaiser, DR | 1 |
| Mullen, K | 1 |
| Bank, AJ | 1 |
| Joannides, R | 1 |
| Bizet-Nafeh, C | 1 |
| Costentin, A | 1 |
| Iacob, M | 1 |
| Derumeaux, G | 1 |
| Cribier, A | 1 |
| Thuillez, C | 1 |
| Zeng, H | 1 |
| Sun, L | 1 |
| Li, W | 1 |
| Du, J | 1 |
| Poole-Wilson, PA | 1 |
| Gorlin, R | 1 |
| Opolski, G | 4 |
| Hedbäck, B | 1 |
| Nordenfelt, I | 1 |
| Svanström, B | 1 |
| Vedin, A | 1 |
| Wilhelmsson, C | 1 |
| Oberg, K | 1 |
| Enenkel, W | 2 |
| Parratt, JR | 1 |
| Duck, HJ | 1 |
| Trenckmann, H | 1 |
| Fleischmann, JH | 1 |
| Neugebauer, A | 1 |
| Schauer, J | 1 |
| Cairns, JA | 1 |
| Solignac, A | 1 |
| De Servi, S | 1 |
| Massie, B | 2 |
| Rubin, S | 1 |
| Gelberg, H | 1 |
| Brundage, BH | 2 |
| Ports, TA | 2 |
| Warren, SE | 1 |
| Francis, GS | 1 |
| Mehta, J | 2 |
| Conti, CR | 2 |
| Stetson, JB | 1 |
| Bergbauer, M | 1 |
| Cottrell, JE | 1 |
| Turndorf, H | 1 |
| Langevin, E | 2 |
| O'Dell, R | 1 |
| Rubenstein, C | 1 |
| San Pedro, S | 1 |
| Kimata, S | 1 |
| Elsässer, S | 1 |
| Cyran, J | 1 |
| Kühnl, C | 1 |
| Zähringer, J | 1 |
| Lüderitz, B | 1 |
| Sekiguchi, M | 2 |
| Hiroe, M | 2 |
| Osamura, Y | 1 |
| Take, M | 1 |
| Strumza, P | 1 |
| Mechmeche, R | 1 |
| Rocha, P | 1 |
| Ritchie, JL | 1 |
| Sorensen, S | 1 |
| Kennedy, JW | 1 |
| Hamilton, GW | 1 |
| Fauvel, JM | 2 |
| Birmacker, A | 1 |
| Kayanakis, JG | 1 |
| Krempf, M | 1 |
| Bernadet, P | 1 |
| Mathey, D | 1 |
| Aronow, WS | 1 |
| Faivre, G | 1 |
| Groussin, P | 1 |
| Pesch, C | 1 |
| Chazov, EI | 1 |
| Amsterdam, EA | 4 |
| DeMaria, AN | 1 |
| Miller, RR | 3 |
| Williams, DO | 2 |
| Moskowitz, RM | 1 |
| Kinney, EL | 1 |
| Zelis, RF | 1 |
| Dittel, M | 1 |
| Kiss, E | 1 |
| Nobis, H | 1 |
| Prachar, H | 1 |
| Spiel, R | 1 |
| Mah, PK | 1 |
| Halawa, B | 1 |
| Harpf, H | 1 |
| Baligadoo, S | 2 |
| Ingrand, JC | 1 |
| Maïti, D | 1 |
| Derrida, JP | 2 |
| Savier, CH | 1 |
| Chiche, P | 2 |
| Francoual, M | 2 |
| Miyagishima, Y | 1 |
| Langevin, J | 1 |
| Kennedy, RD | 1 |
| Shah, PK | 2 |
| Vyden, JK | 1 |
| Takano, TT | 1 |
| Rose, HB | 1 |
| Ogawa, T | 1 |
| Herrbach, D | 1 |
| Lesourd, P | 1 |
| Hamlin, RL | 1 |
| Helfant, RH | 2 |
| Bodenheimer, MM | 1 |
| Banka, VS | 1 |
| Schröder, R | 1 |
| Redwood, DR | 2 |
| Werner, J | 1 |
| Hart, R | 1 |
| Awan, N | 1 |
| Kreuzer, H | 2 |
| Sal, R | 1 |
| Lellouche, D | 1 |
| Castaigne, A | 1 |
| Estampes, B | 1 |
| Vernant, P | 1 |
| Lee, SG | 1 |
| Prati, PL | 1 |
| Manfrin, M | 1 |
| Jasiński, K | 1 |
| Poprawski, K | 1 |
| Cagin, NA | 1 |
| Benda, R | 1 |
| Somberg, J | 1 |
| Levitt, B | 2 |
| Reid, PR | 1 |
| Kelly, DT | 1 |
| Taylor, DR | 1 |
| McAnulty, JH | 1 |
| Hattenhauer, MT | 1 |
| Rösch, J | 1 |
| Kloster, FE | 1 |
| Rahimtoola, SH | 4 |
| Zacharoulis, AA | 1 |
| Evans, TR | 1 |
| Ziady, GM | 1 |
| Coltart, DJ | 1 |
| Shillingford, JP | 1 |
| Merrill, A | 1 |
| Vachalowa, J | 2 |
| Mikulic, E | 1 |
| Borer, JS | 1 |
| Cagin, N | 1 |
| Bianchi, C | 1 |
| Vallin, H | 1 |
| Epstein, SE | 1 |
| Larochelle, P | 1 |
| Ogilvie, RI | 1 |
| Hood, WB | 1 |
| Kovick, RB | 1 |
| Tillisch, JH | 1 |
| Berens, SC | 1 |
| Bramowitz, AD | 1 |
| Shine, KI | 1 |
| Warren, SG | 1 |
| Brewer, DL | 1 |
| Orgain, ES | 1 |
| Schöfer, H | 1 |
| Forrester, JS | 2 |
| da Luz, PL | 1 |
| Vismara, LA | 1 |
| Pascal, N | 1 |
| Taylor, WR | 1 |
| Magnusson, P | 1 |
| Takano, T | 2 |
| Swan, HJ | 1 |
| Drew, D | 1 |
| Klausner, SC | 1 |
| Polansky, J | 1 |
| Zacherle, B | 1 |
| Meister, SG | 1 |
| Engel, TR | 1 |
| Guiha, N | 1 |
| Furr, CM | 1 |
| Feitosa, GS | 1 |
| Hart, K | 1 |
| Frankl, WS | 1 |
| Wolf, PS | 1 |
| Urbaszek, W | 1 |
| Löwe, HR | 1 |
| Rentsch, W | 1 |
| Pankau, H | 1 |
| Günther, K | 1 |
| Russel, RO | 1 |
| Moraski, RE | 1 |
| Kosminskiĭ, PG | 1 |
| Vaniev, SB | 2 |
| Vasechkin, SS | 1 |
| Lazarev, IA | 1 |
| Gruzdev, AK | 1 |
| Magnitskiĭ, AV | 1 |
| Sidorenko, BA | 1 |
| Ma, S | 1 |
| Iguchi, H | 1 |
| Kakami, M | 1 |
| Flugelman, MY | 3 |
| Mareev, VIu | 3 |
| Kazeĭ, DV | 3 |
| Ageev, FT | 2 |
| Shevliagin, SA | 1 |
| Grigor'iants, RA | 1 |
| Wortmann, A | 1 |
| Herrmann, I | 1 |
| Göhl, K | 1 |
| Bachmann, K | 1 |
| Imaizumi, T | 2 |
| Hirooka, Y | 1 |
| Takeshita, A | 2 |
| Biasucci, L | 1 |
| Sabba, C | 1 |
| Strom, JA | 2 |
| Galvao, M | 1 |
| Solomon, S | 1 |
| Nikolic, SD | 1 |
| Forman, R | 1 |
| Thadani, U | 3 |
| Wuerz, RC | 1 |
| Meador, SA | 1 |
| Hayoz, D | 1 |
| Hornig, B | 1 |
| Brunner, HR | 1 |
| Taniguchi, K | 1 |
| Tsujibayashi, T | 1 |
| Itoh, H | 1 |
| Katahira, J | 1 |
| Tanaka, M | 1 |
| Nakao, K | 1 |
| Inukai, T | 1 |
| Schneider, W | 1 |
| Hartmann, A | 1 |
| Rezaković, DE | 1 |
| Popadić, M | 1 |
| Popović, G | 1 |
| Pavicić, L | 1 |
| Stalec, J | 1 |
| Nodari, S | 1 |
| Gei, P | 1 |
| Danesi, R | 1 |
| Furloni, R | 1 |
| Cuminetti, S | 1 |
| Dei Cas, L | 1 |
| Zucker, IH | 1 |
| Kékes, E | 1 |
| Anderson, KA | 1 |
| Butorov, IV | 1 |
| Matkovskiĭ, SK | 1 |
| Butorova, VG | 1 |
| Ol'binskaia, LI | 1 |
| Poptsov, VN | 1 |
| Gofman, AM | 1 |
| Cohen-Solal, A | 1 |
| Gourgon, R | 1 |
| David, WJ | 1 |
| Chryssos, BE | 1 |
| Gibelin, P | 1 |
| Ferrari, E | 1 |
| Tiger, F | 1 |
| Morand, P | 1 |
| Lalonde, G | 3 |
| Lemieux, R | 1 |
| Negrescu, EV | 1 |
| Sazonova, LN | 2 |
| Baldenkov, GN | 2 |
| Mazaev, AV | 1 |
| Tkachuk, VA | 1 |
| Blumenberg, D | 1 |
| Wilson, JR | 1 |
| Lanoce, V | 1 |
| Frey, MJ | 1 |
| Ferraro, N | 1 |
| Isnard, R | 1 |
| Aouate, JM | 1 |
| Thomas, D | 1 |
| Grosgogeat, Y | 1 |
| Ichikawa, S | 1 |
| Wakao, Y | 1 |
| Muto, M | 1 |
| Takahashi, M | 1 |
| Shefer, A | 1 |
| Marmor, A | 2 |
| Haude, M | 1 |
| Steffen, W | 1 |
| Erbel, R | 1 |
| Meyer, J | 1 |
| Dirschinger, J | 1 |
| Hall, D | 1 |
| Rudolph, W | 1 |
| Zhilin, SV | 1 |
| Vorob'ev, BI | 1 |
| Kastanaian, AA | 1 |
| Masalitinova, IV | 1 |
| Lebeau, R | 1 |
| Bichet, D | 2 |
| Shehadeh, H | 1 |
| Tamura, M | 1 |
| Kawano, T | 1 |
| Main, JS | 1 |
| Tugarinov, SA | 1 |
| Chaus, NI | 1 |
| Krivitskiĭ, NM | 1 |
| Kislukhin, VV | 1 |
| Khandiukov, SB | 1 |
| Laslett, LJ | 1 |
| Baker, L | 1 |
| Rajecka, A | 1 |
| Pogorzelska, H | 1 |
| Madeja, G | 1 |
| Dück, KD | 1 |
| Richard, F | 1 |
| Vaksmann, G | 1 |
| Rey, E | 2 |
| Francart, C | 1 |
| Olive, G | 2 |
| Dupuis, C | 1 |
| Bayliss, J | 1 |
| Thomas, L | 1 |
| Poole-Wilson, P | 1 |
| Verma, SP | 3 |
| Silke, B | 3 |
| Reynolds, GW | 2 |
| Hafizullah, M | 1 |
| Nelson, GI | 1 |
| Jackson, NC | 1 |
| Richmond, A | 1 |
| Zwaveling, JH | 1 |
| Gans, SJ | 1 |
| Langescheid, C | 1 |
| Lavine, SJ | 1 |
| Campbell, CA | 1 |
| Held, AC | 1 |
| Johnson, V | 1 |
| Keren, G | 2 |
| Katz, S | 1 |
| Strom, J | 1 |
| Sonnenblick, EH | 2 |
| Moser, G | 1 |
| Herpai, Z | 1 |
| Capewell, S | 1 |
| Taverner, D | 1 |
| Hannan, WJ | 1 |
| Muir, AL | 1 |
| Dixon, MS | 1 |
| Culling, W | 1 |
| Engelmann, L | 1 |
| Wetzler, G | 1 |
| Kucher, A | 1 |
| Frömmel, H | 1 |
| Liusov, VA | 1 |
| Ioseliani, DG | 1 |
| Koval', AN | 1 |
| Volov, NA | 1 |
| Gorin, VV | 1 |
| Slavutskiĭ, SIa | 1 |
| Curyło, AM | 1 |
| Webster, MW | 1 |
| Sharpe, DN | 1 |
| Coxon, R | 2 |
| Murphy, J | 1 |
| Hannan, S | 1 |
| Nicholls, MG | 1 |
| Espiner, EA | 1 |
| Ikenouchi, H | 1 |
| Hirata, Y | 1 |
| Iizuka, M | 1 |
| Serizawa, T | 1 |
| Weber, S | 2 |
| Chien, YW | 1 |
| Trippodo, NC | 1 |
| Frohlich, ED | 1 |
| Negresku, EV | 1 |
| Men'shikov, MIu | 1 |
| Mirrakhimov, MM | 1 |
| Moldotashev, IK | 1 |
| Kadyraliev, KK | 1 |
| Keller, N | 1 |
| Sykulski, R | 1 |
| Thamsborg, G | 1 |
| Storm, T | 1 |
| Larsen, J | 1 |
| Kiowski, W | 1 |
| Packer, M | 4 |
| Lee, WH | 3 |
| Medina, N | 3 |
| Yushak, M | 3 |
| Artman, M | 1 |
| Graham, TP | 1 |
| Jordan, RA | 2 |
| Seth, L | 1 |
| Casebolt, P | 1 |
| Hayes, MJ | 1 |
| Wilen, MM | 2 |
| Franciosa, J | 1 |
| Markarian, SS | 1 |
| George, BL | 2 |
| Friedman, WF | 2 |
| Svensson, G | 1 |
| Strandberg, LE | 1 |
| Erhardt, L | 1 |
| Furuta, Y | 1 |
| Takahira, T | 1 |
| Sakurai, M | 1 |
| Hosono, M | 1 |
| Guillot, M | 1 |
| Braud, J | 1 |
| Leveque, C | 1 |
| Iselin, M | 1 |
| Piero Carboni, G | 1 |
| Hubbard, WN | 1 |
| Fish, DR | 1 |
| McBrien, DJ | 1 |
| Autenrieth, G | 1 |
| Menke, G | 1 |
| Woodcock, BG | 1 |
| Rietbrock, N | 1 |
| Bier, A | 1 |
| Laniado, S | 1 |
| Sanghera, SS | 2 |
| Goldberg, AA | 2 |
| Parsons, DG | 2 |
| Talley, RC | 1 |
| Moe, G | 1 |
| Dormidontov, EN | 1 |
| Petrov, DV | 1 |
| Katz, NM | 1 |
| Kubanick, TE | 1 |
| Ahmed, SW | 1 |
| Green, CE | 1 |
| Pearle, DL | 1 |
| Satler, LF | 1 |
| Wallace, RB | 1 |
| Vogt, A | 1 |
| Lefkowitz, CA | 1 |
| Moe, GW | 1 |
| Sharpe, N | 1 |
| Webster, M | 1 |
| Luke, R | 1 |
| Roth, A | 3 |
| Kulick, D | 2 |
| Freidenberger, L | 1 |
| Hong, R | 1 |
| Zharov, EI | 1 |
| Sal'nikov, SN | 1 |
| Vertkin, AL | 1 |
| Krüger, R | 1 |
| Hirosawa, K | 1 |
| Honda, T | 1 |
| Matsumoto, N | 1 |
| Yasuda, H | 1 |
| Kanazawa, T | 1 |
| Miura, M | 1 |
| Hayakawa, H | 1 |
| Belskii, NE | 1 |
| Shira, AI | 1 |
| Gilmar, IS | 1 |
| McIntosh, N | 1 |
| Hsueh, W | 1 |
| Mattioli, G | 1 |
| Tondi, S | 1 |
| Magnavacchi, P | 1 |
| Zennaro, RG | 1 |
| Nardini, M | 1 |
| Daskalov, TR | 1 |
| Mohsenifar, Z | 1 |
| Amin, D | 1 |
| Jasper, AC | 1 |
| Koerner, SK | 1 |
| Kessler, PD | 1 |
| Gottlieb, SS | 1 |
| Heikkilä, J | 1 |
| Pellinen, TJ | 1 |
| Blake, P | 1 |
| McAllister, A | 1 |
| Yardley, J | 1 |
| Schneider, AJ | 1 |
| Teule, GJ | 1 |
| Groeneveld, AB | 1 |
| Nauta, J | 1 |
| Luth, WJ | 1 |
| Thijs, LG | 1 |
| Zeller, FP | 1 |
| Klamerus, KJ | 1 |
| Duprez, D | 1 |
| De Pue, N | 1 |
| Jordaens, L | 1 |
| Clement, D | 1 |
| Kobayashi, A | 1 |
| Hiramatsu, S | 1 |
| Katoh, Y | 1 |
| Muramatsu, J | 1 |
| Kikawada, R | 1 |
| Whitsett, TL | 1 |
| Tangø, M | 1 |
| Trap-Jensen, J | 1 |
| Rehling, M | 1 |
| Jespersen, C | 1 |
| Lyngborg, K | 1 |
| Bolognese, L | 1 |
| Sarasso, G | 1 |
| Rognoni, G | 1 |
| Makmur, J | 1 |
| Fornaro, G | 1 |
| Perucca, A | 1 |
| Rossi, P | 1 |
| Stejfa, M | 1 |
| Vítovec, J | 1 |
| Roubalík, P | 1 |
| Blaha, M | 1 |
| Groth, H | 1 |
| Spuler, A | 1 |
| Vetter, W | 1 |
| Opasich, C | 1 |
| Riccardi, G | 1 |
| Febo, O | 1 |
| Tramarin, R | 1 |
| Lepore, AM | 1 |
| Luca, C | 1 |
| Cobelli, F | 1 |
| Lindvall, K | 1 |
| Eriksson, SV | 1 |
| Lagerstrand, L | 1 |
| Sjögren, A | 1 |
| Natarajan, D | 1 |
| Khurana, TR | 1 |
| Karhade, V | 1 |
| Nigam, PD | 1 |
| Whitsett, T | 1 |
| Ostrzycki, A | 3 |
| Zieliński, T | 1 |
| Jankowski, K | 1 |
| Seith, L | 1 |
| Henry, DA | 1 |
| Beck, OA | 1 |
| Conlon, TP | 1 |
| Das, D | 1 |
| Novikov, SV | 1 |
| Evdokimova, NKh | 1 |
| Pailleret, JJ | 1 |
| Cattan, S | 1 |
| Guérin, F | 1 |
| Degeorges, M | 1 |
| Ashihara, T | 1 |
| Lemke, R | 1 |
| Henriquez, B | 1 |
| Weber, L | 1 |
| Tonnemacher, D | 1 |
| Karbasnikova, GV | 2 |
| Zabel'ian, OM | 2 |
| Barbakova, AA | 1 |
| Valeeva, RM | 2 |
| Zhuikova, AA | 1 |
| Broun, DK | 1 |
| Zapevalov, MV | 1 |
| Kubo, SH | 1 |
| Fox, SC | 1 |
| Prida, XE | 1 |
| Cody, RJ | 1 |
| Langnickel, R | 1 |
| Bluth, R | 1 |
| Gogin, EE | 1 |
| Koniaev, BV | 1 |
| Nesterenko, IuB | 1 |
| Makarenko, AS | 1 |
| Leshchinskiĭ, LA | 1 |
| Vtorov, AE | 1 |
| Golikov, AP | 1 |
| Fishchenko, AD | 1 |
| Trofimov, AK | 1 |
| Schiavoni, G | 1 |
| Mazzari, M | 1 |
| Mongiardo, R | 1 |
| Frustaci, A | 1 |
| Rebuzzi, AG | 1 |
| Pennestrì, F | 1 |
| Amico, C | 1 |
| Bosimini, E | 1 |
| Albanese, S | 1 |
| Manzoli, U | 1 |
| Reynolds, JL | 2 |
| Whitlock, RM | 1 |
| Green, JF | 1 |
| Vatner, SF | 1 |
| Higgins, CB | 1 |
| Braunwald, E | 1 |
| Moll, J | 1 |
| Löhner, J | 1 |
| Khalfen, ESh | 1 |
| Sorokina, VS | 1 |
| Iaikova, MM | 1 |
| Russek, HI | 1 |
| Lochner, W | 2 |
| Hurwitz, MM | 1 |
| Gold, HK | 1 |
| Leinbach, RC | 1 |
| Sanders, CA | 1 |
| Bruce, RA | 1 |
| Eleady-Cole, R | 1 |
| Bennett, LJ | 1 |
| Kusumi, F | 1 |
| Belousov, SS | 1 |
| Gorkina, ME | 1 |
| Malakhova, MA | 1 |
| Ferrero, C | 2 |
| Doret, JP | 2 |
| Foex, P | 2 |
| Eichenberger, G | 2 |
| Collart, F | 2 |
| Burakovskiĭ, VI | 1 |
| Bukharin, VA | 1 |
| Friedli, B | 1 |
| Maeder, J | 1 |
| Eviatar, A | 1 |
| Nager, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension[NCT02425566] | Phase 1 | 12 participants (Anticipated) | Interventional | 2015-04-30 | Active, not recruiting | ||
| A Randomized Controlled Trial to Evaluate Renal Function, Inflammatory Mediators, and Neurohormonal Markers in Acutely Decompensated Heart Failure Patients Receiving Nesiritide Compared to Nitroglycerin.[NCT00842023] | Phase 4 | 89 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| A Randomised Controlled Trial of the Effect of Remote Ischaemic Conditioning on Coronary Endothelial Function in Patients With Angina.[NCT02666235] | Phase 2 | 60 participants (Actual) | Interventional | 2011-07-31 | Completed | ||
| Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction[NCT00832702] | 433 participants (Anticipated) | Observational | 2008-09-17 | Active, not recruiting | |||
| Diagnostic and Prognostic Value of Cardiac Biomarkers and Echocardiography for Patients Hospitalized Due to Acute Dyspnea: Prospective Observational Multicenter Cohort Study[NCT03048032] | 1,566 participants (Actual) | Observational | 2015-04-30 | Completed | |||
| Evaluation of Professional Practices on the Management of Cardiogenic Pulmonary Edema (RENAU-OAP)[NCT03148847] | 859 participants (Actual) | Observational | 2015-01-31 | Terminated (stopped due to Only the first part of the study was done.) | |||
| Comparison of Milrinone Versus Dobutamine in a Heterogeneous Population of Critically Ill Patients[NCT03207165] | Phase 4 | 192 participants (Actual) | Interventional | 2017-08-30 | Completed | ||
| The Effects of Intra Aortic Balloon Pump Prior to Revascularization on Mortality of Patients With Acute Coronary Syndrome Complicated With Cardiogenic Shock[NCT03635840] | 92 participants (Anticipated) | Interventional | 2018-01-04 | Recruiting | |||
| Comparison of Dobutamine Versus Milrinone for Renal Recovery in Patients With Cardiorenal Syndrome-A Prospective Cohort Study in Patients With Acute Decompensated Heart Failure[NCT02644057] | Phase 2 | 0 participants (Actual) | Interventional | 2016-03-31 | Withdrawn (stopped due to Could not enroll patients) | ||
| Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure Reduced Ejection Fraction and Acute Decompensation With Low Cardiac Output: A Single Center, Randomized, Non-Blinded, and Parallel Study (PRIORITY-ADHF Study)[NCT02767024] | Phase 4 | 0 participants (Actual) | Interventional | 2018-05-01 | Withdrawn (stopped due to No patients enrolled) | ||
| [NCT00000491] | Phase 3 | 0 participants | Interventional | 1974-10-31 | Completed | ||
| Vitamin C Supplementation Intervention for Patients With Heart Failure-A Pilot Study[NCT04036110] | 36 participants (Actual) | Interventional | 2018-08-14 | Completed | |||
| The Use of Nesiritide in the Management of Acute Diastolic Heart Failure[NCT00083772] | Phase 4 | 9 participants (Actual) | Interventional | 2004-05-17 | Terminated | ||
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Hemodynamic and Clinical Effects of Natrecor (Nesiritide) Compared With Nitroglycerin Therapy for Symptomatic Decompensated CHF, The VMAC Trial: Vasodilation in the Management of Acu[NCT00270374] | Phase 3 | 498 participants (Actual) | Interventional | 1999-10-31 | Completed | ||
| Double Blind Randomized Placebo Controlled Trial of Natrecor in Patients Hospitalized for Decompensated Heart Failure in the Presence of a Normal Left Ventricular Ejection Fraction[NCT00505791] | Phase 4 | 0 participants (Actual) | Interventional | 2007-08-31 | Withdrawn (stopped due to Unable to enroll patients) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Interleukin-6 (NCT00842023)
Timeframe: 48 hours
| Intervention | pg/mL (Mean) |
|---|---|
| Nesiritide Infusion | 25 |
| Nitroglycerin Infusion | 50 |
Serum creatinine values and changes in serum creatinine (NCT00842023)
Timeframe: Baseline, 24 hours, 48 hours
| Intervention | mg/dL (Mean) | ||
|---|---|---|---|
| Serum creatinine at baseline | Serum creatinine at 24 hours | Serum creatinine at 48 hours | |
| Nesiritide | 1.3 | 1.3 | 1.3 |
| Nitroglycerin | 1.3 | 1.4 | 1.4 |
Cystatin-C is a protease inhibitor and a sensitive endogenous marker of renal function. (NCT00842023)
Timeframe: Baseline, 24 hours, 48 hours
| Intervention | ng/mL (Mean) | ||
|---|---|---|---|
| Cystatin-C at Baseline | Cystatin-C at 24 Hours | Cystatin-C at 48 Hours | |
| Nesiritide | 1332 | 1475 | 1449 |
| Nitroglycerin | 2026 | 3108 | 2739 |
The ELISA (enzyme-linked immunosorbent assay) used to detect and quantify Vitamin C in serum (NCT04036110)
Timeframe: Baseline
| Intervention | ng/mL (Mean) |
|---|---|
| Intervention 1 (500 mg) | 13372 |
| Intervention 2 (1000 mg) | 16079 |
| Control (Placebo) | 13111 |
The ELISA (enzyme-linked immunosorbent assay) used to detect and quantify Vitamin C in serum (NCT04036110)
Timeframe: Month 3
| Intervention | ng/mL (Mean) |
|---|---|
| Intervention 1 (500 mg) | 21309 |
| Intervention 2 (1000 mg) | 20574 |
| Control (Placebo) | 12537 |
The MindWare Mobile impedance cardiograph (model number 50-2303-00) used to measure participant's cardiac function using the parameter of cardiac output. Measured at Baseline and Month 3. (NCT04036110)
Timeframe: Baseline and up to 3 months after enrollment
| Intervention | L/min (Mean) | |
|---|---|---|
| Baseline | Month 3 | |
| Control (Placebo) | 5.6 | 14.2 |
| Intervention 1 (500 mg) | 6.9 | 12.7 |
Health related quality of life is measured using the Minnesota Living with Heart Failure questionnaire (MLHFQ). The MLHFQ is a patient-reported outcome to measure the patient's perceptions of the influence of heart failure on physical and emotional aspects of life. The questionnaire has 21 items to assess the impact of frequent physical symptoms of heart failure and the effects of heart failure on physical and emotional functions. The response scale for all 21 items on the MLHFQ is based on a 6-point (from 0 to 5). Scores are summed to a range of 0-105, in which with higher scores indicate worse health-related quality of life. Measured at Baseline and Month 3. (NCT04036110)
Timeframe: Baseline and up to 3 months after enrollment
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Baseline | Month 3 | |
| Control (Placebo) | 44.2 | 27.6 |
| Intervention 1 (500 mg) | 45.3 | 68.2 |
| Intervention 2 (1000 mg) | 31.4 | 47.4 |
The ELISA (enzyme-linked immunosorbent assay) used to detect and quantify 8-iso-PGF2a isoprostane in serum to reflect oxidative stress. Measured at Baseline and Month 3. (NCT04036110)
Timeframe: Baseline and up to 3 months after enrollment
| Intervention | pg/mL (Mean) | |
|---|---|---|
| Baseline | 3 months | |
| Control (Placebo) | 13832 | 2580 |
| Intervention 1 (500 mg) | 23144 | 507 |
| Intervention 2 (1000 mg) | 10406 | 2431 |
Symptom burden is measured using items from the Memorial Symptom Assessment Scale-Heart Failure (MSAS-HF). The MSAS-HF is an 8-item questionnaire to measure HF symptoms experienced by patients with HF. Patients will be first asked if the symptom was present during the previous 7 days. If present, three characteristics of each symptom will be rated: frequency of symptom, severity of symptom, and degree of symptom distress. Frequency is rated on a scale from 0 to 5 (1=no symptom to 5=all the time), severity rated on a scale from 0 to 5 (0=not at all to 5=extremely) and distress rated on a scale from 0 to 5 (0=not at all to 5=extremely). Burden score for each symptom can range from 0 (no burden) to 4 (greatest symptom frequency, severity, and distress). The total MAS-HF scores are summed to a range of 0-180, with higher scores indicating higher symptom burden. Measured at Baseline and Month 3. (NCT04036110)
Timeframe: Baseline and up to 3 months after enrollment
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Baseline | Month 3 | |
| Control (Placebo) | 31.2 | 20.1 |
| Intervention 1 (500 mg) | 47.5 | 24.5 |
| Intervention 2 (1000 mg) | 20.2 | 24.8 |
96 reviews available for nitroglycerin and Heart Failure
| Article | Year |
|---|---|
Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis.
Topics: Acute Disease; Heart Failure; Humans; Hypertension; Nitroglycerin; Piperazines; Randomized Controlle | 2019 |
Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis.
Topics: Acute Disease; Heart Failure; Humans; Hypertension; Nitroglycerin; Piperazines; Randomized Controlle | 2019 |
Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature.
Topics: Heart Failure; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Pulmo | 2019 |
Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature.
Topics: Heart Failure; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Pulmo | 2019 |
Role of high-dose intravenous nitrates in hypertensive acute heart failure.
Topics: Emergency Service, Hospital; Heart Failure; Humans; Hypertension; Infusions, Intravenous; Nitroglyce | 2020 |
Role of high-dose intravenous nitrates in hypertensive acute heart failure.
Topics: Emergency Service, Hospital; Heart Failure; Humans; Hypertension; Infusions, Intravenous; Nitroglyce | 2020 |
Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
Topics: Adrenomedullin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardio | 2013 |
Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
Topics: Adrenomedullin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardio | 2013 |
Nitrates for acute heart failure syndromes.
Topics: Acute Disease; Adult; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Randomiz | 2013 |
Nitrates for acute heart failure syndromes.
Topics: Acute Disease; Adult; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Randomiz | 2013 |
Impact of intravenous nitroglycerin in the management of acute decompensated heart failure.
Topics: Acute Disease; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Microcirculation; Nitrog | 2015 |
Impact of intravenous nitroglycerin in the management of acute decompensated heart failure.
Topics: Acute Disease; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Microcirculation; Nitrog | 2015 |
Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials.
Topics: Heart Failure; Humans; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Nitroglycerin; Rand | 2016 |
Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials.
Topics: Heart Failure; Humans; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Nitroglycerin; Rand | 2016 |
Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis.
Topics: Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Randomized Con | 2016 |
Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis.
Topics: Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Randomized Con | 2016 |
Nesiritide: the clinical experience.
Topics: Acute Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure | 2008 |
Nesiritide: the clinical experience.
Topics: Acute Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure | 2008 |
[Recent findings on nitrates: their action, bioactivation and development of tolerance].
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Coronary Disease; Drug Tolerance; End | 2008 |
[Recent findings on nitrates: their action, bioactivation and development of tolerance].
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Coronary Disease; Drug Tolerance; End | 2008 |
Prehospital management of congestive heart failure.
Topics: Advanced Cardiac Life Support; Angiotensin-Converting Enzyme Inhibitors; Bronchodilator Agents; Clin | 2009 |
Prehospital management of congestive heart failure.
Topics: Advanced Cardiac Life Support; Angiotensin-Converting Enzyme Inhibitors; Bronchodilator Agents; Clin | 2009 |
Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Diuretics; Emergency Servi | 2009 |
Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Diuretics; Emergency Servi | 2009 |
[Organic nitrates: still interesting after all these years].
Topics: Angina Pectoris; Animals; Drug Tolerance; Free Radicals; Heart; Heart Diseases; Heart Failure; Hemod | 2009 |
[Organic nitrates: still interesting after all these years].
Topics: Angina Pectoris; Animals; Drug Tolerance; Free Radicals; Heart; Heart Diseases; Heart Failure; Hemod | 2009 |
Coupling microcirculation to systemic hemodynamics.
Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Heart Failure; Hemodynamics; Humans; Hydrocor | 2010 |
Coupling microcirculation to systemic hemodynamics.
Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Heart Failure; Hemodynamics; Humans; Hydrocor | 2010 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Mil | 2011 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Mil | 2011 |
Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
Topics: Acute Disease; Blood Pressure; Diuretics; Dyspnea; Furosemide; Heart Failure; Nitroglycerin; Vasodil | 2011 |
Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
Topics: Acute Disease; Blood Pressure; Diuretics; Dyspnea; Furosemide; Heart Failure; Nitroglycerin; Vasodil | 2011 |
The role of venodilators in the perioperative management of heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Hydral | 2012 |
The role of venodilators in the perioperative management of heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Hydral | 2012 |
Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department.
Topics: Atrial Natriuretic Factor; Decision Trees; Diuretics; Emergency Treatment; Heart Failure; Humans; Le | 2002 |
Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department.
Topics: Atrial Natriuretic Factor; Decision Trees; Diuretics; Emergency Treatment; Heart Failure; Humans; Le | 2002 |
B-type natriuretic peptide: from bench to bedside.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiotonic Agents; Diuretics; | 2003 |
B-type natriuretic peptide: from bench to bedside.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiotonic Agents; Diuretics; | 2003 |
Intravenous vasodilator therapy in congestive heart failure.
Topics: Dobutamine; Endothelin Receptor Antagonists; Heart Failure; Humans; Injections, Intravenous; Nitrogl | 2003 |
Intravenous vasodilator therapy in congestive heart failure.
Topics: Dobutamine; Endothelin Receptor Antagonists; Heart Failure; Humans; Injections, Intravenous; Nitrogl | 2003 |
The failing heart and the hemodynamic response to vasodilator therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Decision Making; Heart Failure; Hemody | 2003 |
The failing heart and the hemodynamic response to vasodilator therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Decision Making; Heart Failure; Hemody | 2003 |
Science or fiction: use of nesiritide as a first-line agent?
Topics: Acute Disease; Health Care Costs; Heart Failure; Humans; Natriuretic Peptide, Brain; Nitroglycerin; | 2003 |
Science or fiction: use of nesiritide as a first-line agent?
Topics: Acute Disease; Health Care Costs; Heart Failure; Humans; Natriuretic Peptide, Brain; Nitroglycerin; | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure | 2003 |
Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Topics: Cardiotonic Agents; Decision Trees; Emergency Treatment; Heart Failure; Humans; Milrinone; Natriuret | 2004 |
Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Topics: Cardiotonic Agents; Decision Trees; Emergency Treatment; Heart Failure; Humans; Milrinone; Natriuret | 2004 |
Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance; Heart Failure; Hemodyna | 2004 |
Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance; Heart Failure; Hemodyna | 2004 |
Overview of current noninodilator therapies for acute heart failure syndromes.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Heart Failure; Humans; | 2005 |
Overview of current noninodilator therapies for acute heart failure syndromes.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Heart Failure; Humans; | 2005 |
Critical review and recommendations for nesiritide use in the emergency department.
Topics: Cardiotonic Agents; Emergency Service, Hospital; Heart Failure; Humans; Natriuretic Agents; Natriure | 2005 |
Critical review and recommendations for nesiritide use in the emergency department.
Topics: Cardiotonic Agents; Emergency Service, Hospital; Heart Failure; Humans; Natriuretic Agents; Natriure | 2005 |
Optimizing outcomes in the patient with acute decompensated heart failure.
Topics: Biomarkers; Cardiotonic Agents; Diuretics; Heart Failure; Hemodynamics; Humans; Hydrazones; Milrinon | 2006 |
Optimizing outcomes in the patient with acute decompensated heart failure.
Topics: Biomarkers; Cardiotonic Agents; Diuretics; Heart Failure; Hemodynamics; Humans; Hydrazones; Milrinon | 2006 |
[Acute heart failure].
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Diuretics; Echocardiogr | 2006 |
[Acute heart failure].
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Diuretics; Echocardiogr | 2006 |
Vasodilators in acute heart failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Diuretics; Drug T | 2007 |
Vasodilators in acute heart failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Diuretics; Drug T | 2007 |
[Chronic heart failure treatment in the year 2006].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting E | 2006 |
[Chronic heart failure treatment in the year 2006].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting E | 2006 |
[Respiratory management of acute and chronic heart failure].
Topics: Acute Disease; Chronic Disease; Diagnosis, Differential; Heart Failure; Humans; Morphine; Nitroglyce | 2007 |
[Respiratory management of acute and chronic heart failure].
Topics: Acute Disease; Chronic Disease; Diagnosis, Differential; Heart Failure; Humans; Morphine; Nitroglyce | 2007 |
[Mechanisms of the therapeutic action of vasodilator agents in cardiac insufficiency (review of the literature)].
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Disease; Dogs; Heart Failure; Humans; Muscle Relaxan | 1981 |
[Mechanisms of the therapeutic action of vasodilator agents in cardiac insufficiency (review of the literature)].
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Disease; Dogs; Heart Failure; Humans; Muscle Relaxan | 1981 |
The transdermal administration of nitrates: an overview.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Blood Pressure; Coronary Disease; Ex | 1983 |
The transdermal administration of nitrates: an overview.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Blood Pressure; Coronary Disease; Ex | 1983 |
Vasodilators in acute circulatory failure.
Topics: Albuterol; Captopril; Chlorpromazine; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin; Ni | 1983 |
Vasodilators in acute circulatory failure.
Topics: Albuterol; Captopril; Chlorpromazine; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin; Ni | 1983 |
Perioperative management of drug therapy.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Antihypertensive Agents; Cardiac Glycosides; Diuretics; Hear | 1983 |
Perioperative management of drug therapy.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Antihypertensive Agents; Cardiac Glycosides; Diuretics; Hear | 1983 |
Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Angina, Unstable; Animals; Cardiac Sur | 1984 |
Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Angina, Unstable; Animals; Cardiac Sur | 1984 |
[Vasodilator agents in the treatment of cardiac insufficiency].
Topics: Captopril; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; Phentola | 1984 |
[Vasodilator agents in the treatment of cardiac insufficiency].
Topics: Captopril; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; Phentola | 1984 |
Intravenous nitroglycerin and cardiac failure.
Topics: Heart Failure; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Infarction; | 1984 |
Intravenous nitroglycerin and cardiac failure.
Topics: Heart Failure; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Infarction; | 1984 |
Intravenous nitroglycerin: clinical pharmacology and therapeutic considerations.
Topics: Angina, Unstable; Coronary Artery Bypass; Heart Failure; Humans; Infusions, Parenteral; Myocardial I | 1984 |
Intravenous nitroglycerin: clinical pharmacology and therapeutic considerations.
Topics: Angina, Unstable; Coronary Artery Bypass; Heart Failure; Humans; Infusions, Parenteral; Myocardial I | 1984 |
Nitrate delivery systems in perspective. A decade of progress.
Topics: Administration, Intranasal; Administration, Oral; Administration, Topical; Angina Pectoris; Heart Fa | 1984 |
Nitrate delivery systems in perspective. A decade of progress.
Topics: Administration, Intranasal; Administration, Oral; Administration, Topical; Angina Pectoris; Heart Fa | 1984 |
Acute alveolar edema.
Topics: Acute Disease; Adrenal Cortex Hormones; Altitude Sickness; Aminophylline; Anti-Arrhythmia Agents; Ca | 1983 |
Acute alveolar edema.
Topics: Acute Disease; Adrenal Cortex Hormones; Altitude Sickness; Aminophylline; Anti-Arrhythmia Agents; Ca | 1983 |
[Treatment of heart failure with vasodilators].
Topics: Captopril; Cardiomegaly; Cardiotonic Agents; Coronary Disease; Heart Failure; Heart Function Tests; | 1980 |
[Treatment of heart failure with vasodilators].
Topics: Captopril; Cardiomegaly; Cardiotonic Agents; Coronary Disease; Heart Failure; Heart Function Tests; | 1980 |
Nitrate tolerance and dependence.
Topics: Ambulatory Care; Angina Pectoris; Animals; Cardiovascular Diseases; Dogs; Drug Tolerance; Heart Fail | 1980 |
Nitrate tolerance and dependence.
Topics: Ambulatory Care; Angina Pectoris; Animals; Cardiovascular Diseases; Dogs; Drug Tolerance; Heart Fail | 1980 |
Radionuclide wall motion study and ejection fraction in clinical practice.
Topics: Aminophylline; Coronary Artery Bypass; Coronary Disease; Doxorubicin; Erythrocytes; Heart; Heart Dis | 1980 |
Radionuclide wall motion study and ejection fraction in clinical practice.
Topics: Aminophylline; Coronary Artery Bypass; Coronary Disease; Doxorubicin; Erythrocytes; Heart; Heart Dis | 1980 |
Nitroglycerin and long-acting nitrates.
Topics: Administration, Oral; Coronary Circulation; Coronary Disease; Delayed-Action Preparations; Drug Tole | 1980 |
Nitroglycerin and long-acting nitrates.
Topics: Administration, Oral; Coronary Circulation; Coronary Disease; Delayed-Action Preparations; Drug Tole | 1980 |
Vasodilator therapy for chronic heart failure.
Topics: Captopril; Chronic Disease; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglyceri | 1980 |
Vasodilator therapy for chronic heart failure.
Topics: Captopril; Chronic Disease; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglyceri | 1980 |
Intravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications.
Topics: Angina Pectoris; Animals; Cardiovascular System; Heart Diseases; Heart Failure; Humans; Hypertension | 1981 |
Intravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications.
Topics: Angina Pectoris; Animals; Cardiovascular System; Heart Diseases; Heart Failure; Humans; Hypertension | 1981 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocar | 1980 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocar | 1980 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Di | 1980 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Di | 1980 |
Cardiovascular clinical pharmacology of impedance reducing agents.
Topics: Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; | 1981 |
Cardiovascular clinical pharmacology of impedance reducing agents.
Topics: Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; | 1981 |
[The role of vasodilators in the treatment of congestive heart failure and myocardial ischaemia (author's transl)].
Topics: Coronary Disease; Electrocardiography; Heart Failure; Humans; Nitroglycerin; Nitroprusside; Phentola | 1981 |
[The role of vasodilators in the treatment of congestive heart failure and myocardial ischaemia (author's transl)].
Topics: Coronary Disease; Electrocardiography; Heart Failure; Humans; Nitroglycerin; Nitroprusside; Phentola | 1981 |
Early intervention in patients with heart failure and left ventricular dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Heart Failure; Humans; Myocardia | 1995 |
Early intervention in patients with heart failure and left ventricular dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Heart Failure; Humans; Myocardia | 1995 |
Mechanisms of action of nitrates.
Topics: Angina Pectoris; Blood Platelets; Cyclic GMP-Dependent Protein Kinases; Cytochrome P-450 Enzyme Syst | 1994 |
Mechanisms of action of nitrates.
Topics: Angina Pectoris; Blood Platelets; Cyclic GMP-Dependent Protein Kinases; Cytochrome P-450 Enzyme Syst | 1994 |
Nitrates and nitrate tolerance in congestive heart failure.
Topics: Animals; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Neurotransmitte | 1993 |
Nitrates and nitrate tolerance in congestive heart failure.
Topics: Animals; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Neurotransmitte | 1993 |
Mechanisms of nitrate tolerance.
Topics: Angina Pectoris; Animals; Drug Administration Routes; Drug Therapy, Combination; Drug Tolerance; Hea | 1994 |
Mechanisms of nitrate tolerance.
Topics: Angina Pectoris; Animals; Drug Administration Routes; Drug Therapy, Combination; Drug Tolerance; Hea | 1994 |
[Vasodilator therapy in cardiac failure].
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroglycerin | 1993 |
[Vasodilator therapy in cardiac failure].
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroglycerin | 1993 |
[Effectiveness, tolerance, adverse effects of prolonged therapy with nitrate compounds].
Topics: Drug Tolerance; Heart Failure; Humans; Nitrates; Nitroglycerin; Treatment Outcome; Vasodilator Agent | 1996 |
[Effectiveness, tolerance, adverse effects of prolonged therapy with nitrate compounds].
Topics: Drug Tolerance; Heart Failure; Humans; Nitrates; Nitroglycerin; Treatment Outcome; Vasodilator Agent | 1996 |
[Emergency treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Analgesics, Opioid; Angioplasty, Balloon, Coronary | 1999 |
[Emergency treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Analgesics, Opioid; Angioplasty, Balloon, Coronary | 1999 |
[Cardiac therapy in the old patient].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Body Water; Calcium; Clonidine; Digitalis Glycos | 1979 |
[Cardiac therapy in the old patient].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Body Water; Calcium; Clonidine; Digitalis Glycos | 1979 |
Myocardial infarction size: measurement and modification.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Disease; Creatine Kinase; Digitalis Glycoside | 1977 |
Myocardial infarction size: measurement and modification.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Disease; Creatine Kinase; Digitalis Glycoside | 1977 |
Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Topics: Aorta; Cardiac Output; Chronic Disease; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans | 1978 |
Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Topics: Aorta; Cardiac Output; Chronic Disease; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans | 1978 |
Nitroglycerin and nitrate esters.
Topics: Angina Pectoris; Animals; Blood Pressure; Cardiac Output; Coronary Circulation; Esters; Heart Failur | 1978 |
Nitroglycerin and nitrate esters.
Topics: Angina Pectoris; Animals; Blood Pressure; Cardiac Output; Coronary Circulation; Esters; Heart Failur | 1978 |
Intravenous nitroglycerin: a review.
Topics: Animals; Cardiac Catheterization; Coronary Vessels; Heart Failure; Humans; Hypertension; Hypotension | 1978 |
Intravenous nitroglycerin: a review.
Topics: Animals; Cardiac Catheterization; Coronary Vessels; Heart Failure; Humans; Hypertension; Hypotension | 1978 |
[Vasodilator therapy in heart failure (author's transl)].
Topics: Aortic Valve Insufficiency; Coronary Vessels; Heart Failure; Heart Septal Defects, Ventricular; Huma | 1978 |
[Vasodilator therapy in heart failure (author's transl)].
Topics: Aortic Valve Insufficiency; Coronary Vessels; Heart Failure; Heart Septal Defects, Ventricular; Huma | 1978 |
[Acute heart failure and vasodilator therapy].
Topics: Acute Disease; Aged; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Oi | 1978 |
[Acute heart failure and vasodilator therapy].
Topics: Acute Disease; Aged; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Oi | 1978 |
[The efficacy of the intra-aortic balloon pump for patients with heart failure complicating acute myocardial infarction (author's transl)].
Topics: Adult; Aged; Aortic Valve Insufficiency; Assisted Circulation; Dopamine; Furosemide; Heart Failure; | 1979 |
[The efficacy of the intra-aortic balloon pump for patients with heart failure complicating acute myocardial infarction (author's transl)].
Topics: Adult; Aged; Aortic Valve Insufficiency; Assisted Circulation; Dopamine; Furosemide; Heart Failure; | 1979 |
[Use of vasodilator agents in circulatory insufficienty].
Topics: Blood Circulation; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitro | 1979 |
[Use of vasodilator agents in circulatory insufficienty].
Topics: Blood Circulation; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitro | 1979 |
Drug therapy for cardiovascular disease in the aged.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Benzothiadiazines; C | 1975 |
Drug therapy for cardiovascular disease in the aged.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Benzothiadiazines; C | 1975 |
Vasodilator therapy of cardiac failure: (first of two parts).
Topics: Blood Vessels; Diuretics; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Nitrat | 1977 |
Vasodilator therapy of cardiac failure: (first of two parts).
Topics: Blood Vessels; Diuretics; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Nitrat | 1977 |
[Vasodilator therapy of congestive heart failure].
Topics: Acute Disease; Blood Pressure; Cardiac Output; Chronic Disease; Heart Failure; Humans; Isosorbide Di | 1977 |
[Vasodilator therapy of congestive heart failure].
Topics: Acute Disease; Blood Pressure; Cardiac Output; Chronic Disease; Heart Failure; Humans; Isosorbide Di | 1977 |
[Vasodilators: treatment of cardiac insufficiency].
Topics: Heart Failure; Humans; Hydralazine; Mitral Valve Insufficiency; Myocardial Infarction; Nitroglycerin | 1977 |
[Vasodilators: treatment of cardiac insufficiency].
Topics: Heart Failure; Humans; Hydralazine; Mitral Valve Insufficiency; Myocardial Infarction; Nitroglycerin | 1977 |
[Vasodilator agents in the treatment of heart failure].
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitroprusside; P | 1978 |
[Vasodilator agents in the treatment of heart failure].
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitroprusside; P | 1978 |
[Treatment of cardiac failure with vasodilators (author's transl)].
Topics: Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; Hydralazine; Hypotension; I | 1978 |
[Treatment of cardiac failure with vasodilators (author's transl)].
Topics: Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; Hydralazine; Hypotension; I | 1978 |
Modification of infarct size.
Topics: Animals; Assisted Circulation; Coronary Circulation; Creatine Kinase; Electrocardiography; Heart; He | 1975 |
Modification of infarct size.
Topics: Animals; Assisted Circulation; Coronary Circulation; Creatine Kinase; Electrocardiography; Heart; He | 1975 |
Cardiac asthma--its origin, recognition and management.
Topics: Airway Resistance; Aminophylline; Animals; Bronchial Spasm; Digitalis Glycosides; Diuretics; Dyspnea | 1976 |
Cardiac asthma--its origin, recognition and management.
Topics: Airway Resistance; Aminophylline; Animals; Bronchial Spasm; Digitalis Glycosides; Diuretics; Dyspnea | 1976 |
Nitrate therapy in heart failure.
Topics: Administration, Cutaneous; Chronic Disease; Drug Administration Schedule; Heart Failure; Humans; Inf | 1991 |
Nitrate therapy in heart failure.
Topics: Administration, Cutaneous; Chronic Disease; Drug Administration Schedule; Heart Failure; Humans; Inf | 1991 |
A practical guide to nitrate use.
Topics: Angina Pectoris; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; | 1991 |
A practical guide to nitrate use.
Topics: Angina Pectoris; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; | 1991 |
[Ventricular "remodeling" after myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Heart Ventricles; Humans; Myocardial Infarc | 1991 |
[Ventricular "remodeling" after myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Heart Ventricles; Humans; Myocardial Infarc | 1991 |
Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure.
Topics: Adult; Blood Platelets; Calcium; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Nifedipin | 1990 |
Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure.
Topics: Adult; Blood Platelets; Calcium; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Nifedipin | 1990 |
[Tolerance of treatment with nitrate derivatives].
Topics: Administration, Cutaneous; Blood Pressure; Coronary Disease; Drug Tolerance; Heart Failure; Heart Ra | 1990 |
[Tolerance of treatment with nitrate derivatives].
Topics: Administration, Cutaneous; Blood Pressure; Coronary Disease; Drug Tolerance; Heart Failure; Heart Ra | 1990 |
[Nitrates in the treatment of heart failure].
Topics: Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrate | 1990 |
[Nitrates in the treatment of heart failure].
Topics: Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrate | 1990 |
[Use of nitroglycerin in the treatment of congestive heart failure].
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Nitroglycerin | 1989 |
[Use of nitroglycerin in the treatment of congestive heart failure].
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Nitroglycerin | 1989 |
[Echocardiography under physical loading].
Topics: Adult; Aging; Coronary Disease; Echocardiography; Exercise Test; Heart; Heart Failure; Hemodynamics; | 1986 |
[Echocardiography under physical loading].
Topics: Adult; Aging; Coronary Disease; Echocardiography; Exercise Test; Heart; Heart Failure; Hemodynamics; | 1986 |
Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
Topics: Angina Pectoris; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitrates; Nitro | 1987 |
Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
Topics: Angina Pectoris; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitrates; Nitro | 1987 |
Controversies in the use of transdermal nitroglycerin systems.
Topics: Administration, Topical; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodyna | 1987 |
Controversies in the use of transdermal nitroglycerin systems.
Topics: Administration, Topical; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodyna | 1987 |
Nitrates.
Topics: Animals; Cardiovascular Diseases; Coronary Disease; Heart Failure; Humans; Nitrates; Nitroglycerin | 1988 |
Nitrates.
Topics: Animals; Cardiovascular Diseases; Coronary Disease; Heart Failure; Humans; Nitrates; Nitroglycerin | 1988 |
Nitrate therapy: continuous or pulse dosing.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Heart Failure; Humans; Isosorbide Dini | 1987 |
Nitrate therapy: continuous or pulse dosing.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Heart Failure; Humans; Isosorbide Dini | 1987 |
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.
Topics: Angina Pectoris; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Heart Failure; Hemodynam | 1988 |
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.
Topics: Angina Pectoris; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Heart Failure; Hemodynam | 1988 |
Hemodynamic effects of nitroglycerin and long-acting nitrates.
Topics: Angina Pectoris; Arteries; Arterioles; Blood Circulation; Coronary Circulation; Coronary Disease; Ex | 1985 |
Hemodynamic effects of nitroglycerin and long-acting nitrates.
Topics: Angina Pectoris; Arteries; Arterioles; Blood Circulation; Coronary Circulation; Coronary Disease; Ex | 1985 |
Nitrate tolerance.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Drug Administration Schedule; Drug T | 1985 |
Nitrate tolerance.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Drug Administration Schedule; Drug T | 1985 |
Mechanisms of nitrate action in patients with severe left ventricular failure: conceptual problems with the theory of venosequestration.
Topics: Arteries; Blood Volume; Heart Failure; Heart Ventricles; Humans; Isosorbide Dinitrate; Nitroglycerin | 1985 |
Mechanisms of nitrate action in patients with severe left ventricular failure: conceptual problems with the theory of venosequestration.
Topics: Arteries; Blood Volume; Heart Failure; Heart Ventricles; Humans; Isosorbide Dinitrate; Nitroglycerin | 1985 |
Pharmacology of nitroglycerin and long-acting nitrates.
Topics: Absorption; Administration, Oral; Administration, Topical; Angina Pectoris; Animals; Cheek; Delayed- | 1985 |
Pharmacology of nitroglycerin and long-acting nitrates.
Topics: Absorption; Administration, Oral; Administration, Topical; Angina Pectoris; Animals; Cheek; Delayed- | 1985 |
New nitroglycerin formulations: transdermal and transmucosal nitroglycerin.
Topics: Administration, Oral; Administration, Topical; Heart Failure; Humans; Mouth Mucosa; Nitroglycerin; T | 1985 |
New nitroglycerin formulations: transdermal and transmucosal nitroglycerin.
Topics: Administration, Oral; Administration, Topical; Heart Failure; Humans; Mouth Mucosa; Nitroglycerin; T | 1985 |
Current concepts in the drug management of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Circulation; Diagnosis, Differential; Digital | 1974 |
Current concepts in the drug management of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Circulation; Diagnosis, Differential; Digital | 1974 |
[Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
Topics: Animals; Aorta; Blood Circulation; Blood Flow Velocity; Blood Pressure; Coronary Vessels; Depression | 1970 |
[Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
Topics: Animals; Aorta; Blood Circulation; Blood Flow Velocity; Blood Pressure; Coronary Vessels; Depression | 1970 |
98 trials available for nitroglycerin and Heart Failure
| Article | Year |
|---|---|
Effect of nitroglycerin on splanchnic and pulmonary blood volume.
Topics: Blood Pressure; Blood Volume; Heart Failure; Humans; Lung; Nitroglycerin; Radioisotopes | 2022 |
Effect of nitroglycerin on splanchnic and pulmonary blood volume.
Topics: Blood Pressure; Blood Volume; Heart Failure; Humans; Lung; Nitroglycerin; Radioisotopes | 2022 |
Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study.
Topics: Adult; Double-Blind Method; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Nitroglycerin; Py | 2022 |
Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study.
Topics: Adult; Double-Blind Method; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Nitroglycerin; Py | 2022 |
Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite.
Topics: Aged; Brachial Artery; Cohort Studies; Drug Tolerance; Female; Forearm; Heart Failure; Hemodynamics; | 2013 |
Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite.
Topics: Aged; Brachial Artery; Cohort Studies; Drug Tolerance; Female; Forearm; Heart Failure; Hemodynamics; | 2013 |
A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Echocardiography; Heart Failure; Humans; Kidney Funct | 2015 |
A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Echocardiography; Heart Failure; Humans; Kidney Funct | 2015 |
Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure-a randomized, controlled, double-blind, crossover trial.
Topics: Administration, Inhalation; Aged; Cardiac Catheterization; Cardiac Output; Cheyne-Stokes Respiration | 2016 |
Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure-a randomized, controlled, double-blind, crossover trial.
Topics: Administration, Inhalation; Aged; Cardiac Catheterization; Cardiac Output; Cheyne-Stokes Respiration | 2016 |
Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diastole; Dyspnea; Echocardiography; Emergency | 2017 |
Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diastole; Dyspnea; Echocardiography; Emergency | 2017 |
A response-adaptive design of initial therapy for emergency department patients with heart failure.
Topics: Acute Disease; Bayes Theorem; Blood Pressure; Diuretics; Dyspnea; Emergency Service, Hospital; Furos | 2017 |
A response-adaptive design of initial therapy for emergency department patients with heart failure.
Topics: Acute Disease; Bayes Theorem; Blood Pressure; Diuretics; Dyspnea; Emergency Service, Hospital; Furos | 2017 |
Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Cause of Death; Female; Heart Failure; | 2017 |
Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Cause of Death; Female; Heart Failure; | 2017 |
Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
Topics: Adenosine Diphosphate; Aged; Blood; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Re | 2010 |
Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
Topics: Adenosine Diphosphate; Aged; Blood; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Re | 2010 |
Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Female; Heart Failure; Humans; Infusions, Intrav | 2011 |
Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Female; Heart Failure; Humans; Infusions, Intrav | 2011 |
Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cystatin C; Female; Glomerular Filtration R | 2011 |
Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cystatin C; Female; Glomerular Filtration R | 2011 |
Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Flow Velocity; Coronary Circulation; Coronary Vessels; | 2013 |
Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Flow Velocity; Coronary Circulation; Coronary Vessels; | 2013 |
Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
Topics: Cardiac Catheterization; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Hemodynamic | 2004 |
Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
Topics: Cardiac Catheterization; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Hemodynamic | 2004 |
Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy.
Topics: Acute Disease; Cardiac Catheterization; Coronary Disease; Double-Blind Method; Female; Heart Failure | 2004 |
Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy.
Topics: Acute Disease; Cardiac Catheterization; Coronary Disease; Double-Blind Method; Female; Heart Failure | 2004 |
Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction.
Topics: Aged; Angina Pectoris; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Myocardial Infar | 2004 |
Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction.
Topics: Aged; Angina Pectoris; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Myocardial Infar | 2004 |
Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Brachial Artery; Dobutamine; Drug Therapy, Combination; Endot | 2004 |
Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Brachial Artery; Dobutamine; Drug Therapy, Combination; Endot | 2004 |
[Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study].
Topics: Adolescent; Adult; Aged; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Natri | 2006 |
[Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study].
Topics: Adolescent; Adult; Aged; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Natri | 2006 |
Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
Topics: Aged; Emergency Service, Hospital; Feasibility Studies; Female; Heart Failure; Humans; Infusions, In | 2007 |
Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
Topics: Aged; Emergency Service, Hospital; Feasibility Studies; Female; Heart Failure; Humans; Infusions, In | 2007 |
Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure.
Topics: Aged; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Hydrazones; Intercellul | 2008 |
Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure.
Topics: Aged; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Hydrazones; Intercellul | 2008 |
Effect of atrial natriuretic peptide on adiponectin in patients with heart failure.
Topics: Adiponectin; Atrial Natriuretic Factor; Body Mass Index; Brain-Derived Neurotrophic Factor; Dose-Res | 2008 |
Effect of atrial natriuretic peptide on adiponectin in patients with heart failure.
Topics: Adiponectin; Atrial Natriuretic Factor; Body Mass Index; Brain-Derived Neurotrophic Factor; Dose-Res | 2008 |
[Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
Topics: Aged; Aged, 80 and over; Blood Pressure; Female; Heart Failure; Humans; Infusions, Intravenous; Male | 2008 |
[Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
Topics: Aged; Aged, 80 and over; Blood Pressure; Female; Heart Failure; Humans; Infusions, Intravenous; Male | 2008 |
[Long-term drug treatment of chronic heart failure].
Topics: Adrenergic beta-Antagonists; Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitroglyce | 1984 |
[Long-term drug treatment of chronic heart failure].
Topics: Adrenergic beta-Antagonists; Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitroglyce | 1984 |
A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction.
Topics: Aged; Creatine Kinase; Echocardiography; Electrocardiography; Female; Heart; Heart Failure; Hemodyna | 1983 |
A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction.
Topics: Aged; Creatine Kinase; Echocardiography; Electrocardiography; Female; Heart; Heart Failure; Hemodyna | 1983 |
Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Angina, Unstable; Animals; Cardiac Sur | 1984 |
Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Angina, Unstable; Animals; Cardiac Sur | 1984 |
Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure.
Topics: Adult; Aged; Cheek; Drug Evaluation; Exercise Test; Heart; Heart Failure; Hemodynamics; Humans; Midd | 1984 |
Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure.
Topics: Adult; Aged; Cheek; Drug Evaluation; Exercise Test; Heart; Heart Failure; Hemodynamics; Humans; Midd | 1984 |
Multicenter studies of 2% nitroglycerin ointment in patients with heart failure.
Topics: Administration, Topical; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Female; Heart Fai | 1984 |
Multicenter studies of 2% nitroglycerin ointment in patients with heart failure.
Topics: Administration, Topical; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Female; Heart Fai | 1984 |
[Efficacy of using vasodilating preparations in latent heart failure in patients with chronic ischemic heart disease].
Topics: Blood Pressure; Clinical Trials as Topic; Coronary Disease; Exercise Test; Female; Heart Failure; Hu | 1984 |
[Efficacy of using vasodilating preparations in latent heart failure in patients with chronic ischemic heart disease].
Topics: Blood Pressure; Clinical Trials as Topic; Coronary Disease; Exercise Test; Female; Heart Failure; Hu | 1984 |
[Haemodynamic effects after application of nitroglycerin sublingually or as ointment in patients with left ventricular heart failure (author's transl)].
Topics: Administration, Oral; Aged; Blood Pressure; Cardiac Output; Heart Failure; Humans; Middle Aged; Mout | 1980 |
[Haemodynamic effects after application of nitroglycerin sublingually or as ointment in patients with left ventricular heart failure (author's transl)].
Topics: Administration, Oral; Aged; Blood Pressure; Cardiac Output; Heart Failure; Humans; Middle Aged; Mout | 1980 |
[Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
Topics: Administration, Oral; Adult; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans | 1980 |
[Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
Topics: Administration, Oral; Adult; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans | 1980 |
[Prolonged hemodynamic effects of a nitroglycerin microcapsule preparation administed orally (author's transl)].
Topics: Administration, Oral; Adult; Aged; Capsules; Dose-Response Relationship, Drug; Female; Heart Failure | 1980 |
[Prolonged hemodynamic effects of a nitroglycerin microcapsule preparation administed orally (author's transl)].
Topics: Administration, Oral; Adult; Aged; Capsules; Dose-Response Relationship, Drug; Female; Heart Failure | 1980 |
[Drugs modifying preload and/or afterload in patients with post-infarct circulatory insufficiency].
Topics: Aged; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Infusions, Parente | 1980 |
[Drugs modifying preload and/or afterload in patients with post-infarct circulatory insufficiency].
Topics: Aged; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Infusions, Parente | 1980 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocar | 1980 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocar | 1980 |
[Changes in diameters of small pulmonary venous and arterial vessels after nitroglycerin (author's transl)].
Topics: Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Pul | 1981 |
[Changes in diameters of small pulmonary venous and arterial vessels after nitroglycerin (author's transl)].
Topics: Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Pul | 1981 |
Radionuclide evaluation of CHF.
Topics: Adolescent; Adult; Coronary Disease; Digoxin; Female; Heart Aneurysm; Heart Failure; Hemodynamics; H | 1981 |
Radionuclide evaluation of CHF.
Topics: Adolescent; Adult; Coronary Disease; Digoxin; Female; Heart Aneurysm; Heart Failure; Hemodynamics; H | 1981 |
Vasodilators in heart failure.
Topics: Clinical Trials as Topic; Heart Failure; Humans; Nitroglycerin | 1982 |
Vasodilators in heart failure.
Topics: Clinical Trials as Topic; Heart Failure; Humans; Nitroglycerin | 1982 |
Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Drug Therapy, Combination; Drug Tolerance; Female | 1995 |
Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Drug Therapy, Combination; Drug Tolerance; Female | 1995 |
Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Cyclic GMP; Female; Heart Failure; Hemodynamics; | 1995 |
Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Cyclic GMP; Female; Heart Failure; Hemodynamics; | 1995 |
Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
Topics: Adult; Aged; Angina Pectoris; Captopril; Coronary Disease; Digoxin; Double-Blind Method; Drug Therap | 1993 |
Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
Topics: Adult; Aged; Angina Pectoris; Captopril; Coronary Disease; Digoxin; Double-Blind Method; Drug Therap | 1993 |
Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; | 1994 |
Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; | 1994 |
Comparison of the effects of two different galenical preparations of glyceryl trinitrate on pulmonary artery pressure and on the finger pulse curve.
Topics: Adult; Aged; Blood Pressure; Cardiac Catheterization; Double-Blind Method; Female; Fingers; Heart Fa | 1993 |
Comparison of the effects of two different galenical preparations of glyceryl trinitrate on pulmonary artery pressure and on the finger pulse curve.
Topics: Adult; Aged; Blood Pressure; Cardiac Catheterization; Double-Blind Method; Female; Fingers; Heart Fa | 1993 |
Prevention of nitrate tolerance with concomitant administration of hydralazine.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolera | 1996 |
Prevention of nitrate tolerance with concomitant administration of hydralazine.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolera | 1996 |
Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Fa | 1995 |
Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Fa | 1995 |
Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure.
Topics: Acetylcholine; Adult; Cross-Over Studies; Endothelium, Vascular; Heart Failure; Humans; Male; Nitric | 1996 |
Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure.
Topics: Acetylcholine; Adult; Cross-Over Studies; Endothelium, Vascular; Heart Failure; Humans; Male; Nitric | 1996 |
[A trial of the use of the transdermal preparation Deponit for treating stenocardia].
Topics: Administration, Cutaneous; Adult; Aged; Angina Pectoris; Angina, Unstable; Exercise Test; Female; He | 1996 |
[A trial of the use of the transdermal preparation Deponit for treating stenocardia].
Topics: Administration, Cutaneous; Adult; Aged; Angina Pectoris; Angina, Unstable; Exercise Test; Female; He | 1996 |
Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
Topics: Aged; Death, Sudden, Cardiac; Double-Blind Method; Drug Tolerance; Female; Heart Failure; Humans; Is | 1996 |
Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
Topics: Aged; Death, Sudden, Cardiac; Double-Blind Method; Drug Tolerance; Female; Heart Failure; Humans; Is | 1996 |
The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Double-Blind Method; Drug Tolerance; Female; Heart | 1997 |
The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Double-Blind Method; Drug Tolerance; Female; Heart | 1997 |
Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
Topics: Aged; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusion | 1997 |
Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
Topics: Aged; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusion | 1997 |
Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure.
Topics: Aged; Ascorbic Acid; Blood Platelets; Blood Pressure; Cyclic GMP; Double-Blind Method; Drug Toleranc | 1998 |
Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure.
Topics: Aged; Ascorbic Acid; Blood Platelets; Blood Pressure; Cyclic GMP; Double-Blind Method; Drug Toleranc | 1998 |
Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
Topics: Administration, Cutaneous; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor | 1998 |
Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
Topics: Administration, Cutaneous; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor | 1998 |
Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
Topics: Adrenergic Antagonists; Aged; Blood Flow Velocity; Blood Platelets; Blood Pressure; Carbazoles; Carv | 1998 |
Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
Topics: Adrenergic Antagonists; Aged; Blood Flow Velocity; Blood Platelets; Blood Pressure; Carbazoles; Carv | 1998 |
Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent.
Topics: Aged; Aged, 80 and over; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Male; Muscle | 1998 |
Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent.
Topics: Aged; Aged, 80 and over; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Male; Muscle | 1998 |
Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation.
Topics: Acetylcholine; Administration, Oral; Aged; Arginine; Blood Flow Velocity; Endothelium, Vascular; Exe | 2000 |
Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation.
Topics: Acetylcholine; Administration, Oral; Aged; Arginine; Blood Flow Velocity; Endothelium, Vascular; Exe | 2000 |
Impact of left ventricular size on pharmacologic reverse remodeling in heart failure.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution | 2000 |
Impact of left ventricular size on pharmacologic reverse remodeling in heart failure.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution | 2000 |
Impaired vasodilatation response to amrinone in the forearm of patients with congestive heart failure: role of endothelium-derived nitric oxide.
Topics: Acetylcholine; Aged; Amrinone; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Fail | 2000 |
Impaired vasodilatation response to amrinone in the forearm of patients with congestive heart failure: role of endothelium-derived nitric oxide.
Topics: Acetylcholine; Aged; Amrinone; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Fail | 2000 |
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure.
Topics: Blood Flow Velocity; Brachial Artery; Chronic Disease; Dose-Response Relationship, Drug; Endothelin | 2001 |
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure.
Topics: Blood Flow Velocity; Brachial Artery; Chronic Disease; Dose-Response Relationship, Drug; Endothelin | 2001 |
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure.
Topics: Aged; Aspirin; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind M | 2001 |
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure.
Topics: Aged; Aspirin; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind M | 2001 |
Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure.
Topics: Adult; Aged; Analysis of Variance; Antioxidants; Ascorbic Acid; Chronic Disease; Cross-Over Studies; | 2001 |
Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure.
Topics: Adult; Aged; Analysis of Variance; Antioxidants; Ascorbic Acid; Chronic Disease; Cross-Over Studies; | 2001 |
A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
Topics: Cardiac Output; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intraven | 2001 |
A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
Topics: Cardiac Output; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intraven | 2001 |
Brachial artery elastic mechanics in patients with heart failure.
Topics: Administration, Sublingual; Adult; Aged; Brachial Artery; Elasticity; Female; Heart Failure; Humans; | 2001 |
Brachial artery elastic mechanics in patients with heart failure.
Topics: Administration, Sublingual; Adult; Aged; Brachial Artery; Elasticity; Female; Heart Failure; Humans; | 2001 |
Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Female; Hand; Heart Failure; Hemodyna | 2001 |
Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Female; Hand; Heart Failure; Hemodyna | 2001 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Thera | 2002 |
Effects of a new beta1-selective beta-blocker H 87/07 in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; | 1977 |
Effects of a new beta1-selective beta-blocker H 87/07 in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; | 1977 |
Use of nitroglycerin ointment in congestive heart failure. Results of acute and chronic therapy.
Topics: Blood Pressure; Clinical Trials as Topic; Diastole; Drug Evaluation; Female; Heart Failure; Heart Ra | 1978 |
Use of nitroglycerin ointment in congestive heart failure. Results of acute and chronic therapy.
Topics: Blood Pressure; Clinical Trials as Topic; Diastole; Drug Evaluation; Female; Heart Failure; Heart Ra | 1978 |
Prolonged hemodynamic effects (12 hours) of orally administered sustained-release nitroglycerin.
Topics: Administration, Oral; Adult; Aged; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation | 1979 |
Prolonged hemodynamic effects (12 hours) of orally administered sustained-release nitroglycerin.
Topics: Administration, Oral; Adult; Aged; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation | 1979 |
Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The positive side).
Topics: Administration, Oral; Angina Pectoris; Biological Availability; Blood Pressure; Cardiac Output; Clin | 1977 |
Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The positive side).
Topics: Administration, Oral; Angina Pectoris; Biological Availability; Blood Pressure; Cardiac Output; Clin | 1977 |
[The treatment of recent myocardial infarction by prolonged infusion of trinitrin (author's transl)].
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Female; Heart Failure; Heart Rate; Hum | 1977 |
[The treatment of recent myocardial infarction by prolonged infusion of trinitrin (author's transl)].
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Female; Heart Failure; Heart Rate; Hum | 1977 |
Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
Topics: Administration, Oral; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Delayed-Action Prepa | 1975 |
Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
Topics: Administration, Oral; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Delayed-Action Prepa | 1975 |
GISSI-3 study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Dipeptides; Drug Combinations; F | 1992 |
GISSI-3 study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Dipeptides; Drug Combinations; F | 1992 |
[Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
Topics: Arrhythmias, Cardiac; Captopril; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isos | 1992 |
[Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
Topics: Arrhythmias, Cardiac; Captopril; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isos | 1992 |
Hemodynamic comparison of combined therapy by nitroglycerin tape and ibopamine with combination of nitroglycerin tape and nifedipine.
Topics: Administration, Cutaneous; Administration, Oral; Cardiac Complexes, Premature; Cardiotonic Agents; D | 1990 |
Hemodynamic comparison of combined therapy by nitroglycerin tape and ibopamine with combination of nitroglycerin tape and nifedipine.
Topics: Administration, Cutaneous; Administration, Oral; Cardiac Complexes, Premature; Cardiotonic Agents; D | 1990 |
Hemodynamic mechanisms of the effect of nitroglycerin in patients with acute myocardial infarction.
Topics: Adult; Aged; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocard | 1991 |
Hemodynamic mechanisms of the effect of nitroglycerin in patients with acute myocardial infarction.
Topics: Adult; Aged; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocard | 1991 |
[The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
Topics: Administration, Cutaneous; Adult; Aged; Delayed-Action Preparations; Drug Evaluation; Drug Tolerance | 1991 |
[The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
Topics: Administration, Cutaneous; Adult; Aged; Delayed-Action Preparations; Drug Evaluation; Drug Tolerance | 1991 |
Hemodynamic resistance to intravenous nitroglycerin in severe congestive heart failure and restored response after diuresis.
Topics: Aged; Catheterization, Swan-Ganz; Diuresis; Drug Resistance; Female; Furosemide; Heart Failure; Hemo | 1991 |
Hemodynamic resistance to intravenous nitroglycerin in severe congestive heart failure and restored response after diuresis.
Topics: Aged; Catheterization, Swan-Ganz; Diuresis; Drug Resistance; Female; Furosemide; Heart Failure; Hemo | 1991 |
[Value of the replacement of intravenous trinitrin by oral trinitrin in the acute phase of myocardial infarction complicated by regressive left ventricular insufficiency].
Topics: Administration, Oral; Aged; Double-Blind Method; Female; Heart Failure; Humans; Injections, Intraven | 1991 |
[Value of the replacement of intravenous trinitrin by oral trinitrin in the acute phase of myocardial infarction complicated by regressive left ventricular insufficiency].
Topics: Administration, Oral; Aged; Double-Blind Method; Female; Heart Failure; Humans; Injections, Intraven | 1991 |
Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
Topics: Administration, Oral; Administration, Sublingual; Aerosols; Chemistry, Pharmaceutical; Female; Heart | 1990 |
Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
Topics: Administration, Oral; Administration, Sublingual; Aerosols; Chemistry, Pharmaceutical; Female; Heart | 1990 |
Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure.
Topics: Administration, Sublingual; Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Mal | 1990 |
Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure.
Topics: Administration, Sublingual; Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Mal | 1990 |
[Differential use of peripheral vasodilators in the treatment of chronic circulatory failure in patients with mitral valve insufficiency].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hydralazine; | 1990 |
[Differential use of peripheral vasodilators in the treatment of chronic circulatory failure in patients with mitral valve insufficiency].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hydralazine; | 1990 |
Captopril does not prevent nitroglycerin tolerance in heart failure.
Topics: Adult; Aged; Captopril; Drug Therapy, Combination; Drug Tolerance; Female; Heart Failure; Hemodynami | 1990 |
Captopril does not prevent nitroglycerin tolerance in heart failure.
Topics: Adult; Aged; Captopril; Drug Therapy, Combination; Drug Tolerance; Female; Heart Failure; Hemodynami | 1990 |
Effects of intravenous nitroglycerin on hemodynamics in neonates with refractory congestive heart failure or PFC.
Topics: Female; Heart Failure; Hemodynamics; Humans; Infant, Newborn; Infusions, Intravenous; Male; Nitrogly | 1990 |
Effects of intravenous nitroglycerin on hemodynamics in neonates with refractory congestive heart failure or PFC.
Topics: Female; Heart Failure; Hemodynamics; Humans; Infant, Newborn; Infusions, Intravenous; Male; Nitrogly | 1990 |
Sublingual nitroglycerin administered by spray versus tablet: comparative timing of hemodynamic effects.
Topics: Administration, Sublingual; Aged; Angina Pectoris; Cardiac Catheterization; Female; Heart Failure; H | 1990 |
Sublingual nitroglycerin administered by spray versus tablet: comparative timing of hemodynamic effects.
Topics: Administration, Sublingual; Aged; Angina Pectoris; Cardiac Catheterization; Female; Heart Failure; H | 1990 |
[Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency].
Topics: Adult; Aged; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Mitral Valve | 1990 |
[Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency].
Topics: Adult; Aged; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Mitral Valve | 1990 |
[Long-term nitrate therapy in coronary heart disease--loss of effect by developing tolerance].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Tolerance; Electrocardiogr | 1990 |
[Long-term nitrate therapy in coronary heart disease--loss of effect by developing tolerance].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Tolerance; Electrocardiogr | 1990 |
Haemodynamic dose-response effects of a transdermal nitrate delivery system in acute myocardial infarction with and without left heart failure.
Topics: Administration, Cutaneous; Adult; Aged; Dose-Response Relationship, Drug; Heart Failure; Hemodynamic | 1988 |
Haemodynamic dose-response effects of a transdermal nitrate delivery system in acute myocardial infarction with and without left heart failure.
Topics: Administration, Cutaneous; Adult; Aged; Dose-Response Relationship, Drug; Heart Failure; Hemodynamic | 1988 |
Haemodynamic comparison of different routes of nitrate administration in postmyocardial infarction left ventricular failure.
Topics: Administration, Buccal; Administration, Cutaneous; Adult; Aged; Heart Failure; Hemodynamics; Humans; | 1989 |
Haemodynamic comparison of different routes of nitrate administration in postmyocardial infarction left ventricular failure.
Topics: Administration, Buccal; Administration, Cutaneous; Adult; Aged; Heart Failure; Hemodynamics; Humans; | 1989 |
[Development and status of nitrate therapy in East Germany].
Topics: Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Germany, East; Heart | 1989 |
[Development and status of nitrate therapy in East Germany].
Topics: Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Germany, East; Heart | 1989 |
Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.
Topics: Administration, Topical; Double-Blind Method; Drug Evaluation; Drug Tolerance; Heart Failure; Hemody | 1986 |
Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.
Topics: Administration, Topical; Double-Blind Method; Drug Evaluation; Drug Tolerance; Heart Failure; Hemody | 1986 |
Buccal nitroglycerin in congestive cardiac failure: a multicentre study.
Topics: Administration, Oral; Aged; Cheek; Clinical Trials as Topic; Female; Heart Failure; Humans; Male; Ni | 1986 |
Buccal nitroglycerin in congestive cardiac failure: a multicentre study.
Topics: Administration, Oral; Aged; Cheek; Clinical Trials as Topic; Female; Heart Failure; Humans; Male; Ni | 1986 |
Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure.
Topics: Administration, Cutaneous; Adult; Arm; Biological Availability; Female; Heart Failure; Humans; Infus | 1986 |
Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure.
Topics: Administration, Cutaneous; Adult; Arm; Biological Availability; Female; Heart Failure; Humans; Infus | 1986 |
Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.
Topics: Administration, Cutaneous; Adult; Aged; Drug Administration Schedule; Drug Tolerance; Female; Heart | 1987 |
Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.
Topics: Administration, Cutaneous; Adult; Aged; Drug Administration Schedule; Drug Tolerance; Female; Heart | 1987 |
[Clinical usefulness of a transdermal nitroglycerin patch as a sustained vasodilator for patients with heart failure].
Topics: Aged; Clinical Trials as Topic; Delayed-Action Preparations; Heart Failure; Hemodynamics; Humans; Mi | 1987 |
[Clinical usefulness of a transdermal nitroglycerin patch as a sustained vasodilator for patients with heart failure].
Topics: Aged; Clinical Trials as Topic; Delayed-Action Preparations; Heart Failure; Hemodynamics; Humans; Mi | 1987 |
Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.
Topics: Aged; Cardiac Catheterization; Clinical Trials as Topic; Coronary Disease; Drug Tolerance; Epinephri | 1987 |
Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.
Topics: Aged; Cardiac Catheterization; Clinical Trials as Topic; Coronary Disease; Drug Tolerance; Epinephri | 1987 |
Increase of cardiac output by afterload reduction in patients with severe congestive heart failure using nitroglycerin discs. A double-blind placebo-controlled haemodynamic study.
Topics: Administration, Topical; Adult; Aged; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; | 1987 |
Increase of cardiac output by afterload reduction in patients with severe congestive heart failure using nitroglycerin discs. A double-blind placebo-controlled haemodynamic study.
Topics: Administration, Topical; Adult; Aged; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; | 1987 |
The immediate effect of nitroglycerin on total body blood volume distribution in patients with congestive heart failure: a non-invasive study.
Topics: Abdomen; Aged; Aged, 80 and over; Blood Volume; Female; Heart Failure; Humans; Leg; Male; Nitroglyce | 1987 |
The immediate effect of nitroglycerin on total body blood volume distribution in patients with congestive heart failure: a non-invasive study.
Topics: Abdomen; Aged; Aged, 80 and over; Blood Volume; Female; Heart Failure; Humans; Leg; Male; Nitroglyce | 1987 |
Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure.
Topics: Administration, Cutaneous; Aged; Cardiomyopathy, Dilated; Clinical Trials as Topic; Double-Blind Met | 1988 |
Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure.
Topics: Administration, Cutaneous; Aged; Cardiomyopathy, Dilated; Clinical Trials as Topic; Double-Blind Met | 1988 |
Efficacy and tolerability of transdermal nitroglycerin in heart failure. A noninvasive placebo controlled double-blind cross over study.
Topics: Administration, Cutaneous; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Echo | 1988 |
Efficacy and tolerability of transdermal nitroglycerin in heart failure. A noninvasive placebo controlled double-blind cross over study.
Topics: Administration, Cutaneous; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Echo | 1988 |
Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
Topics: Administration, Topical; Aged; Blood Pressure; Dose-Response Relationship, Drug; Heart Failure; Hear | 1985 |
Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
Topics: Administration, Topical; Aged; Blood Pressure; Dose-Response Relationship, Drug; Heart Failure; Hear | 1985 |
Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
Topics: Alprenolol; Amino Alcohols; Angina Pectoris; Blood Pressure; Cardiac Complexes, Premature; Clinical | 1972 |
Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
Topics: Alprenolol; Amino Alcohols; Angina Pectoris; Blood Pressure; Cardiac Complexes, Premature; Clinical | 1972 |
Persantin.
Topics: Animals; Blood Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Heart Failure; Humans; | 1966 |
Persantin.
Topics: Animals; Blood Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Heart Failure; Humans; | 1966 |
442 other studies available for nitroglycerin and Heart Failure
| Article | Year |
|---|---|
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure.
Topics: Administration, Intravenous; Administration, Oral; Animals; Blood Pressure; Chemistry Techniques, Sy | 2017 |
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure.
Topics: Administration, Intravenous; Administration, Oral; Animals; Blood Pressure; Chemistry Techniques, Sy | 2017 |
Response to "practical implication of nitroglycerin test for diagnosing heart failure in emergency department".
Topics: Emergency Service, Hospital; Heart Failure; Humans; Nitroglycerin | 2021 |
Response to "practical implication of nitroglycerin test for diagnosing heart failure in emergency department".
Topics: Emergency Service, Hospital; Heart Failure; Humans; Nitroglycerin | 2021 |
Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry.
Topics: Acute Disease; Aftercare; Emergency Service, Hospital; Heart Failure; Humans; Nitroglycerin; Patient | 2021 |
Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry.
Topics: Acute Disease; Aftercare; Emergency Service, Hospital; Heart Failure; Humans; Nitroglycerin; Patient | 2021 |
Evaluation of the effect of intravenous nitroglycerine on short-term survival of patients with acute heart failure according to congestion and perfusion status at emergency department arrival.
Topics: Acute Disease; Emergency Service, Hospital; Female; Heart Failure; Humans; Nitroglycerin; Perfusion; | 2022 |
Evaluation of the effect of intravenous nitroglycerine on short-term survival of patients with acute heart failure according to congestion and perfusion status at emergency department arrival.
Topics: Acute Disease; Emergency Service, Hospital; Female; Heart Failure; Humans; Nitroglycerin; Perfusion; | 2022 |
Hemodynamic profile changes in reaction to nitroglycerin in patients with heart failure with mildly reduced ejection fraction: A pilot study.
Topics: Heart Failure; Hemodynamics; Humans; Nitroglycerin; Pilot Projects; Stroke Volume; Ventricular Funct | 2023 |
Hemodynamic profile changes in reaction to nitroglycerin in patients with heart failure with mildly reduced ejection fraction: A pilot study.
Topics: Heart Failure; Hemodynamics; Humans; Nitroglycerin; Pilot Projects; Stroke Volume; Ventricular Funct | 2023 |
Low- versus high-dose nitroglycerin infusion in the management of acute pulmonary edema.
Topics: Blood Pressure; Heart Failure; Humans; Nitroglycerin; Pulmonary Edema; Retrospective Studies | 2023 |
Low- versus high-dose nitroglycerin infusion in the management of acute pulmonary edema.
Topics: Blood Pressure; Heart Failure; Humans; Nitroglycerin; Pulmonary Edema; Retrospective Studies | 2023 |
Taming the Tiger: Ultra high dose nitroglycerin in managing sympathetic crashing acute pulmonary edema patient.
Topics: Heart Failure; Humans; Hypertension; Male; Middle Aged; Nitroglycerin; Pulmonary Edema; Vasodilator | 2023 |
Taming the Tiger: Ultra high dose nitroglycerin in managing sympathetic crashing acute pulmonary edema patient.
Topics: Heart Failure; Humans; Hypertension; Male; Middle Aged; Nitroglycerin; Pulmonary Edema; Vasodilator | 2023 |
High-dose nitroglycerin infusion for the management of sympathetic crashing acute pulmonary edema (SCAPE): A case series.
Topics: Acute Disease; Aged; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Nitro | 2021 |
High-dose nitroglycerin infusion for the management of sympathetic crashing acute pulmonary edema (SCAPE): A case series.
Topics: Acute Disease; Aged; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Nitro | 2021 |
Prehospital Treatment of Acute Pulmonary Edema with Intravenous Bolus and Infusion Nitroglycerin.
Topics: Aged; Aged, 80 and over; Blood Pressure; Emergency Medical Services; Female; Heart Failure; Humans; | 2020 |
Prehospital Treatment of Acute Pulmonary Edema with Intravenous Bolus and Infusion Nitroglycerin.
Topics: Aged; Aged, 80 and over; Blood Pressure; Emergency Medical Services; Female; Heart Failure; Humans; | 2020 |
Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione.
Topics: Administration, Intravenous; COVID-19; Drug Compounding; Glutathione; Heart Failure; Humans; Infusio | 2021 |
Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione.
Topics: Administration, Intravenous; COVID-19; Drug Compounding; Glutathione; Heart Failure; Humans; Infusio | 2021 |
Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
Topics: Acute Disease; Dyspnea; Emergency Service, Hospital; Heart Failure; Humans; Natriuretic Peptide, Bra | 2021 |
Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
Topics: Acute Disease; Dyspnea; Emergency Service, Hospital; Heart Failure; Humans; Natriuretic Peptide, Bra | 2021 |
High-Dose Nitroglycerin Bolus for Sympathetic Crashing Acute Pulmonary Edema: A Prospective Observational Pilot Study.
Topics: Heart Failure; Humans; Nitroglycerin; Noninvasive Ventilation; Pilot Projects; Prospective Studies; | 2021 |
High-Dose Nitroglycerin Bolus for Sympathetic Crashing Acute Pulmonary Edema: A Prospective Observational Pilot Study.
Topics: Heart Failure; Humans; Nitroglycerin; Noninvasive Ventilation; Pilot Projects; Prospective Studies; | 2021 |
Practical implication of nitroglycerin test for diagnosing heart failure in emergency department.
Topics: Emergency Service, Hospital; Heart Failure; Humans; Nitroglycerin | 2021 |
Practical implication of nitroglycerin test for diagnosing heart failure in emergency department.
Topics: Emergency Service, Hospital; Heart Failure; Humans; Nitroglycerin | 2021 |
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
Topics: Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hy | 2018 |
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
Topics: Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hy | 2018 |
Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.
Topics: Acute Disease; After-Hours Care; Aged; Dyspnea; Emergency Service, Hospital; Female; Heart Failure; | 2018 |
Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.
Topics: Acute Disease; After-Hours Care; Aged; Dyspnea; Emergency Service, Hospital; Female; Heart Failure; | 2018 |
Early diffuse coronary artery spasm after heart valve surgery in the carcinoid syndrome.
Topics: Aged; Carcinoid Heart Disease; Coronary Angiography; Coronary Artery Disease; Heart Failure; Humans; | 2013 |
Early diffuse coronary artery spasm after heart valve surgery in the carcinoid syndrome.
Topics: Aged; Carcinoid Heart Disease; Coronary Angiography; Coronary Artery Disease; Heart Failure; Humans; | 2013 |
Prehospital high-dose sublingual nitroglycerin rarely causes hypotension.
Topics: Administration, Sublingual; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Emerge | 2013 |
Prehospital high-dose sublingual nitroglycerin rarely causes hypotension.
Topics: Administration, Sublingual; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Emerge | 2013 |
[Acute myocardial infarction complicated by acute pulmonary oedema and cardiogenic collapse during dobutamine stress echocardiography].
Topics: Diabetes Mellitus, Type 2; Diuretics; Echocardiography, Stress; Furosemide; Heart Failure; Humans; M | 2013 |
[Acute myocardial infarction complicated by acute pulmonary oedema and cardiogenic collapse during dobutamine stress echocardiography].
Topics: Diabetes Mellitus, Type 2; Diuretics; Echocardiography, Stress; Furosemide; Heart Failure; Humans; M | 2013 |
M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
Topics: Aldosterone; Angiotensin II; Animals; Arterial Pressure; Atrial Natriuretic Factor; Cardiac Pacing, | 2014 |
M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
Topics: Aldosterone; Angiotensin II; Animals; Arterial Pressure; Atrial Natriuretic Factor; Cardiac Pacing, | 2014 |
Hemodynamic effects of nitroglycerin ointment in emergency department patients.
Topics: Acute Coronary Syndrome; Adult; Aged; Arterial Pressure; Emergency Service, Hospital; Female; Heart | 2014 |
Hemodynamic effects of nitroglycerin ointment in emergency department patients.
Topics: Acute Coronary Syndrome; Adult; Aged; Arterial Pressure; Emergency Service, Hospital; Female; Heart | 2014 |
Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning.
Topics: Animals; Death; Disease Models, Animal; Edema; Erythropoietin; Guanidines; Heart; Heart Failure; Hea | 2014 |
Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning.
Topics: Animals; Death; Disease Models, Animal; Edema; Erythropoietin; Guanidines; Heart; Heart Failure; Hea | 2014 |
Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anti | 2014 |
Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anti | 2014 |
The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Topics: Aged; Atrial Fibrillation; Body Mass Index; Cardiovascular Diseases; Carotid Intima-Media Thickness; | 2014 |
The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Topics: Aged; Atrial Fibrillation; Body Mass Index; Cardiovascular Diseases; Carotid Intima-Media Thickness; | 2014 |
Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans.
Topics: Aged; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Animals; Arteries; C | 2015 |
Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans.
Topics: Aged; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Animals; Arteries; C | 2015 |
Influence of Intravenous Nitrate Treatment on Early Mortality Among Patients With Acute Heart Failure. NITRO-EAHFE Study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Emergency Service, Hospital; Female; Heart Failure; Humans; | 2015 |
Influence of Intravenous Nitrate Treatment on Early Mortality Among Patients With Acute Heart Failure. NITRO-EAHFE Study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Emergency Service, Hospital; Female; Heart Failure; Humans; | 2015 |
Successful Treatment with an Antihypertensive Drug Regimen Including Eplerenone in a Patient with Malignant Phase Hypertension with Renal Failure.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cal | 2015 |
Successful Treatment with an Antihypertensive Drug Regimen Including Eplerenone in a Patient with Malignant Phase Hypertension with Renal Failure.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cal | 2015 |
Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure.
Topics: Acute Disease; Adult; Aged; Emergency Service, Hospital; Female; Heart Failure; Hospitalization; Hum | 2017 |
Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure.
Topics: Acute Disease; Adult; Aged; Emergency Service, Hospital; Female; Heart Failure; Hospitalization; Hum | 2017 |
Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
Topics: Aged; Brachial Artery; Carotid Intima-Media Thickness; Echocardiography; Endothelium, Vascular; Fema | 2017 |
Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
Topics: Aged; Brachial Artery; Carotid Intima-Media Thickness; Echocardiography; Endothelium, Vascular; Fema | 2017 |
Analysis of short-term reproducibility of arterial vasoreactivity by pulse-wave analysis after pharmacological challenge.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Endothelium, Vascular; Female; | 2009 |
Analysis of short-term reproducibility of arterial vasoreactivity by pulse-wave analysis after pharmacological challenge.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Endothelium, Vascular; Female; | 2009 |
Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Benzodiazepines; Captopril; Continuous Posi | 2008 |
Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Benzodiazepines; Captopril; Continuous Posi | 2008 |
Activation of inducible NOS in peripheral vessels and outcomes in heart failure patients.
Topics: Acetylcholine; Aged; Blood Flow Velocity; Cardiomyopathy, Dilated; Dose-Response Relationship, Drug; | 2008 |
Activation of inducible NOS in peripheral vessels and outcomes in heart failure patients.
Topics: Acetylcholine; Aged; Blood Flow Velocity; Cardiomyopathy, Dilated; Dose-Response Relationship, Drug; | 2008 |
Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Topics: Cyclic GMP; Drug Therapy, Combination; Heart Failure; Humans; Hypertension, Pulmonary; Isosorbide Di | 2009 |
Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Topics: Cyclic GMP; Drug Therapy, Combination; Heart Failure; Humans; Hypertension, Pulmonary; Isosorbide Di | 2009 |
Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure.
Topics: Acute Disease; Aged; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Hum | 2009 |
Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure.
Topics: Acute Disease; Aged; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Hum | 2009 |
Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure.
Topics: Aged; Analysis of Variance; Chronic Disease; Dose-Response Relationship, Drug; Drug Monitoring; Fema | 2009 |
Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure.
Topics: Aged; Analysis of Variance; Chronic Disease; Dose-Response Relationship, Drug; Drug Monitoring; Fema | 2009 |
International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes.
Topics: Adult; Aged; Clinical Trials as Topic; Disease Management; Electrocardiography; Emergency Service, H | 2010 |
International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes.
Topics: Adult; Aged; Clinical Trials as Topic; Disease Management; Electrocardiography; Emergency Service, H | 2010 |
Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Topics: Aged; Chi-Square Distribution; Cross-Sectional Studies; Emergency Service, Hospital; Female; Furosem | 2011 |
Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Topics: Aged; Chi-Square Distribution; Cross-Sectional Studies; Emergency Service, Hospital; Female; Furosem | 2011 |
Developmental toxicity of glyceryl trinitrate in quail embryos.
Topics: Animals; Coturnix; Craniofacial Abnormalities; Embryonic Development; Heart Failure; Microphthalmos; | 2011 |
Developmental toxicity of glyceryl trinitrate in quail embryos.
Topics: Animals; Coturnix; Craniofacial Abnormalities; Embryonic Development; Heart Failure; Microphthalmos; | 2011 |
Comparison of nitrite compounds and carperitide for initial treatment of acute decompensated heart failure.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Isosorbide Dinitr | 2011 |
Comparison of nitrite compounds and carperitide for initial treatment of acute decompensated heart failure.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Isosorbide Dinitr | 2011 |
Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure.
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Cohort Studies; Female; Heart Failure; Humans; Inci | 2012 |
Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure.
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Cohort Studies; Female; Heart Failure; Humans; Inci | 2012 |
Effect of intermittent nesiritide administration on kidney function.
Topics: Acute Kidney Injury; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Natriuretic Pepti | 2012 |
Effect of intermittent nesiritide administration on kidney function.
Topics: Acute Kidney Injury; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Natriuretic Pepti | 2012 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Co | 2012 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Co | 2012 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Co | 2012 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Co | 2012 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Co | 2012 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Co | 2012 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Co | 2012 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Co | 2012 |
CHF treatment: is furosemide on the way out? Rethinking the pulmonary edema cocktail.
Topics: Acute Disease; Analgesics, Opioid; Diuretics; Drug Therapy, Combination; Emergency Treatment; Furose | 2012 |
CHF treatment: is furosemide on the way out? Rethinking the pulmonary edema cocktail.
Topics: Acute Disease; Analgesics, Opioid; Diuretics; Drug Therapy, Combination; Emergency Treatment; Furose | 2012 |
Influence of ALDH2 Glu504Lys polymorphism on nitroglycerin response in chronic heart failure and involvement of Calcitonin Gene Related Peptide (CGRP).
Topics: Adult; Aged; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Calcitonin Gene-Related | 2012 |
Influence of ALDH2 Glu504Lys polymorphism on nitroglycerin response in chronic heart failure and involvement of Calcitonin Gene Related Peptide (CGRP).
Topics: Adult; Aged; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Calcitonin Gene-Related | 2012 |
[Vascular remodeling indicators and their impact on prognosis in patients with chronic heart failure].
Topics: Aorta; Blood Flow Velocity; Carotid Intima-Media Thickness; Case-Control Studies; Chronic Disease; E | 2012 |
[Vascular remodeling indicators and their impact on prognosis in patients with chronic heart failure].
Topics: Aorta; Blood Flow Velocity; Carotid Intima-Media Thickness; Case-Control Studies; Chronic Disease; E | 2012 |
Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Topics: Cardiotonic Agents; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglyc | 2002 |
Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Topics: Cardiotonic Agents; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglyc | 2002 |
Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Topics: Cardiotonic Agents; Data Interpretation, Statistical; Heart Failure; Hemodynamics; Humans; Natriuret | 2002 |
Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Topics: Cardiotonic Agents; Data Interpretation, Statistical; Heart Failure; Hemodynamics; Humans; Natriuret | 2002 |
Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure.
Topics: Acetylcholine; Administration, Inhalation; Angiotensin II; Animals; Diastole; Disease Models, Animal | 2003 |
Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure.
Topics: Acetylcholine; Administration, Inhalation; Angiotensin II; Animals; Diastole; Disease Models, Animal | 2003 |
Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure.
Topics: Aldosterone; Angiotensin II; Animals; Cardiac Output; Cardiac Pacing, Artificial; Disease Models, An | 2003 |
Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure.
Topics: Aldosterone; Angiotensin II; Animals; Cardiac Output; Cardiac Pacing, Artificial; Disease Models, An | 2003 |
Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
Topics: Aged; Analysis of Variance; Cardiac Catheterization; Cardiotonic Agents; Female; Heart Failure; Hear | 2003 |
Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
Topics: Aged; Analysis of Variance; Cardiac Catheterization; Cardiotonic Agents; Female; Heart Failure; Hear | 2003 |
Effects of a nitro compound patch on neuropathy in Churg-Strauss syndrome.
Topics: Adrenergic beta-Agonists; Asthma; Churg-Strauss Syndrome; Cyclophosphamide; Drug Hypersensitivity; F | 2003 |
Effects of a nitro compound patch on neuropathy in Churg-Strauss syndrome.
Topics: Adrenergic beta-Agonists; Asthma; Churg-Strauss Syndrome; Cyclophosphamide; Drug Hypersensitivity; F | 2003 |
Acute and chronic effects of flosequinan on resting and exercise haemodynamics in congestive heart failure.
Topics: Adult; Aged; Exercise; Exercise Test; Exercise Tolerance; Heart Failure; Hemodynamics; Humans; Male; | 1993 |
Acute and chronic effects of flosequinan on resting and exercise haemodynamics in congestive heart failure.
Topics: Adult; Aged; Exercise; Exercise Test; Exercise Tolerance; Heart Failure; Hemodynamics; Humans; Male; | 1993 |
[Nebulization of trinitrin in dyspneic episodes of left cardiac insufficiency].
Topics: Dyspnea; Heart Failure; Humans; Nitrites; Nitroglycerin | 1956 |
[Nebulization of trinitrin in dyspneic episodes of left cardiac insufficiency].
Topics: Dyspnea; Heart Failure; Humans; Nitrites; Nitroglycerin | 1956 |
Effects of sublingual administration of nitroglycerin on pulmonary-artery pressure in patients with failure of the left ventricle.
Topics: Administration, Sublingual; Arteries; Blood Pressure; Blood Pressure Determination; Heart Failure; H | 1957 |
Effects of sublingual administration of nitroglycerin on pulmonary-artery pressure in patients with failure of the left ventricle.
Topics: Administration, Sublingual; Arteries; Blood Pressure; Blood Pressure Determination; Heart Failure; H | 1957 |
Effects of sublingual nitroglycerin on pulmonary arterial pressure in patients with left ventricular failure.
Topics: Arterial Pressure; Heart Failure; Humans; Hypertension; Nitrites; Nitroglycerin | 1959 |
Effects of sublingual nitroglycerin on pulmonary arterial pressure in patients with left ventricular failure.
Topics: Arterial Pressure; Heart Failure; Humans; Hypertension; Nitrites; Nitroglycerin | 1959 |
Conditioned reflex reproduction of the effects of novurit (mercurial diuretic) and nitroglycerin in patients with cardiac decompensation, hypertension and coronary insufficiency.
Topics: Alkylmercury Compounds; Conditioning, Classical; Coronary Disease; Diuretics; Drug Combinations; Hea | 1961 |
Conditioned reflex reproduction of the effects of novurit (mercurial diuretic) and nitroglycerin in patients with cardiac decompensation, hypertension and coronary insufficiency.
Topics: Alkylmercury Compounds; Conditioning, Classical; Coronary Disease; Diuretics; Drug Combinations; Hea | 1961 |
INTRACTABLE ANGINA.
Topics: Anemia; Angina Pectoris; Anticoagulants; Anxiety; Cardiac Surgical Procedures; Cardiovascular Diseas | 1963 |
INTRACTABLE ANGINA.
Topics: Anemia; Angina Pectoris; Anticoagulants; Anxiety; Cardiac Surgical Procedures; Cardiovascular Diseas | 1963 |
NOCTURNAL ANGINA PECTORIS.
Topics: Angina Pectoris; Coronary Disease; Dipyridamole; Duodenal Obstruction; Heart Failure; Heart Valve Di | 1964 |
NOCTURNAL ANGINA PECTORIS.
Topics: Angina Pectoris; Coronary Disease; Dipyridamole; Duodenal Obstruction; Heart Failure; Heart Valve Di | 1964 |
PERSANTIN-- A DOUBLE BLIND STUDY.
Topics: Biomedical Research; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy; Geriatrics; | 1964 |
PERSANTIN-- A DOUBLE BLIND STUDY.
Topics: Biomedical Research; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy; Geriatrics; | 1964 |
[NITROGLYCERINE--A FORGOTTEN MEANS IN "REVERSIBLE BLOOD-LETTING"?].
Topics: Angina Pectoris; Heart Failure; Humans; Nitroglycerin; Pharmacology | 1965 |
[NITROGLYCERINE--A FORGOTTEN MEANS IN "REVERSIBLE BLOOD-LETTING"?].
Topics: Angina Pectoris; Heart Failure; Humans; Nitroglycerin; Pharmacology | 1965 |
Nesiritide in acute heart failure.
Topics: Acute Disease; Cardiac Output, Low; Clinical Trials as Topic; Heart Failure; Humans; Natriuretic Age | 2003 |
Nesiritide in acute heart failure.
Topics: Acute Disease; Cardiac Output, Low; Clinical Trials as Topic; Heart Failure; Humans; Natriuretic Age | 2003 |
What is your diagnosis? Dilated cardiomyopathy (DCM) causing congestive heart failure.
Topics: Animals; Cardiomyopathy, Dilated; Cat Diseases; Cats; Diagnosis, Differential; Digoxin; Enalapril; F | 2003 |
What is your diagnosis? Dilated cardiomyopathy (DCM) causing congestive heart failure.
Topics: Animals; Cardiomyopathy, Dilated; Cat Diseases; Cats; Diagnosis, Differential; Digoxin; Enalapril; F | 2003 |
[Not just effective against symptoms of ischemia. Nitrates also improve prognosis].
Topics: Aged; Coronary Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitroglycerin; Pr | 2002 |
[Not just effective against symptoms of ischemia. Nitrates also improve prognosis].
Topics: Aged; Coronary Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitroglycerin; Pr | 2002 |
[Effects of nitroglycerin on plasma calcitonin gene-related peptide and endothelin in congestive heart failure].
Topics: Adult; Aged; Aged, 80 and over; Calcitonin Gene-Related Peptide; Coronary Disease; Endothelins; Fema | 2003 |
[Effects of nitroglycerin on plasma calcitonin gene-related peptide and endothelin in congestive heart failure].
Topics: Adult; Aged; Aged, 80 and over; Calcitonin Gene-Related Peptide; Coronary Disease; Endothelins; Fema | 2003 |
Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilation in conscious dogs.
Topics: Acetylcholine; Animals; Blotting, Western; Bradykinin; Cardiac Output; Cardiac Pacing, Artificial; D | 2004 |
Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilation in conscious dogs.
Topics: Acetylcholine; Animals; Blotting, Western; Bradykinin; Cardiac Output; Cardiac Pacing, Artificial; D | 2004 |
Reduced vascular compliance is associated with impaired endothelium-dependent dilatation in the brachial artery of patients with congestive heart failure.
Topics: Blood Flow Velocity; Brachial Artery; Case-Control Studies; Compliance; Endothelium, Vascular; Femal | 2004 |
Reduced vascular compliance is associated with impaired endothelium-dependent dilatation in the brachial artery of patients with congestive heart failure.
Topics: Blood Flow Velocity; Brachial Artery; Case-Control Studies; Compliance; Endothelium, Vascular; Femal | 2004 |
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
Topics: Aged; Biomarkers; Brachial Artery; Cell Count; Coronary Circulation; Endothelial Cells; Endothelium, | 2004 |
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
Topics: Aged; Biomarkers; Brachial Artery; Cell Count; Coronary Circulation; Endothelial Cells; Endothelium, | 2004 |
The clinical challenge of cardiorenal syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case Management; Cohort Studies; Creatinine; Disease Progr | 2004 |
The clinical challenge of cardiorenal syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case Management; Cohort Studies; Creatinine; Disease Progr | 2004 |
Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor.
Topics: Acetylcholine; Animals; Aorta; Blood Vessels; Calcium; Dogs; Endothelium, Vascular; Enzyme Inhibitor | 2004 |
Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor.
Topics: Acetylcholine; Animals; Aorta; Blood Vessels; Calcium; Dogs; Endothelium, Vascular; Enzyme Inhibitor | 2004 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Ho | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Pept | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Pept | 2005 |
Nesiritide - not verified.
Topics: Adverse Drug Reaction Reporting Systems; Drug Approval; Drug Costs; Drug Industry; Health Services M | 2005 |
Nesiritide - not verified.
Topics: Adverse Drug Reaction Reporting Systems; Drug Approval; Drug Costs; Drug Industry; Health Services M | 2005 |
Risk of death with nesiritide.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brai | 2005 |
Risk of death with nesiritide.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brai | 2005 |
Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure.
Topics: Analysis of Variance; Cardiac Catheterization; Case-Control Studies; Dose-Response Relationship, Dru | 2005 |
Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure.
Topics: Analysis of Variance; Cardiac Catheterization; Case-Control Studies; Dose-Response Relationship, Dru | 2005 |
Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Antioxidants; Cell Adhesion | 2005 |
Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Antioxidants; Cell Adhesion | 2005 |
Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Topics: Adult; Aged; Antihypertensive Agents; Cardiac Output; Female; Heart Failure; Heart Valve Diseases; H | 2006 |
Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Topics: Adult; Aged; Antihypertensive Agents; Cardiac Output; Female; Heart Failure; Heart Valve Diseases; H | 2006 |
Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
Topics: Administration, Inhalation; Adult; Aged; Cardiac Catheterization; Female; Heart Failure; Heart Trans | 2007 |
Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
Topics: Administration, Inhalation; Adult; Aged; Cardiac Catheterization; Female; Heart Failure; Heart Trans | 2007 |
Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling.
Topics: Acetylcholine; Animals; Bradykinin; Coronary Circulation; Coronary Vessels; Cyclic GMP; Cyclic GMP-D | 2007 |
Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling.
Topics: Acetylcholine; Animals; Bradykinin; Coronary Circulation; Coronary Vessels; Cyclic GMP; Cyclic GMP-D | 2007 |
Nitro line with CPAP: a new standard of care.
Topics: Continuous Positive Airway Pressure; Emergency Medical Services; Heart Failure; Humans; Nitroglyceri | 2007 |
Nitro line with CPAP: a new standard of care.
Topics: Continuous Positive Airway Pressure; Emergency Medical Services; Heart Failure; Humans; Nitroglyceri | 2007 |
Acute decompensated heart failure.
Topics: Acute Disease; Administration, Sublingual; Dose-Response Relationship, Drug; Drug Administration Sch | 2007 |
Acute decompensated heart failure.
Topics: Acute Disease; Administration, Sublingual; Dose-Response Relationship, Drug; Drug Administration Sch | 2007 |
Impaired nitroglycerin biotransformation in patients with chronic heart failure.
Topics: Adult; Biotransformation; Chronic Disease; Heart Failure; Humans; Male; Middle Aged; Nitroglycerin; | 2008 |
Impaired nitroglycerin biotransformation in patients with chronic heart failure.
Topics: Adult; Biotransformation; Chronic Disease; Heart Failure; Humans; Male; Middle Aged; Nitroglycerin; | 2008 |
[Vasodilator therapy in cardiology].
Topics: Amyl Nitrite; Angina Pectoris; Cardiovascular Diseases; Coronary Disease; Heart Failure; Hemodynamic | 1980 |
[Vasodilator therapy in cardiology].
Topics: Amyl Nitrite; Angina Pectoris; Cardiovascular Diseases; Coronary Disease; Heart Failure; Hemodynamic | 1980 |
Acute left ventricular failure.
Topics: Acute Disease; Anti-Anxiety Agents; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; D | 1983 |
Acute left ventricular failure.
Topics: Acute Disease; Anti-Anxiety Agents; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; D | 1983 |
[Therapy of acute myocardial infarct before hospital admission].
Topics: Aged; Atropine; Bradycardia; Cardiac Complexes, Premature; Diagnosis, Differential; First Aid; Furos | 1982 |
[Therapy of acute myocardial infarct before hospital admission].
Topics: Aged; Atropine; Bradycardia; Cardiac Complexes, Premature; Diagnosis, Differential; First Aid; Furos | 1982 |
[Dilatation (congestive) cardiomyopathy: clinical aspects, diagnosis and treatment].
Topics: Adolescent; Adult; Cardiomegaly; Cardiomyopathy, Dilated; Coronary Disease; Diagnosis, Differential; | 1984 |
[Dilatation (congestive) cardiomyopathy: clinical aspects, diagnosis and treatment].
Topics: Adolescent; Adult; Cardiomegaly; Cardiomyopathy, Dilated; Coronary Disease; Diagnosis, Differential; | 1984 |
[Prolonged hemodynamic effects of pentaerythrityl tetranitrate combined with piridoxylate].
Topics: Double-Blind Method; Drug Combinations; Glyoxylates; Heart Failure; Hemodynamics; Humans; Nitroglyce | 1983 |
[Prolonged hemodynamic effects of pentaerythrityl tetranitrate combined with piridoxylate].
Topics: Double-Blind Method; Drug Combinations; Glyoxylates; Heart Failure; Hemodynamics; Humans; Nitroglyce | 1983 |
[Functional scintigraphic blood pool study. A radiologic technic for non-invasive study of pharmacologically induced blood volume fluctuations].
Topics: Adult; Aged; Angina Pectoris; Blood Volume; Blood Volume Determination; Erythrocytes; Heart Failure; | 1983 |
[Functional scintigraphic blood pool study. A radiologic technic for non-invasive study of pharmacologically induced blood volume fluctuations].
Topics: Adult; Aged; Angina Pectoris; Blood Volume; Blood Volume Determination; Erythrocytes; Heart Failure; | 1983 |
A profile of intravenous nitroglycerin use in cardiopulmonary bypass surgery.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiovascular Diseases; Coronary Disease; Fema | 1983 |
A profile of intravenous nitroglycerin use in cardiopulmonary bypass surgery.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiovascular Diseases; Coronary Disease; Fema | 1983 |
[Hemodynamic effect of skin applications of a nitroglycerin ointment in acute myocardial infarct].
Topics: Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Drug Evaluation; Heart Failure; Hemo | 1983 |
[Hemodynamic effect of skin applications of a nitroglycerin ointment in acute myocardial infarct].
Topics: Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Drug Evaluation; Heart Failure; Hemo | 1983 |
[Nitroglycerin in the therapy of pulmonary edema in myocardial infarct].
Topics: Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure | 1983 |
[Nitroglycerin in the therapy of pulmonary edema in myocardial infarct].
Topics: Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure | 1983 |
New nitrate delivery systems: buccal nitroglycerin.
Topics: Angina Pectoris; Cheek; Heart Failure; Humans; Nitroglycerin; Patient Acceptance of Health Care; Tab | 1983 |
New nitrate delivery systems: buccal nitroglycerin.
Topics: Angina Pectoris; Cheek; Heart Failure; Humans; Nitroglycerin; Patient Acceptance of Health Care; Tab | 1983 |
[Effect of various drugs on peripheral hemodynamics in left-ventricular insufficiency in patients with chronic ischemic heart disease].
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Female; Heart Failure; Heart Ventricles; Hemodynamic | 1983 |
[Effect of various drugs on peripheral hemodynamics in left-ventricular insufficiency in patients with chronic ischemic heart disease].
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Female; Heart Failure; Heart Ventricles; Hemodynamic | 1983 |
Nitroglycerin and long-acting nitrates in clinical practice.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Vasospasm; Drug Tolerance; Heart Failure; Humans | 1983 |
Nitroglycerin and long-acting nitrates in clinical practice.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Vasospasm; Drug Tolerance; Heart Failure; Humans | 1983 |
Effect of combined nitroglycerin and dobutamine infusion in left ventricular dysfunction.
Topics: Catecholamines; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Hemo | 1983 |
Effect of combined nitroglycerin and dobutamine infusion in left ventricular dysfunction.
Topics: Catecholamines; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Hemo | 1983 |
[The role of vasodilator agents in the emergency treatment of heart failure].
Topics: Aged; Captopril; Emergencies; Female; Heart Failure; Humans; Male; Nitroglycerin; Nitroprusside; Phe | 1983 |
[The role of vasodilator agents in the emergency treatment of heart failure].
Topics: Aged; Captopril; Emergencies; Female; Heart Failure; Humans; Male; Nitroglycerin; Nitroprusside; Phe | 1983 |
[Hemodynamic effect of nitroglycerin gel in cardiac insufficiency secondary to acute myocardial infarction].
Topics: Administration, Topical; Adult; Aged; Female; Gels; Heart Failure; Hemodynamics; Humans; Male; Middl | 1983 |
[Hemodynamic effect of nitroglycerin gel in cardiac insufficiency secondary to acute myocardial infarction].
Topics: Administration, Topical; Adult; Aged; Female; Gels; Heart Failure; Hemodynamics; Humans; Male; Middl | 1983 |
[Current aspects of drug treatment of patients with congestive heart failure].
Topics: Blood Pressure; Digoxin; Diuretics; Heart Failure; Humans; Nitroglycerin; Prazosin; Vasodilator Agen | 1983 |
[Current aspects of drug treatment of patients with congestive heart failure].
Topics: Blood Pressure; Digoxin; Diuretics; Heart Failure; Humans; Nitroglycerin; Prazosin; Vasodilator Agen | 1983 |
Chronic heart failure in the elderly: vasodilator therapy.
Topics: Aged; Blood Pressure; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine | 1983 |
Chronic heart failure in the elderly: vasodilator therapy.
Topics: Aged; Blood Pressure; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine | 1983 |
Beneficial effects of dopamine combined with intravenous nitroglycerin on hemodynamics in patients with severe left ventricular failure.
Topics: Adult; Aged; Cardiac Output; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Rate; Hemodyn | 1983 |
Beneficial effects of dopamine combined with intravenous nitroglycerin on hemodynamics in patients with severe left ventricular failure.
Topics: Adult; Aged; Cardiac Output; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Rate; Hemodyn | 1983 |
Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infus | 1983 |
Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infus | 1983 |
Vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitro | 1983 |
Vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitro | 1983 |
Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.
Topics: Administration, Topical; Chronic Disease; Drug Evaluation; Gels; Heart Failure; Hemodynamics; Humans | 1983 |
Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.
Topics: Administration, Topical; Chronic Disease; Drug Evaluation; Gels; Heart Failure; Hemodynamics; Humans | 1983 |
Changes in regional body blood volume caused by nitroglycerin.
Topics: Adult; Aged; Blood Volume; Coronary Disease; Female; Heart Failure; Humans; Male; Middle Aged; Nitro | 1983 |
Changes in regional body blood volume caused by nitroglycerin.
Topics: Adult; Aged; Blood Volume; Coronary Disease; Female; Heart Failure; Humans; Male; Middle Aged; Nitro | 1983 |
[Hemodynamic effects of sublingual molsidomine in patients with or without cardiac failure].
Topics: Adult; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Molsidomine; Mouth Floor; Nitroglycer | 1983 |
[Hemodynamic effects of sublingual molsidomine in patients with or without cardiac failure].
Topics: Adult; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Molsidomine; Mouth Floor; Nitroglycer | 1983 |
Intravenous nitroglycerin in transfusion therapy for severe anemia. Association with congestive heart failure.
Topics: Aged; Anemia; Female; Heart Failure; Humans; Injections, Intravenous; Male; Nitroglycerin; Transfusi | 1984 |
Intravenous nitroglycerin in transfusion therapy for severe anemia. Association with congestive heart failure.
Topics: Aged; Anemia; Female; Heart Failure; Humans; Injections, Intravenous; Male; Nitroglycerin; Transfusi | 1984 |
Vasodilator drugs.
Topics: Calcium Channel Blockers; Captopril; Heart Failure; Humans; Hydralazine; Minoxidil; Nitroglycerin; N | 1984 |
Vasodilator drugs.
Topics: Calcium Channel Blockers; Captopril; Heart Failure; Humans; Hydralazine; Minoxidil; Nitroglycerin; N | 1984 |
Timing, mechanism and clinical setting of witnessed deaths in postmyocardial infarction patients.
Topics: Arrhythmias, Cardiac; Coronary Disease; Death; Death, Sudden; Digitalis Glycosides; Electrocardiogra | 1984 |
Timing, mechanism and clinical setting of witnessed deaths in postmyocardial infarction patients.
Topics: Arrhythmias, Cardiac; Coronary Disease; Death; Death, Sudden; Digitalis Glycosides; Electrocardiogra | 1984 |
The medical treatment of cardiac failure due to acute myocardial infarction.
Topics: Heart Failure; Heart Septal Defects, Ventricular; Humans; Mitral Valve Insufficiency; Myocardial Inf | 1984 |
The medical treatment of cardiac failure due to acute myocardial infarction.
Topics: Heart Failure; Heart Septal Defects, Ventricular; Humans; Mitral Valve Insufficiency; Myocardial Inf | 1984 |
Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Coronary Circulation; Epoprostenol; Female; Heart Failure; Heart Rat | 1984 |
Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Coronary Circulation; Epoprostenol; Female; Heart Failure; Heart Rat | 1984 |
[Drug therapy for pump failure--indications and limitations].
Topics: Catecholamines; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; Shock, Cardiogenic; Vas | 1983 |
[Drug therapy for pump failure--indications and limitations].
Topics: Catecholamines; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; Shock, Cardiogenic; Vas | 1983 |
Parenteral nitroglycerin: clinical usefulness and limitations.
Topics: Angina Pectoris; Angina, Unstable; Coronary Artery Bypass; Dose-Response Relationship, Drug; Heart F | 1984 |
Parenteral nitroglycerin: clinical usefulness and limitations.
Topics: Angina Pectoris; Angina, Unstable; Coronary Artery Bypass; Dose-Response Relationship, Drug; Heart F | 1984 |
[Clinical and hemodynamic effects of an isosorbide dinitrate tape on patients with congestive heart failure--comparative study with nitroglycerin ointment].
Topics: Adult; Aged; Dosage Forms; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; | 1983 |
[Clinical and hemodynamic effects of an isosorbide dinitrate tape on patients with congestive heart failure--comparative study with nitroglycerin ointment].
Topics: Adult; Aged; Dosage Forms; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; | 1983 |
The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure.
Topics: Aged; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Male; Mi | 1984 |
The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure.
Topics: Aged; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Male; Mi | 1984 |
Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
Topics: Adult; Aged; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Mal | 1984 |
Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
Topics: Adult; Aged; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Mal | 1984 |
Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: end-systolic pressure--volume relation.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Ferricyanides; Heart Failure; Heart Ventricles; | 1984 |
Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: end-systolic pressure--volume relation.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Ferricyanides; Heart Failure; Heart Ventricles; | 1984 |
The brief saga of transdermal nitroglycerin discs: paradise lost?
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Nitroglycerin | 1984 |
The brief saga of transdermal nitroglycerin discs: paradise lost?
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Nitroglycerin | 1984 |
Mechanism of action of nitrates. Role of changes in venous capacitance and in the left ventricular diastolic pressure-volume relation.
Topics: Animals; Cardiac Output; Coronary Circulation; Dogs; Heart Failure; Humans; Nitrates; Nitroglycerin; | 1984 |
Mechanism of action of nitrates. Role of changes in venous capacitance and in the left ventricular diastolic pressure-volume relation.
Topics: Animals; Cardiac Output; Coronary Circulation; Dogs; Heart Failure; Humans; Nitrates; Nitroglycerin; | 1984 |
[Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
Topics: Adult; Aged; Captopril; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Heart F | 1984 |
[Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
Topics: Adult; Aged; Captopril; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Heart F | 1984 |
Pericardial pressure assessed by right atrial pressure: a basis for calculation of left ventricular transmural pressure.
Topics: Animals; Dogs; Heart; Heart Atria; Heart Failure; Heart Ventricles; Nitroglycerin; Pericardium; Pres | 1984 |
Pericardial pressure assessed by right atrial pressure: a basis for calculation of left ventricular transmural pressure.
Topics: Animals; Dogs; Heart; Heart Atria; Heart Failure; Heart Ventricles; Nitroglycerin; Pericardium; Pres | 1984 |
Left ventricular mechanics in dilated cardiomyopathy.
Topics: Adolescent; Adult; Blood Pressure; Cardiomyopathy, Dilated; Female; Heart; Heart Failure; Heart Vent | 1984 |
Left ventricular mechanics in dilated cardiomyopathy.
Topics: Adolescent; Adult; Blood Pressure; Cardiomyopathy, Dilated; Female; Heart; Heart Failure; Heart Vent | 1984 |
[Effect of nitroglycerine on cerebral blood flow and central hemodynamics in patients with chronic heart failure].
Topics: Adolescent; Adult; Aged; Blood Flow Velocity; Cardiac Output; Cerebrovascular Circulation; Female; H | 1984 |
[Effect of nitroglycerine on cerebral blood flow and central hemodynamics in patients with chronic heart failure].
Topics: Adolescent; Adult; Aged; Blood Flow Velocity; Cardiac Output; Cerebrovascular Circulation; Female; H | 1984 |
Cardiogenic pulmonary edema.
Topics: Aminophylline; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Human | 1984 |
Cardiogenic pulmonary edema.
Topics: Aminophylline; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Human | 1984 |
Transdermal nitroglycerin: a reevaluation.
Topics: Administration, Topical; Angina Pectoris; Heart Failure; Humans; Nitroglycerin | 1984 |
Transdermal nitroglycerin: a reevaluation.
Topics: Administration, Topical; Angina Pectoris; Heart Failure; Humans; Nitroglycerin | 1984 |
[Ambulatory treatment of chronic heart failure with peripheral vasodilators].
Topics: Ambulatory Care; Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Isosorbide Dinit | 1984 |
[Ambulatory treatment of chronic heart failure with peripheral vasodilators].
Topics: Ambulatory Care; Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Isosorbide Dinit | 1984 |
[Clinical experience with the use of nitroglycerin in the acute period of myocardial infarct].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Anticoagulants; Cardiac Glycosides; Drug Evaluation; Drug Thera | 1984 |
[Clinical experience with the use of nitroglycerin in the acute period of myocardial infarct].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Anticoagulants; Cardiac Glycosides; Drug Evaluation; Drug Thera | 1984 |
Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
Topics: Cardiac Output; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorb | 1984 |
Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
Topics: Cardiac Output; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorb | 1984 |
[Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
Topics: Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardi | 1984 |
[Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
Topics: Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardi | 1984 |
The role of vasodilators in managing congestive heart failure.
Topics: Cardiotonic Agents; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Hydralazine; Myocardial | 1980 |
The role of vasodilators in managing congestive heart failure.
Topics: Cardiotonic Agents; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Hydralazine; Myocardial | 1980 |
Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema.
Topics: Administration, Oral; Adult; Aged; Digitalis Glycosides; Diuretics; Edema, Cardiac; Furosemide; Hear | 1980 |
Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema.
Topics: Administration, Oral; Adult; Aged; Digitalis Glycosides; Diuretics; Edema, Cardiac; Furosemide; Hear | 1980 |
[Use of nitrates in the treatment of cardiac insufficiency in acute myocardial infarct].
Topics: Blood Pressure; Capillary Resistance; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; S | 1980 |
[Use of nitrates in the treatment of cardiac insufficiency in acute myocardial infarct].
Topics: Blood Pressure; Capillary Resistance; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; S | 1980 |
Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; He | 1980 |
Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; He | 1980 |
The altered baroreceptor response to nitroglycerin in congestive heart failure.
Topics: Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Pressoreceptors; Vasodi | 1980 |
The altered baroreceptor response to nitroglycerin in congestive heart failure.
Topics: Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Pressoreceptors; Vasodi | 1980 |
Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure.
Topics: Adult; Aged; Biological Availability; Blood Pressure; Dose-Response Relationship, Drug; Female; Hear | 1980 |
Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure.
Topics: Adult; Aged; Biological Availability; Blood Pressure; Dose-Response Relationship, Drug; Female; Hear | 1980 |
Pharmacodynamic basis of the use of vasodilators in the treatment of heart failure.
Topics: Cardiac Output; Diuretics; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Contraction; | 1980 |
Pharmacodynamic basis of the use of vasodilators in the treatment of heart failure.
Topics: Cardiac Output; Diuretics; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Contraction; | 1980 |
[Peripheral effects of nitrate compounds (author's transl)].
Topics: Angina Pectoris; Arteries; Heart Failure; Muscle, Smooth, Vascular; Myocardium; Nitroglycerin; Oxyge | 1980 |
[Peripheral effects of nitrate compounds (author's transl)].
Topics: Angina Pectoris; Arteries; Heart Failure; Muscle, Smooth, Vascular; Myocardium; Nitroglycerin; Oxyge | 1980 |
Hemodynamic effects of nitrates in chronic heart failure and myocardial infarction.
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; N | 1980 |
Hemodynamic effects of nitrates in chronic heart failure and myocardial infarction.
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; N | 1980 |
[Long-acting nitrate compounds (author's transl)].
Topics: Delayed-Action Preparations; Heart Failure; Humans; Kinetics; Nitrates; Nitroglycerin; Vasodilator A | 1980 |
[Long-acting nitrate compounds (author's transl)].
Topics: Delayed-Action Preparations; Heart Failure; Humans; Kinetics; Nitrates; Nitroglycerin; Vasodilator A | 1980 |
Pharmacokinetic-hemodynamic studies of nitroglycerin in congestive cardiac failure.
Topics: Heart Failure; Hemodynamics; Humans; Kinetics; Nitroglycerin | 1980 |
Pharmacokinetic-hemodynamic studies of nitroglycerin in congestive cardiac failure.
Topics: Heart Failure; Hemodynamics; Humans; Kinetics; Nitroglycerin | 1980 |
[Treatment of left ventricular failure with percutaneous nitroglycerin (author's transl)].
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Ointments; Time | 1980 |
[Treatment of left ventricular failure with percutaneous nitroglycerin (author's transl)].
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Ointments; Time | 1980 |
Nitrate tolerance and dependence. A critical assessment.
Topics: Angina Pectoris; Animals; Dogs; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrate | 1980 |
Nitrate tolerance and dependence. A critical assessment.
Topics: Angina Pectoris; Animals; Dogs; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrate | 1980 |
Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Catecholamines; Dobutamine; Drug Synergism; Heart Failure; Hemodynamics | 1980 |
Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Catecholamines; Dobutamine; Drug Synergism; Heart Failure; Hemodynamics | 1980 |
[Use of vasodilator agents for treating acute cardiac insufficiency].
Topics: Acute Disease; Adult; Aged; Coronary Disease; Drug Therapy, Combination; Female; Heart Failure; Hemo | 1980 |
[Use of vasodilator agents for treating acute cardiac insufficiency].
Topics: Acute Disease; Adult; Aged; Coronary Disease; Drug Therapy, Combination; Female; Heart Failure; Hemo | 1980 |
[Treatment of left ventricular insufficiency with percutaneous trinitrin].
Topics: Aged; Blood Pressure; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Ag | 1980 |
[Treatment of left ventricular insufficiency with percutaneous trinitrin].
Topics: Aged; Blood Pressure; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Ag | 1980 |
[Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
Topics: Blood Pressure; Cardiac Output; Cardiomyopathies; Catecholamines; Coronary Disease; Dopamine; Epinep | 1980 |
[Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
Topics: Blood Pressure; Cardiac Output; Cardiomyopathies; Catecholamines; Coronary Disease; Dopamine; Epinep | 1980 |
[Use of nitrates in clinical practice].
Topics: Angina Pectoris; Cardiovascular System; Electrocardiography; Heart Failure; Humans; Myocardial Infar | 1980 |
[Use of nitrates in clinical practice].
Topics: Angina Pectoris; Cardiovascular System; Electrocardiography; Heart Failure; Humans; Myocardial Infar | 1980 |
Current status of hemodynamic monitoring: indication, diagnoses, complications.
Topics: Acute Disease; Arrhythmias, Cardiac; Cardiac Output; Glucose; Heart Failure; Heart Ventricles; Hemod | 1981 |
Current status of hemodynamic monitoring: indication, diagnoses, complications.
Topics: Acute Disease; Arrhythmias, Cardiac; Cardiac Output; Glucose; Heart Failure; Heart Ventricles; Hemod | 1981 |
[Effect of nitroglycerine on haemodynamics and on catecholamine metabolism in patients with congestive left heart failure (author's transl)].
Topics: Catecholamines; Dopamine; Epinephrine; Heart Failure; Hemodynamics; Humans; Middle Aged; Nitroglycer | 1980 |
[Effect of nitroglycerine on haemodynamics and on catecholamine metabolism in patients with congestive left heart failure (author's transl)].
Topics: Catecholamines; Dopamine; Epinephrine; Heart Failure; Hemodynamics; Humans; Middle Aged; Nitroglycer | 1980 |
Afterload reduction in the therapy of heart failure.
Topics: Diuretics; Heart Failure; Humans; Nitroglycerin; Nitroprusside; Phentolamine | 1980 |
Afterload reduction in the therapy of heart failure.
Topics: Diuretics; Heart Failure; Humans; Nitroglycerin; Nitroprusside; Phentolamine | 1980 |
[Hemodynamic effects of percutaneous trinitrin].
Topics: Adult; Aged; Blood Pressure; Female; Heart Atria; Heart Failure; Hemodynamics; Humans; Male; Middle | 1981 |
[Hemodynamic effects of percutaneous trinitrin].
Topics: Adult; Aged; Blood Pressure; Female; Heart Atria; Heart Failure; Hemodynamics; Humans; Male; Middle | 1981 |
Mechanism of action of nitroglycerin during exercise in a rat model of heart failure. Improvement of blood flow to the renal, splanchnic, and cutaneous beds.
Topics: Animals; Bronchial Arteries; Cardiac Output; Disease Models, Animal; Exercise Test; Heart; Heart Fai | 1981 |
Mechanism of action of nitroglycerin during exercise in a rat model of heart failure. Improvement of blood flow to the renal, splanchnic, and cutaneous beds.
Topics: Animals; Bronchial Arteries; Cardiac Output; Disease Models, Animal; Exercise Test; Heart; Heart Fai | 1981 |
Nitrates, package inserts, and the Food and Drug Administration. A clinical paradox.
Topics: Angina Pectoris; Biological Availability; Delayed-Action Preparations; Drug Labeling; Heart Failure; | 1981 |
Nitrates, package inserts, and the Food and Drug Administration. A clinical paradox.
Topics: Angina Pectoris; Biological Availability; Delayed-Action Preparations; Drug Labeling; Heart Failure; | 1981 |
[Treatment of severe cardiac insufficiency with endovenous nitroglycerin].
Topics: Adult; Aged; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; | 1981 |
[Treatment of severe cardiac insufficiency with endovenous nitroglycerin].
Topics: Adult; Aged; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; | 1981 |
Enhancement of phentolamine by nitrates in patients with congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans | 1981 |
Enhancement of phentolamine by nitrates in patients with congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans | 1981 |
[Acute pulmonary edema. Clinical experience in re-evaluation of the therapeutic role of chlorpromazine].
Topics: Aged; Chlorpromazine; Heart Diseases; Heart Failure; Humans; Intermittent Positive-Pressure Ventilat | 1981 |
[Acute pulmonary edema. Clinical experience in re-evaluation of the therapeutic role of chlorpromazine].
Topics: Aged; Chlorpromazine; Heart Diseases; Heart Failure; Humans; Intermittent Positive-Pressure Ventilat | 1981 |
[Peripheral vasodilators in the treatment of cardiac insufficiency].
Topics: Heart Failure; Humans; Infusions, Parenteral; Molsidomine; Morpholines; Nitroglycerin; Nitroprusside | 1981 |
[Peripheral vasodilators in the treatment of cardiac insufficiency].
Topics: Heart Failure; Humans; Infusions, Parenteral; Molsidomine; Morpholines; Nitroglycerin; Nitroprusside | 1981 |
Association of asynchronous protodiastolic segmental wall motion with impaired left ventricular relaxation.
Topics: Adult; Coronary Disease; Diastole; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Is | 1981 |
Association of asynchronous protodiastolic segmental wall motion with impaired left ventricular relaxation.
Topics: Adult; Coronary Disease; Diastole; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Is | 1981 |
Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure.
Topics: Cardiac Output; Extremities; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Injections, | 1981 |
Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure.
Topics: Cardiac Output; Extremities; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Injections, | 1981 |
Reversibility of abnormal arterial baroreflex control of heart rate in heart failure.
Topics: Animals; Arteries; Blood Pressure; Dogs; Heart Failure; Heart Rate; Heart Ventricles; Nitroglycerin; | 1981 |
Reversibility of abnormal arterial baroreflex control of heart rate in heart failure.
Topics: Animals; Arteries; Blood Pressure; Dogs; Heart Failure; Heart Rate; Heart Ventricles; Nitroglycerin; | 1981 |
The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
Topics: Heart Failure; Heart Rupture; Hemodynamics; Humans; Hydralazine; Mitral Valve Insufficiency; Myocard | 1981 |
The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
Topics: Heart Failure; Heart Rupture; Hemodynamics; Humans; Hydralazine; Mitral Valve Insufficiency; Myocard | 1981 |
[Experience in using nitroglycerin in the acute period of myocardial infarct].
Topics: Aged; Drug Evaluation; Dyspnea, Paroxysmal; Electrocardiography; Female; Heart Failure; Hemodynamics | 1981 |
[Experience in using nitroglycerin in the acute period of myocardial infarct].
Topics: Aged; Drug Evaluation; Dyspnea, Paroxysmal; Electrocardiography; Female; Heart Failure; Hemodynamics | 1981 |
The nitrites and nitrates.
Topics: Angina Pectoris; Angina Pectoris, Variant; Drug Interactions; Ethanol; Heart Failure; Liver; Mouth F | 1982 |
The nitrites and nitrates.
Topics: Angina Pectoris; Angina Pectoris, Variant; Drug Interactions; Ethanol; Heart Failure; Liver; Mouth F | 1982 |
Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.
Topics: Aged; Cardiac Output; Drug Evaluation; Echocardiography; Female; Heart Failure; Hemodynamics; Humans | 1982 |
Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.
Topics: Aged; Cardiac Output; Drug Evaluation; Echocardiography; Female; Heart Failure; Hemodynamics; Humans | 1982 |
Preload and afterload without anguish: a simplified framework.
Topics: Cardiac Output; Coronary Circulation; Heart Failure; Heart Function Tests; Humans; Hydralazine; Nitr | 1982 |
Preload and afterload without anguish: a simplified framework.
Topics: Cardiac Output; Coronary Circulation; Heart Failure; Heart Function Tests; Humans; Hydralazine; Nitr | 1982 |
[Therapeutic possibilities of nitroglycerine ointment formulation (author's transl)].
Topics: Angina Pectoris; Heart Failure; Humans; Nitroglycerin; Ointments | 1982 |
[Therapeutic possibilities of nitroglycerine ointment formulation (author's transl)].
Topics: Angina Pectoris; Heart Failure; Humans; Nitroglycerin; Ointments | 1982 |
Therapeutic scope of intravenous nitroglycerin.
Topics: Acute Disease; Angina Pectoris; Coronary Artery Bypass; Heart Failure; Humans; Hypertension; Infusio | 1982 |
Therapeutic scope of intravenous nitroglycerin.
Topics: Acute Disease; Angina Pectoris; Coronary Artery Bypass; Heart Failure; Humans; Hypertension; Infusio | 1982 |
Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Hemodynamics; Humans; Infusions, | 1982 |
Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Hemodynamics; Humans; Infusions, | 1982 |
Use of intravenous nitroglycerin in the coronary care unit.
Topics: Angina Pectoris; Cardiac Output; Coronary Care Units; Electrocardiography; Heart Failure; Humans; In | 1982 |
Use of intravenous nitroglycerin in the coronary care unit.
Topics: Angina Pectoris; Cardiac Output; Coronary Care Units; Electrocardiography; Heart Failure; Humans; In | 1982 |
Intravenous nitroglycerin.
Topics: Angina Pectoris, Variant; Heart Failure; Hemodynamics; Humans; Hypertension; Hypotension; Infusions, | 1982 |
Intravenous nitroglycerin.
Topics: Angina Pectoris, Variant; Heart Failure; Hemodynamics; Humans; Hypertension; Hypotension; Infusions, | 1982 |
[Slower lidocaine elimination and dose adjustment in patients with heart failure].
Topics: Arrhythmias, Cardiac; Coronary Disease; Heart Failure; Humans; Infusions, Parenteral; Lidocaine; Nit | 1982 |
[Slower lidocaine elimination and dose adjustment in patients with heart failure].
Topics: Arrhythmias, Cardiac; Coronary Disease; Heart Failure; Humans; Infusions, Parenteral; Lidocaine; Nit | 1982 |
[Comparison between the hemodynamic effects of nitroglycerine ointment and oral isosorbide dinitrate in the treatment of left ventricular failure (author's transl)].
Topics: Administration, Oral; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate | 1981 |
[Comparison between the hemodynamic effects of nitroglycerine ointment and oral isosorbide dinitrate in the treatment of left ventricular failure (author's transl)].
Topics: Administration, Oral; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate | 1981 |
[Effect of nitroglycerin and N-ethoxycarbonyl-3-morpholinosydnonomine on the walls of large arteries].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Heart Failure; Humans; Male; Middle Aged; Mols | 1982 |
[Effect of nitroglycerin and N-ethoxycarbonyl-3-morpholinosydnonomine on the walls of large arteries].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Heart Failure; Humans; Male; Middle Aged; Mols | 1982 |
[Regional circulatory changes in heart failure as affected by intravenous nitroglycerin administration].
Topics: Abdomen; Coronary Disease; Fingers; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Leg; | 1982 |
[Regional circulatory changes in heart failure as affected by intravenous nitroglycerin administration].
Topics: Abdomen; Coronary Disease; Fingers; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Leg; | 1982 |
Arterial-venous nitroglycerin gradient during intravenous infusion in man.
Topics: Adult; Aged; Blood Pressure; Female; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; | 1982 |
Arterial-venous nitroglycerin gradient during intravenous infusion in man.
Topics: Adult; Aged; Blood Pressure; Female; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; | 1982 |
Peripheral vascular effects of nitroglycerin in a conscious rat model of heart failure.
Topics: Animals; Blood Pressure; Carbon Dioxide; Cardiac Output; Disease Models, Animal; Heart Failure; Hear | 1982 |
Peripheral vascular effects of nitroglycerin in a conscious rat model of heart failure.
Topics: Animals; Blood Pressure; Carbon Dioxide; Cardiac Output; Disease Models, Animal; Heart Failure; Hear | 1982 |
[Pathophysiological aspects of heart failure complicating the course of myocardial infarct].
Topics: Adult; Aged; Cardiac Catheterization; Cardiac Glycosides; Echocardiography; Heart Failure; Hemodynam | 1982 |
[Pathophysiological aspects of heart failure complicating the course of myocardial infarct].
Topics: Adult; Aged; Cardiac Catheterization; Cardiac Glycosides; Echocardiography; Heart Failure; Hemodynam | 1982 |
[Trinitroglycerin ointment and oral isosorbide dinitrate: comparison of the hemodynamic effects induced in acute myocardial infarct with left ventricular insufficiency].
Topics: Aged; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Mid | 1981 |
[Trinitroglycerin ointment and oral isosorbide dinitrate: comparison of the hemodynamic effects induced in acute myocardial infarct with left ventricular insufficiency].
Topics: Aged; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Mid | 1981 |
[Hemodynamic effects of nitroglycerin in patients with post-infarction circulatory failure].
Topics: Blood Pressure; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin | 1982 |
[Hemodynamic effects of nitroglycerin in patients with post-infarction circulatory failure].
Topics: Blood Pressure; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin | 1982 |
[Baroreflexes and congestive heart failure].
Topics: Autonomic Nervous System; Baroreflex; Blood Pressure; Female; Heart Failure; Heart Rate; Humans; Mal | 1995 |
[Baroreflexes and congestive heart failure].
Topics: Autonomic Nervous System; Baroreflex; Blood Pressure; Female; Heart Failure; Heart Rate; Humans; Mal | 1995 |
Continuous versus intermittent nitroglycerin administration in experimental heart failure: vascular relaxation and radioligand binding to adrenoceptors and ion channels.
Topics: Administration, Cutaneous; Animals; Aorta, Thoracic; Binding Sites; Drug Tolerance; Glyburide; Heart | 1993 |
Continuous versus intermittent nitroglycerin administration in experimental heart failure: vascular relaxation and radioligand binding to adrenoceptors and ion channels.
Topics: Administration, Cutaneous; Animals; Aorta, Thoracic; Binding Sites; Drug Tolerance; Glyburide; Heart | 1993 |
Endothelial control of arterial distensibility is impaired in chronic heart failure.
Topics: Acetylcholine; Adenosine; Blood Flow Velocity; Brachial Artery; Cardiomyopathy, Dilated; Case-Contro | 1995 |
Endothelial control of arterial distensibility is impaired in chronic heart failure.
Topics: Acetylcholine; Adenosine; Blood Flow Velocity; Brachial Artery; Cardiomyopathy, Dilated; Case-Contro | 1995 |
[Changes in external respiration due to vasoactive therapy in patients with heart failure].
Topics: Adult; Aged; Female; Heart Failure; Humans; Lung; Male; Middle Aged; Nitroglycerin; Pentoxifylline; | 1995 |
[Changes in external respiration due to vasoactive therapy in patients with heart failure].
Topics: Adult; Aged; Female; Heart Failure; Humans; Lung; Male; Middle Aged; Nitroglycerin; Pentoxifylline; | 1995 |
Nitrates and severe aortic stenosis.
Topics: Acute Disease; Aged; Aortic Valve Stenosis; Heart Failure; Humans; Male; Nitroglycerin | 1995 |
Nitrates and severe aortic stenosis.
Topics: Acute Disease; Aged; Aortic Valve Stenosis; Heart Failure; Humans; Male; Nitroglycerin | 1995 |
Modulation of noradrenaline release through presynaptic alpha 2-adrenoceptors in congestive heart failure.
Topics: Aged; Epinephrine; Feedback; Heart Failure; Humans; Middle Aged; Nitroglycerin; Norepinephrine; Phen | 1995 |
Modulation of noradrenaline release through presynaptic alpha 2-adrenoceptors in congestive heart failure.
Topics: Aged; Epinephrine; Feedback; Heart Failure; Humans; Middle Aged; Nitroglycerin; Norepinephrine; Phen | 1995 |
Long-term vasodilator therapy for heart failure: noninvasive evaluation and noninvasive predictors of survival.
Topics: Adolescent; Adult; Antihypertensive Agents; Cardiomyopathy, Dilated; Delayed-Action Preparations; Di | 1995 |
Long-term vasodilator therapy for heart failure: noninvasive evaluation and noninvasive predictors of survival.
Topics: Adolescent; Adult; Antihypertensive Agents; Cardiomyopathy, Dilated; Delayed-Action Preparations; Di | 1995 |
Inotropic agents and nitrates.
Topics: Angina Pectoris; Cardiotonic Agents; Heart Failure; Humans; Nitroglycerin; Patient Care Planning | 1995 |
Inotropic agents and nitrates.
Topics: Angina Pectoris; Cardiotonic Agents; Heart Failure; Humans; Nitroglycerin; Patient Care Planning | 1995 |
The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dobutamine; D | 1994 |
The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dobutamine; D | 1994 |
Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
Topics: Animals; Dogs; Enalaprilat; Heart Failure; Hydralazine; Mesenteric Veins; Nitroglycerin; Plethysmogr | 1995 |
Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
Topics: Animals; Dogs; Enalaprilat; Heart Failure; Hydralazine; Mesenteric Veins; Nitroglycerin; Plethysmogr | 1995 |
[A study of captopril enhancement of nitrate effect coronary arterial disease patients associated with heart failure].
Topics: Adult; Aged; Animals; Captopril; Coronary Circulation; Drug Therapy, Combination; Female; Heart Fail | 1994 |
[A study of captopril enhancement of nitrate effect coronary arterial disease patients associated with heart failure].
Topics: Adult; Aged; Animals; Captopril; Coronary Circulation; Drug Therapy, Combination; Female; Heart Fail | 1994 |
Haemodynamic effects of glyceryl trinitrate during continuous 24 hour infusion in patients with heart failure.
Topics: Acetylcysteine; Adult; Blood Pressure; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; | 1994 |
Haemodynamic effects of glyceryl trinitrate during continuous 24 hour infusion in patients with heart failure.
Topics: Acetylcysteine; Adult; Blood Pressure; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; | 1994 |
Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
Topics: Animals; Blood Pressure; Drug Tolerance; Half-Life; Heart Failure; Hemodynamics; Infusions, Intraven | 1994 |
Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
Topics: Animals; Blood Pressure; Drug Tolerance; Half-Life; Heart Failure; Hemodynamics; Infusions, Intraven | 1994 |
Impaired endothelium-dependent vasodilatory responses in hindlimb blood flow in dogs with congestive heart failure.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Chronic Disease; Dogs; Endothelium, Vascular; Heart F | 1994 |
Impaired endothelium-dependent vasodilatory responses in hindlimb blood flow in dogs with congestive heart failure.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Chronic Disease; Dogs; Endothelium, Vascular; Heart F | 1994 |
[Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
Topics: Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Heart Fai | 1994 |
[Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
Topics: Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Heart Fai | 1994 |
[The clinical and hemodynamic effects of enalapril and its influence on the peri-infarct area in patients with an acute myocardial infarct].
Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Enalapril; Female; Heart; Heart Failure; Hemodynami | 1994 |
[The clinical and hemodynamic effects of enalapril and its influence on the peri-infarct area in patients with an acute myocardial infarct].
Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Enalapril; Female; Heart; Heart Failure; Hemodynami | 1994 |
[Non-invasive assessment of the efficacy of long-term vasodilator therapy of cardiac decompensation in patients with dilated cardiomyopathy].
Topics: Adult; Cardiomyopathy, Dilated; Dihydralazine; Female; Heart Failure; Humans; Male; Middle Aged; Nit | 1993 |
[Non-invasive assessment of the efficacy of long-term vasodilator therapy of cardiac decompensation in patients with dilated cardiomyopathy].
Topics: Adult; Cardiomyopathy, Dilated; Dihydralazine; Female; Heart Failure; Humans; Male; Middle Aged; Nit | 1993 |
Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.
Topics: Atrial Natriuretic Factor; Captopril; Cyclic GMP; Dose-Response Relationship, Drug; Drug Tolerance; | 1994 |
Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.
Topics: Atrial Natriuretic Factor; Captopril; Cyclic GMP; Dose-Response Relationship, Drug; Drug Tolerance; | 1994 |
[Enoximone in the postoperative phase of heart surgery].
Topics: Aged; Cardiac Output, Low; Catecholamines; Coronary Artery Bypass; Drug Therapy, Combination; Electr | 1994 |
[Enoximone in the postoperative phase of heart surgery].
Topics: Aged; Cardiac Output, Low; Catecholamines; Coronary Artery Bypass; Drug Therapy, Combination; Electr | 1994 |
Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure.
Topics: Acetylcholine; Brachial Artery; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Infus | 1994 |
Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure.
Topics: Acetylcholine; Brachial Artery; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Infus | 1994 |
Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure.
Topics: Animals; Blood Pressure; Heart Failure; Heart Rate; Hemodynamics; Infusions, Intravenous; Nitroglyce | 1993 |
Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure.
Topics: Animals; Blood Pressure; Heart Failure; Heart Rate; Hemodynamics; Infusions, Intravenous; Nitroglyce | 1993 |
ED management of acute congestive heart failure in renal dialysis patients.
Topics: Acute Disease; Administration, Cutaneous; Administration, Oral; Administration, Sublingual; Captopri | 1993 |
ED management of acute congestive heart failure in renal dialysis patients.
Topics: Acute Disease; Administration, Cutaneous; Administration, Oral; Administration, Sublingual; Captopri | 1993 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echoc | 1993 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echoc | 1993 |
Safety of prehospital nitroglycerin.
Topics: Administration, Sublingual; Adult; Aged; Aged, 80 and over; Bradycardia; Emergencies; Emergency Medi | 1994 |
Safety of prehospital nitroglycerin.
Topics: Administration, Sublingual; Adult; Aged; Aged, 80 and over; Bradycardia; Emergencies; Emergency Medi | 1994 |
Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Cardia | 1993 |
Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Cardia | 1993 |
[Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance].
Topics: Aged; Coronary Disease; Drug Therapy, Combination; Drug Tolerance; Female; Heart Failure; Hemodynami | 1993 |
[Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance].
Topics: Aged; Coronary Disease; Drug Therapy, Combination; Drug Tolerance; Female; Heart Failure; Hemodynami | 1993 |
Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.
Topics: Acetylcholine; Cyclooxygenase Inhibitors; Endothelins; Female; Forearm; Heart Failure; Humans; Indom | 1993 |
Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.
Topics: Acetylcholine; Cyclooxygenase Inhibitors; Endothelins; Female; Forearm; Heart Failure; Humans; Indom | 1993 |
[Quantitative assessment of the effect of nitroglycerin on left ventricular function with two-dimensional echocardiography in patients with myocardial infarction].
Topics: Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardi | 1993 |
[Quantitative assessment of the effect of nitroglycerin on left ventricular function with two-dimensional echocardiography in patients with myocardial infarction].
Topics: Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardi | 1993 |
Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure.
Topics: Adult; Aged; Arousal; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Hypotension, Orth | 1993 |
Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure.
Topics: Adult; Aged; Arousal; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Hypotension, Orth | 1993 |
Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance.
Topics: Analysis of Variance; Blood Pressure; Case-Control Studies; Female; Heart Failure; Heart Rate; Hemod | 1993 |
Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance.
Topics: Analysis of Variance; Blood Pressure; Case-Control Studies; Female; Heart Failure; Heart Rate; Hemod | 1993 |
[Effects of carperitide (alpha-human atrial natriuretic peptide) on acute congestive heart failure in dogs].
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; | 1993 |
[Effects of carperitide (alpha-human atrial natriuretic peptide) on acute congestive heart failure in dogs].
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; | 1993 |
Nitrate tolerance--problems both new and old.
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Drug | 1996 |
Nitrate tolerance--problems both new and old.
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Drug | 1996 |
[Therapeutic range of transdermal nitro-patches].
Topics: Administration, Cutaneous; Angina Pectoris; Arrhythmias, Cardiac; Evaluation Studies as Topic; Heart | 1995 |
[Therapeutic range of transdermal nitro-patches].
Topics: Administration, Cutaneous; Angina Pectoris; Arrhythmias, Cardiac; Evaluation Studies as Topic; Heart | 1995 |
Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.
Topics: Animals; Aorta; Drug Therapy, Combination; Gene Expression Regulation, Enzymologic; Heart Failure; H | 1996 |
Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.
Topics: Animals; Aorta; Drug Therapy, Combination; Gene Expression Regulation, Enzymologic; Heart Failure; H | 1996 |
Investigations of the peripheral vascular mechanisms implicated in congestive heart failure by the non-invasive evaluation of radial artery compliance and reactivity.
Topics: Blood Pressure; Case-Control Studies; Cold Temperature; Elasticity; Endothelium, Vascular; Female; H | 1996 |
Investigations of the peripheral vascular mechanisms implicated in congestive heart failure by the non-invasive evaluation of radial artery compliance and reactivity.
Topics: Blood Pressure; Case-Control Studies; Cold Temperature; Elasticity; Endothelium, Vascular; Female; H | 1996 |
Sympathetic alternans. Evidence for arterial baroreflex control of muscle sympathetic nerve activity in congestive heart failure.
Topics: Adult; Arteries; Baroreflex; Blood Pressure; Cardiomyopathy, Dilated; Diastole; Heart Failure; Human | 1997 |
Sympathetic alternans. Evidence for arterial baroreflex control of muscle sympathetic nerve activity in congestive heart failure.
Topics: Adult; Arteries; Baroreflex; Blood Pressure; Cardiomyopathy, Dilated; Diastole; Heart Failure; Human | 1997 |
Altered vasodilator response of coronary microvasculature in pacing-induced congestive heart failure.
Topics: Acetylcholine; Animals; Arginine; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Heart Fa | 1996 |
Altered vasodilator response of coronary microvasculature in pacing-induced congestive heart failure.
Topics: Acetylcholine; Animals; Arginine; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Heart Fa | 1996 |
[Nitrate compounds in patients awaiting heart transplantation].
Topics: Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; | 1996 |
[Nitrate compounds in patients awaiting heart transplantation].
Topics: Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; | 1996 |
Endothelium-dependent relaxation is not uniformly impaired in chronic heart failure.
Topics: Acetylcholine; Animals; Aorta, Abdominal; Dinoprost; Endothelium, Vascular; Heart Failure; Hemodynam | 1997 |
Endothelium-dependent relaxation is not uniformly impaired in chronic heart failure.
Topics: Acetylcholine; Animals; Aorta, Abdominal; Dinoprost; Endothelium, Vascular; Heart Failure; Hemodynam | 1997 |
Training improves endothelium-dependent vasodilation in resistance vessels of patients with heart failure.
Topics: Acetylcholine; Blood Pressure; Breathing Exercises; Cardiomyopathy, Dilated; Endothelium, Vascular; | 1997 |
Training improves endothelium-dependent vasodilation in resistance vessels of patients with heart failure.
Topics: Acetylcholine; Blood Pressure; Breathing Exercises; Cardiomyopathy, Dilated; Endothelium, Vascular; | 1997 |
Influence of hemodynamic changes on neuroendocrine response in acute heart failure.
Topics: Acute Disease; Aged; Aldosterone; Cardiac Catheterization; Diuretics; Epinephrine; Female; Heart Fai | 1997 |
Influence of hemodynamic changes on neuroendocrine response in acute heart failure.
Topics: Acute Disease; Aged; Aldosterone; Cardiac Catheterization; Diuretics; Epinephrine; Female; Heart Fai | 1997 |
Relationship between exercise hyperpnea, hemodynamics, and blood gases before and during glyceryl trinitrate infusion in patients with exercise-induced elevation of pulmonary artery wedge pressure.
Topics: Aged; Aged, 80 and over; Blood Gas Analysis; Exercise; Exercise Test; Heart Failure; Hemodynamics; H | 1997 |
Relationship between exercise hyperpnea, hemodynamics, and blood gases before and during glyceryl trinitrate infusion in patients with exercise-induced elevation of pulmonary artery wedge pressure.
Topics: Aged; Aged, 80 and over; Blood Gas Analysis; Exercise; Exercise Test; Heart Failure; Hemodynamics; H | 1997 |
Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure.
Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Drug Design; Drug Tolerance; Heart Failure; | 1997 |
Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure.
Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Drug Design; Drug Tolerance; Heart Failure; | 1997 |
The delayed recovery of impaired endothelium-dependent vasodilatory response after hemodynamic improvement in dogs with congestive heart failure.
Topics: Acetylcholine; Animals; Cardiac Pacing, Artificial; Dogs; Endothelium, Vascular; Femoral Vein; Heart | 1997 |
The delayed recovery of impaired endothelium-dependent vasodilatory response after hemodynamic improvement in dogs with congestive heart failure.
Topics: Acetylcholine; Animals; Cardiac Pacing, Artificial; Dogs; Endothelium, Vascular; Femoral Vein; Heart | 1997 |
Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Drug Administration Rou | 1997 |
Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Drug Administration Rou | 1997 |
Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation.
Topics: Acute Disease; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Hypertension | 1997 |
Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation.
Topics: Acute Disease; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Hypertension | 1997 |
[Administration of nitroglycerin using transdermal patches].
Topics: Administration, Cutaneous; Angina Pectoris; Coronary Vessels; Delayed-Action Preparations; Drug Tole | 1997 |
[Administration of nitroglycerin using transdermal patches].
Topics: Administration, Cutaneous; Angina Pectoris; Coronary Vessels; Delayed-Action Preparations; Drug Tole | 1997 |
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Topics: Acute Disease; Adrenergic beta-Agonists; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calciu | 1998 |
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Topics: Acute Disease; Adrenergic beta-Agonists; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calciu | 1998 |
Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Circulation; Cromakalim; Disease Models, Animal; Do | 1998 |
Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Circulation; Cromakalim; Disease Models, Animal; Do | 1998 |
Acute effects of toborinone on vascular capacitance and conductance in experimental heart failure.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dogs; Enalaprilat; Female; Heart Failure; Hemod | 1998 |
Acute effects of toborinone on vascular capacitance and conductance in experimental heart failure.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dogs; Enalaprilat; Female; Heart Failure; Hemod | 1998 |
Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Ascorbic Acid; Blood Flow Velocity; Brachial Artery; Cardiomyopathy, D | 1998 |
Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Ascorbic Acid; Blood Flow Velocity; Brachial Artery; Cardiomyopathy, D | 1998 |
Effect of ED management on ICU use in acute pulmonary edema.
Topics: Acute Disease; Aged; Analgesics, Opioid; Analysis of Variance; Angiotensin-Converting Enzyme Inhibit | 1999 |
Effect of ED management on ICU use in acute pulmonary edema.
Topics: Acute Disease; Aged; Analgesics, Opioid; Analysis of Variance; Angiotensin-Converting Enzyme Inhibit | 1999 |
Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Female; Heart | 1999 |
Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Female; Heart | 1999 |
Chronic exercise training preserves prostaglandin-induced dilation of epicardial coronary artery during development of heart failure in awake dogs.
Topics: Animals; Arachidonic Acid; Cardiac Pacing, Artificial; Coronary Vessels; Dogs; Dose-Response Relatio | 2000 |
Chronic exercise training preserves prostaglandin-induced dilation of epicardial coronary artery during development of heart failure in awake dogs.
Topics: Animals; Arachidonic Acid; Cardiac Pacing, Artificial; Coronary Vessels; Dogs; Dose-Response Relatio | 2000 |
Has an intensified treatment in the ambulance of patients with acute severe left heart failure improved the outcome?
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ambulances; Combined Modality Therapy; Creatine Kinas | 2000 |
Has an intensified treatment in the ambulance of patients with acute severe left heart failure improved the outcome?
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ambulances; Combined Modality Therapy; Creatine Kinas | 2000 |
Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Cardiovascular Agents; Coron | 2000 |
Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Cardiovascular Agents; Coron | 2000 |
Acute congestive heart failure associated with a limited form of systemic sclerosis and primary biliary cirrhosis.
Topics: Acute Disease; Antibody Specificity; Autoantibodies; Autoimmune Diseases; Centromere; Coronary Circu | 2001 |
Acute congestive heart failure associated with a limited form of systemic sclerosis and primary biliary cirrhosis.
Topics: Acute Disease; Antibody Specificity; Autoantibodies; Autoimmune Diseases; Centromere; Coronary Circu | 2001 |
Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor.
Topics: Acetylcholine; Adult; Aged; Biological Factors; Brachial Artery; Case-Control Studies; Cyclooxygenas | 2001 |
Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor.
Topics: Acetylcholine; Adult; Aged; Biological Factors; Brachial Artery; Case-Control Studies; Cyclooxygenas | 2001 |
[Acute therapy of heart failure with nitroglycerin. Rapid help in routine practice].
Topics: Acute Disease; Administration, Sublingual; Family Practice; Heart Failure; Humans; Nitroglycerin | 2001 |
[Acute therapy of heart failure with nitroglycerin. Rapid help in routine practice].
Topics: Acute Disease; Administration, Sublingual; Family Practice; Heart Failure; Humans; Nitroglycerin | 2001 |
[Emergency care in acute left heart failure. Decreasing preload, oxygen inhalation].
Topics: Administration, Inhalation; Aged; Combined Modality Therapy; Emergency Medical Services; Family Prac | 2001 |
[Emergency care in acute left heart failure. Decreasing preload, oxygen inhalation].
Topics: Administration, Inhalation; Aged; Combined Modality Therapy; Emergency Medical Services; Family Prac | 2001 |
Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Topics: Cost-Benefit Analysis; Dobutamine; Dopamine; Drug Costs; Female; Heart Failure; Hemodynamics; Humans | 2001 |
Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Topics: Cost-Benefit Analysis; Dobutamine; Dopamine; Drug Costs; Female; Heart Failure; Hemodynamics; Humans | 2001 |
Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
Topics: Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Infant; Infusions, In | 2000 |
Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
Topics: Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Infant; Infusions, In | 2000 |
Treatment of acute heart failure: out with the old, in with the new.
Topics: Acute Disease; Atrial Natriuretic Factor; Cardiotonic Agents; Heart Failure; Humans; Milrinone; Natr | 2002 |
Treatment of acute heart failure: out with the old, in with the new.
Topics: Acute Disease; Atrial Natriuretic Factor; Cardiotonic Agents; Heart Failure; Humans; Milrinone; Natr | 2002 |
Principles in selection of therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Arrhythmias, Cardiac; Coronar | 1976 |
Principles in selection of therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Arrhythmias, Cardiac; Coronar | 1976 |
[Possibilities of reducing of the area of myocardial infarction].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Cardiac Glycosides; Heart Failure; Humans; Hya | 1977 |
[Possibilities of reducing of the area of myocardial infarction].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Cardiac Glycosides; Heart Failure; Humans; Hya | 1977 |
Nitroglycerin--the first one hundred years: new facts about an old drug.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Coronary Disease; Delayed-Action Preparations; H | 1979 |
Nitroglycerin--the first one hundred years: new facts about an old drug.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Coronary Disease; Delayed-Action Preparations; H | 1979 |
[Drug therapy of myocardial infarct in ambulatory practice].
Topics: Acidosis; Adrenergic beta-Antagonists; Aftercare; Ajmaline; Ambulatory Care; Anticoagulants; Arrhyth | 1975 |
[Drug therapy of myocardial infarct in ambulatory practice].
Topics: Acidosis; Adrenergic beta-Antagonists; Aftercare; Ajmaline; Ambulatory Care; Anticoagulants; Arrhyth | 1975 |
Vasodilators in heart-failure.
Topics: Drug Evaluation; Heart; Heart Failure; Hemodynamics; Humans; Nitroglycerin; Nitroprusside; Phentolam | 1978 |
Vasodilators in heart-failure.
Topics: Drug Evaluation; Heart; Heart Failure; Hemodynamics; Humans; Nitroglycerin; Nitroprusside; Phentolam | 1978 |
[The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
Topics: Cardiac Output; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Injections, Intravenous; Myoc | 1978 |
[The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
Topics: Cardiac Output; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Injections, Intravenous; Myoc | 1978 |
[Vasodilator agents in treatment of cardiac insufficiency].
Topics: Heart Failure; Hemodynamics; Humans; Nitroglycerin; Vasodilator Agents | 1978 |
[Vasodilator agents in treatment of cardiac insufficiency].
Topics: Heart Failure; Hemodynamics; Humans; Nitroglycerin; Vasodilator Agents | 1978 |
Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Hemodynamics; Humans; H | 1978 |
Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Hemodynamics; Humans; H | 1978 |
Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Heart Failure; Humans; Hydra | 1978 |
Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Heart Failure; Humans; Hydra | 1978 |
Hemodynamic changes due to leg raising and sitting in patients with myocardial infarction with or without nitroglycerin therapy (author's transl).
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Diastole; Female; Heart Failure; Hemodynamics; Humans; | 1978 |
Hemodynamic changes due to leg raising and sitting in patients with myocardial infarction with or without nitroglycerin therapy (author's transl).
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Diastole; Female; Heart Failure; Hemodynamics; Humans; | 1978 |
Intravenous nitroglycerin.
Topics: Collateral Circulation; Coronary Circulation; Coronary Disease; Drug Interactions; Heart Failure; He | 1978 |
Intravenous nitroglycerin.
Topics: Collateral Circulation; Coronary Circulation; Coronary Disease; Drug Interactions; Heart Failure; He | 1978 |
[2. International Symposium on Nitrates; Berlin 1-3 June 1978. Nitrate-effect on the heart and circulation].
Topics: Angina Pectoris; Animals; Blood Circulation; Coronary Disease; Heart; Heart Failure; Humans; Isosorb | 1978 |
[2. International Symposium on Nitrates; Berlin 1-3 June 1978. Nitrate-effect on the heart and circulation].
Topics: Angina Pectoris; Animals; Blood Circulation; Coronary Disease; Heart; Heart Failure; Humans; Isosorb | 1978 |
[Optimum flow of intravenous trinitrine during the acute stage of myocardial infarct with cardiac insufficiency: its effects on survival].
Topics: Acute Disease; Adult; Aged; Female; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; | 1978 |
[Optimum flow of intravenous trinitrine during the acute stage of myocardial infarct with cardiac insufficiency: its effects on survival].
Topics: Acute Disease; Adult; Aged; Female; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; | 1978 |
Afterload reduction in the treatment of cardiac failure.
Topics: Blood Pressure; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; Phentolamine; Praz | 1978 |
Afterload reduction in the treatment of cardiac failure.
Topics: Blood Pressure; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; Phentolamine; Praz | 1978 |
[Peroral nitrate therapy in severe cardiac insufficiency following acute myocardial infarct].
Topics: Administration, Oral; Aged; Delayed-Action Preparations; Heart Failure; Humans; Isosorbide Dinitrate | 1978 |
[Peroral nitrate therapy in severe cardiac insufficiency following acute myocardial infarct].
Topics: Administration, Oral; Aged; Delayed-Action Preparations; Heart Failure; Humans; Isosorbide Dinitrate | 1978 |
[Influence of nitroglycerine combined with dopamine on ventricular pump-function in congestive heart failure (author's transl)].
Topics: Adult; Aged; Coronary Care Units; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart | 1978 |
[Influence of nitroglycerine combined with dopamine on ventricular pump-function in congestive heart failure (author's transl)].
Topics: Adult; Aged; Coronary Care Units; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart | 1978 |
Radionuclide angiography: noninvasive assessment of hemodynamic changes after administration of nitroglycerin.
Topics: Administration, Oral; Adult; Blood Pressure; Cardiac Output; Evaluation Studies as Topic; Female; He | 1979 |
Radionuclide angiography: noninvasive assessment of hemodynamic changes after administration of nitroglycerin.
Topics: Administration, Oral; Adult; Blood Pressure; Cardiac Output; Evaluation Studies as Topic; Female; He | 1979 |
[Comparison of the effects of phentolamine and trinitrine in the treatment of left ventricular failure during the acute phase of myocardial infarct].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Humans; Male; Middle Aged; Myoca | 1978 |
[Comparison of the effects of phentolamine and trinitrine in the treatment of left ventricular failure during the acute phase of myocardial infarct].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Humans; Male; Middle Aged; Myoca | 1978 |
[Vasodilator therapy of heart failure].
Topics: Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Stroke Volume; | 1979 |
[Vasodilator therapy of heart failure].
Topics: Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Stroke Volume; | 1979 |
Clinical use of nitrates. II. Nitrates in congestive heart failure.
Topics: Administration, Oral; Drug Evaluation; Heart Failure; Humans; Nitrates; Nitroglycerin; Ointments; Su | 1979 |
Clinical use of nitrates. II. Nitrates in congestive heart failure.
Topics: Administration, Oral; Drug Evaluation; Heart Failure; Humans; Nitrates; Nitroglycerin; Ointments; Su | 1979 |
[Hemodynamic and cartographic study of intravenous trinitrin in the acute stage of myocardial infarct].
Topics: Acute Disease; Adult; Aged; Female; Heart; Heart Failure; Hemodynamics; Humans; Infusions, Parentera | 1979 |
[Hemodynamic and cartographic study of intravenous trinitrin in the acute stage of myocardial infarct].
Topics: Acute Disease; Adult; Aged; Female; Heart; Heart Failure; Hemodynamics; Humans; Infusions, Parentera | 1979 |
[Treatement of circulatory insufficiency with vasodilator agents].
Topics: Blood Circulation; Ferricyanides; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; | 1979 |
[Treatement of circulatory insufficiency with vasodilator agents].
Topics: Blood Circulation; Ferricyanides; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; | 1979 |
Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure.
Topics: Administration, Oral; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitrogly | 1979 |
Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure.
Topics: Administration, Oral; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitrogly | 1979 |
Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Drug Combinations; Follow-Up Studies; Heart Failure; Hemodynamics; Huma | 1978 |
Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Drug Combinations; Follow-Up Studies; Heart Failure; Hemodynamics; Huma | 1978 |
Nonparenteral vasodilator therapy for chronic congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglycerin; Prazosin; Vasodilator Age | 1979 |
Nonparenteral vasodilator therapy for chronic congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglycerin; Prazosin; Vasodilator Age | 1979 |
Hemodynamic and metabolic responses to upright exercise in patients with congestive heart failure. Treatment with nitroglycerin ointment.
Topics: Adult; Blood Pressure; Catecholamines; Female; Heart; Heart Failure; Hemodynamics; Humans; Lactates; | 1979 |
Hemodynamic and metabolic responses to upright exercise in patients with congestive heart failure. Treatment with nitroglycerin ointment.
Topics: Adult; Blood Pressure; Catecholamines; Female; Heart; Heart Failure; Hemodynamics; Humans; Lactates; | 1979 |
[Round table on vasodilator agents in congestive heart failure].
Topics: Antihypertensive Agents; Heart Failure; Hemodynamics; Humans; Nitroglycerin; Vasodilator Agents | 1979 |
[Round table on vasodilator agents in congestive heart failure].
Topics: Antihypertensive Agents; Heart Failure; Hemodynamics; Humans; Nitroglycerin; Vasodilator Agents | 1979 |
Changing concepts in the management of congestive cardiac failure and acute myocardial infarction.
Topics: Heart Failure; Hospitalization; Humans; Length of Stay; Myocardial Infarction; Nitrates; Nitroglycer | 1979 |
Changing concepts in the management of congestive cardiac failure and acute myocardial infarction.
Topics: Heart Failure; Hospitalization; Humans; Length of Stay; Myocardial Infarction; Nitrates; Nitroglycer | 1979 |
[Progress in the therapy of acute and chronic cardiac insufficiency by means of systemic vasodilators. Studies with prazosin and nitroglycerin].
Topics: Blood Pressure; Catecholamines; Heart Failure; Heart Ventricles; Humans; Nitroglycerin; Prazosin; Qu | 1979 |
[Progress in the therapy of acute and chronic cardiac insufficiency by means of systemic vasodilators. Studies with prazosin and nitroglycerin].
Topics: Blood Pressure; Catecholamines; Heart Failure; Heart Ventricles; Humans; Nitroglycerin; Prazosin; Qu | 1979 |
[Intravenous trinitroglycerin during acute myocardial infarction with cardiac failure. Cooperative study of 68 patients (author's transl)].
Topics: Acute Disease; Drug Tolerance; Heart Diseases; Heart Failure; Heart Ventricles; Hemodynamics; Humans | 1979 |
[Intravenous trinitroglycerin during acute myocardial infarction with cardiac failure. Cooperative study of 68 patients (author's transl)].
Topics: Acute Disease; Drug Tolerance; Heart Diseases; Heart Failure; Heart Ventricles; Hemodynamics; Humans | 1979 |
[The use of intravenous nitroglycerin in chronic cardiac failure].
Topics: Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; M | 1979 |
[The use of intravenous nitroglycerin in chronic cardiac failure].
Topics: Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; M | 1979 |
[Nitroglycerin infusion in patients with or without cardiac failure. Demonstration by multifactorial analysis (analysis of correspondences) of three types of hemodynamic response dependent upon the initial state (author's transl)].
Topics: Adult; Aged; Cardiac Output; Factor Analysis, Statistical; Heart Failure; Hemodynamics; Humans; Infu | 1979 |
[Nitroglycerin infusion in patients with or without cardiac failure. Demonstration by multifactorial analysis (analysis of correspondences) of three types of hemodynamic response dependent upon the initial state (author's transl)].
Topics: Adult; Aged; Cardiac Output; Factor Analysis, Statistical; Heart Failure; Hemodynamics; Humans; Infu | 1979 |
[Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
Topics: Blood Pressure; Coronary Disease; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; | 1979 |
[Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
Topics: Blood Pressure; Coronary Disease; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; | 1979 |
[Comparison of the effects of nitroglycerin for injection and of phentolamine. The treatment of left ventricular failure during the acute phase of myocardial infarction].
Topics: Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial | 1979 |
[Comparison of the effects of nitroglycerin for injection and of phentolamine. The treatment of left ventricular failure during the acute phase of myocardial infarction].
Topics: Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial | 1979 |
[Catecholamine in the myocardium; a fluorescence histochemical study].
Topics: Animals; Atrioventricular Node; Cardiomegaly; Catecholamines; Dogs; Heart Atria; Heart Block; Heart | 1975 |
[Catecholamine in the myocardium; a fluorescence histochemical study].
Topics: Animals; Atrioventricular Node; Cardiomegaly; Catecholamines; Dogs; Heart Atria; Heart Block; Heart | 1975 |
Pulsus alternans induced by glyceryl trinitrate paste in a patient with alcoholic cardiomyopathy.
Topics: Adult; Blood Pressure; Cardiomegaly; Cardiomyopathy, Alcoholic; Heart Failure; Hepatitis, Alcoholic; | 1979 |
Pulsus alternans induced by glyceryl trinitrate paste in a patient with alcoholic cardiomyopathy.
Topics: Adult; Blood Pressure; Cardiomegaly; Cardiomyopathy, Alcoholic; Heart Failure; Hepatitis, Alcoholic; | 1979 |
Ventricular unloading in the management of heart disease: role of vasodilators. Part II.
Topics: Cardiomyopathy, Hypertrophic; Coronary Artery Bypass; Dosage Forms; Heart Diseases; Heart Failure; H | 1977 |
Ventricular unloading in the management of heart disease: role of vasodilators. Part II.
Topics: Cardiomyopathy, Hypertrophic; Coronary Artery Bypass; Dosage Forms; Heart Diseases; Heart Failure; H | 1977 |
[Left ventricular insufficiency in the acute stage of myocardial infarct. Treatment by intravenous trinitrate].
Topics: Acute Disease; Heart Failure; Humans; Injections, Intravenous; Myocardial Infarction; Nitroglycerin | 1977 |
[Left ventricular insufficiency in the acute stage of myocardial infarct. Treatment by intravenous trinitrate].
Topics: Acute Disease; Heart Failure; Humans; Injections, Intravenous; Myocardial Infarction; Nitroglycerin | 1977 |
Current status of nitroglycerin ointment in angina pectoris: a new look at an old drug.
Topics: Administration, Oral; Angina Pectoris; Cardiac Volume; Exercise Test; Heart Failure; Humans; Myocard | 1977 |
Current status of nitroglycerin ointment in angina pectoris: a new look at an old drug.
Topics: Administration, Oral; Angina Pectoris; Cardiac Volume; Exercise Test; Heart Failure; Humans; Myocard | 1977 |
Sublingual nitroglycerin for left ventricular failure and pulmonary edema.
Topics: Aged; Blood Pressure; Cardiac Output; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Nit | 1977 |
Sublingual nitroglycerin for left ventricular failure and pulmonary edema.
Topics: Aged; Blood Pressure; Cardiac Output; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Nit | 1977 |
New ideas in the management of heart failure in dogs.
Topics: Animals; Blood Pressure; Cardiac Output; Dog Diseases; Dogs; Heart Failure; Heart Rate; Nitroglyceri | 1977 |
New ideas in the management of heart failure in dogs.
Topics: Animals; Blood Pressure; Cardiac Output; Dog Diseases; Dogs; Heart Failure; Heart Rate; Nitroglyceri | 1977 |
Asynergy in coronary heart disease. Evolving clinical and pathophysiologic concepts.
Topics: Arrhythmias, Cardiac; Collateral Circulation; Coronary Artery Bypass; Coronary Circulation; Coronary | 1977 |
Asynergy in coronary heart disease. Evolving clinical and pathophysiologic concepts.
Topics: Arrhythmias, Cardiac; Collateral Circulation; Coronary Artery Bypass; Coronary Circulation; Coronary | 1977 |
The effect of local vasodilating agents.
Topics: Acute Disease; Animals; Dogs; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarctio | 1977 |
The effect of local vasodilating agents.
Topics: Acute Disease; Animals; Dogs; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarctio | 1977 |
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female | 1977 |
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female | 1977 |
Afterload reduction in congestive heart failure.
Topics: Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; | 1978 |
Afterload reduction in congestive heart failure.
Topics: Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; | 1978 |
[Nitroglycerin in research and clinical use (proceedings)].
Topics: Aged; Blood Pressure; Cardiac Output; Digitalis Glycosides; Furosemide; Heart Failure; Heart Rate; H | 1978 |
[Nitroglycerin in research and clinical use (proceedings)].
Topics: Aged; Blood Pressure; Cardiac Output; Digitalis Glycosides; Furosemide; Heart Failure; Heart Rate; H | 1978 |
[Mechanism of action, indications and clinical use of nitroglycerin (proceedings)].
Topics: Angina Pectoris; Coronary Vessels; Digitalis Glycosides; Dopamine; Heart Failure; Humans; Myocardial | 1978 |
[Mechanism of action, indications and clinical use of nitroglycerin (proceedings)].
Topics: Angina Pectoris; Coronary Vessels; Digitalis Glycosides; Dopamine; Heart Failure; Humans; Myocardial | 1978 |
Nitroglycerin ointment therapy and leg edema.
Topics: Administration, Topical; Angina Pectoris; Edema; Heart Failure; Humans; Leg; Male; Middle Aged; Nitr | 1978 |
Nitroglycerin ointment therapy and leg edema.
Topics: Administration, Topical; Angina Pectoris; Edema; Heart Failure; Humans; Leg; Male; Middle Aged; Nitr | 1978 |
Current clinical status of nitroglycerin and other nitrates.
Topics: Angina Pectoris; Heart Diseases; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; | 1978 |
Current clinical status of nitroglycerin and other nitrates.
Topics: Angina Pectoris; Heart Diseases; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; | 1978 |
[Nitrates and other peripheral vasodilator agents in acute myocardial infarct and congestive heart failure].
Topics: Acute Disease; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Nitrates; Nitroglycerin; | 1978 |
[Nitrates and other peripheral vasodilator agents in acute myocardial infarct and congestive heart failure].
Topics: Acute Disease; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Nitrates; Nitroglycerin; | 1978 |
Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual.
Topics: Administration, Oral; Adult; Aged; Female; Heart Failure; Humans; Isosorbide; Male; Middle Aged; Mou | 1978 |
Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual.
Topics: Administration, Oral; Adult; Aged; Female; Heart Failure; Humans; Isosorbide; Male; Middle Aged; Mou | 1978 |
Intravenous nitroglycerin in acute myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Drug Evaluation; Female; Heart Fa | 1975 |
Intravenous nitroglycerin in acute myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Drug Evaluation; Female; Heart Fa | 1975 |
Improvement in left ventricular wall motion following nitroglycerin.
Topics: Adult; Angiocardiography; Cardiac Output; Cardiac Volume; Coronary Artery Bypass; Coronary Disease; | 1975 |
Improvement in left ventricular wall motion following nitroglycerin.
Topics: Adult; Angiocardiography; Cardiac Output; Cardiac Volume; Coronary Artery Bypass; Coronary Disease; | 1975 |
Measurement of stroke volume from pulmonary artery pressure record in man.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathy, Hypertrophic; Catecholamine | 1975 |
Measurement of stroke volume from pulmonary artery pressure record in man.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathy, Hypertrophic; Catecholamine | 1975 |
Vasodilators and myocardial infarction.
Topics: Cardiac Catheterization; Diuretics; Heart Failure; Humans; Mitral Valve Insufficiency; Myocardial In | 1975 |
Vasodilators and myocardial infarction.
Topics: Cardiac Catheterization; Diuretics; Heart Failure; Humans; Mitral Valve Insufficiency; Myocardial In | 1975 |
[Effect of nitroglycerine in acute myocardial infarction: I: Sublingual nitroglycerine in the treatment of left-heart failure and pulmonary oedema (author's transl)].
Topics: Acute Disease; Administration, Oral; Aged; Blood Pressure; Cardiac Output; Dosage Forms; Dyspnea; He | 1975 |
[Effect of nitroglycerine in acute myocardial infarction: I: Sublingual nitroglycerine in the treatment of left-heart failure and pulmonary oedema (author's transl)].
Topics: Acute Disease; Administration, Oral; Aged; Blood Pressure; Cardiac Output; Dosage Forms; Dyspnea; He | 1975 |
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction.
Topics: Acute Disease; Adolescent; Adult; Coronary Circulation; Drug Evaluation; Drug Synergism; Drug Therap | 1975 |
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction.
Topics: Acute Disease; Adolescent; Adult; Coronary Circulation; Drug Evaluation; Drug Synergism; Drug Therap | 1975 |
[New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
Topics: Acute Disease; Administration, Oral; Aged; Arteries; Blood Pressure; Cardiac Catheterization; Cardia | 1975 |
[New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
Topics: Acute Disease; Administration, Oral; Aged; Arteries; Blood Pressure; Cardiac Catheterization; Cardia | 1975 |
Effect of drugs on effective vascular compliance in acute heart failure.
Topics: Acute Disease; Animals; Aorta, Thoracic; Coronary Vessels; Dogs; Ethacrynic Acid; Heart Failure; Mal | 1975 |
Effect of drugs on effective vascular compliance in acute heart failure.
Topics: Acute Disease; Animals; Aorta, Thoracic; Coronary Vessels; Dogs; Ethacrynic Acid; Heart Failure; Mal | 1975 |
Vasodilator therapy for chronic left ventricular failure.
Topics: Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Mal | 1976 |
Vasodilator therapy for chronic left ventricular failure.
Topics: Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Mal | 1976 |
Long-term propranolol therapy for angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Asthma; Blood Pressure; Female; Heart Failure; Humans; Middle Aged; Ni | 1976 |
Long-term propranolol therapy for angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Asthma; Blood Pressure; Female; Heart Failure; Humans; Middle Aged; Ni | 1976 |
[Effect of nitroglycerin in acute myocardial infarction. II.Intravenous infusion of nitroglycerin in patients with or without left-heart failure, and its effect on infarct size (author's transl)].
Topics: Acute Disease; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Injections | 1976 |
[Effect of nitroglycerin in acute myocardial infarction. II.Intravenous infusion of nitroglycerin in patients with or without left-heart failure, and its effect on infarct size (author's transl)].
Topics: Acute Disease; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Injections | 1976 |
Peripheral vasodilators in the treatment of cardiac failure.
Topics: Blood Pressure; Cardiac Output; Coronary Circulation; Dose-Response Relationship, Drug; Heart Failur | 1976 |
Peripheral vasodilators in the treatment of cardiac failure.
Topics: Blood Pressure; Cardiac Output; Coronary Circulation; Dose-Response Relationship, Drug; Heart Failur | 1976 |
Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Ferricyanides; Heart; Heart Failure; Heart Rate | 1976 |
Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Ferricyanides; Heart; Heart Failure; Heart Rate | 1976 |
[Nitroglycerin in the therapy of coronary insufficiency and heart failure].
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Heart Failu | 1976 |
[Nitroglycerin in the therapy of coronary insufficiency and heart failure].
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Heart Failu | 1976 |
Letter: Cardiac failure.
Topics: Heart Failure; Humans; Isosorbide Dinitrate; Nitrites; Nitroglycerin | 1976 |
Letter: Cardiac failure.
Topics: Heart Failure; Humans; Isosorbide Dinitrate; Nitrites; Nitroglycerin | 1976 |
Sublingual nitroglycerin in the treatment of left ventricular failure and pulmonary edema.
Topics: Blood Pressure; Cardiac Output; Coronary Disease; Depression, Chemical; Heart Failure; Heart Ventric | 1976 |
Sublingual nitroglycerin in the treatment of left ventricular failure and pulmonary edema.
Topics: Blood Pressure; Cardiac Output; Coronary Disease; Depression, Chemical; Heart Failure; Heart Ventric | 1976 |
Hemodynamic effects of nitroglycerin ointment in congestive heart failure.
Topics: Aged; Blood Pressure; Cardiac Output; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; | 1976 |
Hemodynamic effects of nitroglycerin ointment in congestive heart failure.
Topics: Aged; Blood Pressure; Cardiac Output; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; | 1976 |
Combination vasodilator therapy for severe chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosor | 1976 |
Combination vasodilator therapy for severe chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosor | 1976 |
Sustained haemodynamic action of nitroglycerin ointment.
Topics: Adult; Aged; Blood Pressure; Depression, Chemical; Female; Heart Failure; Heart Rate; Humans; Male; | 1976 |
Sustained haemodynamic action of nitroglycerin ointment.
Topics: Adult; Aged; Blood Pressure; Depression, Chemical; Female; Heart Failure; Heart Rate; Humans; Male; | 1976 |
[Assessment of the coronary circulation regulation by means of the so-called isometric contraction index].
Topics: Coronary Circulation; Furosemide; Heart Failure; Heart Function Tests; Humans; Myocardial Contractio | 1976 |
[Assessment of the coronary circulation regulation by means of the so-called isometric contraction index].
Topics: Coronary Circulation; Furosemide; Heart Failure; Heart Function Tests; Humans; Myocardial Contractio | 1976 |
Treatment of congestive heart failure.
Topics: Benzothiadiazines; Bloodletting; Digitalis Glycosides; Diuretics; Heart; Heart Failure; Heart Functi | 1976 |
Treatment of congestive heart failure.
Topics: Benzothiadiazines; Bloodletting; Digitalis Glycosides; Diuretics; Heart; Heart Failure; Heart Functi | 1976 |
Nitroglycerin: new concepts about an old drug.
Topics: Arrhythmias, Cardiac; Coronary Circulation; Heart Failure; Humans; Myocardial Infarction; Nitroglyce | 1976 |
Nitroglycerin: new concepts about an old drug.
Topics: Arrhythmias, Cardiac; Coronary Circulation; Heart Failure; Humans; Myocardial Infarction; Nitroglyce | 1976 |
[Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin].
Topics: Adult; Aged; Aged, 80 and over; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; | 1992 |
[Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin].
Topics: Adult; Aged; Aged, 80 and over; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; | 1992 |
[The effects of nitroglycerin on refractory congestive heart failure by intravenous infusion].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intrav | 1992 |
[The effects of nitroglycerin on refractory congestive heart failure by intravenous infusion].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intrav | 1992 |
The effects of phentolamine and nitroglycerin on right-sided hemodynamics in cardiac patients can be explained by a shift of the systemic venous return curve and right-ventricular output curve.
Topics: Adrenergic alpha-Antagonists; Animals; Cardiac Output; Dogs; Epinephrine; Heart Failure; Hemodynamic | 1992 |
The effects of phentolamine and nitroglycerin on right-sided hemodynamics in cardiac patients can be explained by a shift of the systemic venous return curve and right-ventricular output curve.
Topics: Adrenergic alpha-Antagonists; Animals; Cardiac Output; Dogs; Epinephrine; Heart Failure; Hemodynamic | 1992 |
Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
Topics: Aged; Atrial Function, Right; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Humans; I | 1992 |
Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
Topics: Aged; Atrial Function, Right; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Humans; I | 1992 |
Cardiodynamic changes during passive tilt and acute nitrate therapy.
Topics: Administration, Sublingual; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; | 1992 |
Cardiodynamic changes during passive tilt and acute nitrate therapy.
Topics: Administration, Sublingual; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; | 1992 |
Decreased skeletal muscle vasodilation in patients with congestive heart failure.
Topics: Acetylcholine; Atrial Natriuretic Factor; Captopril; Endothelium, Vascular; Exercise; Forearm; Heart | 1992 |
Decreased skeletal muscle vasodilation in patients with congestive heart failure.
Topics: Acetylcholine; Atrial Natriuretic Factor; Captopril; Endothelium, Vascular; Exercise; Forearm; Heart | 1992 |
Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure.
Topics: Acetylcholine; Adult; Aged; Blood Flow Velocity; Cardiomyopathy, Dilated; Chronic Disease; Endotheli | 1992 |
Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure.
Topics: Acetylcholine; Adult; Aged; Blood Flow Velocity; Cardiomyopathy, Dilated; Chronic Disease; Endotheli | 1992 |
Nitrate tolerance. How to prevent it or minimize its effect.
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin | 1992 |
Nitrate tolerance. How to prevent it or minimize its effect.
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin | 1992 |
Effects of prehospital medications on mortality and length of stay in congestive heart failure.
Topics: Academic Medical Centers; Aged; Cardiovascular Agents; Confidence Intervals; Emergency Medical Servi | 1992 |
Effects of prehospital medications on mortality and length of stay in congestive heart failure.
Topics: Academic Medical Centers; Aged; Cardiovascular Agents; Confidence Intervals; Emergency Medical Servi | 1992 |
Endothelial function in chronic congestive heart failure.
Topics: Acetylcholine; Adult; Arginine; Blood Flow Velocity; Brachial Artery; Chronic Disease; Endothelium, | 1992 |
Endothelial function in chronic congestive heart failure.
Topics: Acetylcholine; Adult; Arginine; Blood Flow Velocity; Brachial Artery; Chronic Disease; Endothelium, | 1992 |
Efficacy of the glyceryl trinitrate transdermal therapeutic system in a dog model of heart failure.
Topics: Administration, Cutaneous; Animals; Cardiac Output; Dextrans; Disease Models, Animal; Dogs; Female; | 1991 |
Efficacy of the glyceryl trinitrate transdermal therapeutic system in a dog model of heart failure.
Topics: Administration, Cutaneous; Animals; Cardiac Output; Dextrans; Disease Models, Animal; Dogs; Female; | 1991 |
Modulation of baroreflex and baroreceptor function in experimental heart failure.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dogs; Electrophysiology; Heart Failure; Heart Rate; | 1991 |
Modulation of baroreflex and baroreceptor function in experimental heart failure.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dogs; Electrophysiology; Heart Failure; Heart Rate; | 1991 |
[Hemodynamic response to high-dose nitroglycerin infusion in patients with severe heart failure after pretreatment and clinical stabilization].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; M | 1991 |
[Hemodynamic response to high-dose nitroglycerin infusion in patients with severe heart failure after pretreatment and clinical stabilization].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; M | 1991 |
Nitrate therapy in heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Nitroglycerin | 1991 |
Nitrate therapy in heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Nitroglycerin | 1991 |
Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.
Topics: Animals; Disease Models, Animal; Drug Tolerance; Heart; Heart Failure; Hemodynamics; Infusions, Intr | 1991 |
Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.
Topics: Animals; Disease Models, Animal; Drug Tolerance; Heart; Heart Failure; Hemodynamics; Infusions, Intr | 1991 |
[The role of peripheral vasodilators in the treatment of congestive heart failure in chronic cor pulmonale].
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Molsidomine; Nitrog | 1991 |
[The role of peripheral vasodilators in the treatment of congestive heart failure in chronic cor pulmonale].
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Molsidomine; Nitrog | 1991 |
Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
Topics: Animals; Diastole; Drug Therapy, Combination; Drug Tolerance; Heart Failure; Hydralazine; Nitroglyce | 1991 |
Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
Topics: Animals; Diastole; Drug Therapy, Combination; Drug Tolerance; Heart Failure; Hydralazine; Nitroglyce | 1991 |
[Hemodynamic changes in patients with myocardial infarct complicated by acute left ventricular failure during combined nitroglycerin and dobutamine therapy].
Topics: Aged; Blood Pressure; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Hu | 1991 |
[Hemodynamic changes in patients with myocardial infarct complicated by acute left ventricular failure during combined nitroglycerin and dobutamine therapy].
Topics: Aged; Blood Pressure; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Hu | 1991 |
The mystery of nitrate resistance.
Topics: Drug Resistance; Drug Tolerance; Heart Failure; Humans; Nitroglycerin | 1991 |
The mystery of nitrate resistance.
Topics: Drug Resistance; Drug Tolerance; Heart Failure; Humans; Nitroglycerin | 1991 |
Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.
Topics: Acetylcysteine; Blood Pressure; Blood Volume; Drug Tolerance; Heart Failure; Humans; Infusions, Intr | 1990 |
Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.
Topics: Acetylcysteine; Blood Pressure; Blood Volume; Drug Tolerance; Heart Failure; Humans; Infusions, Intr | 1990 |
[Nitroglycerin].
Topics: Heart Failure; Humans; Nitroglycerin | 1990 |
[Nitroglycerin].
Topics: Heart Failure; Humans; Nitroglycerin | 1990 |
Arterial baroreceptor control of peripheral vascular resistance in experimental heart failure.
Topics: Animals; Blood Pressure; Dogs; Heart Failure; Male; Nitroglycerin; Phenylephrine; Pressoreceptors; V | 1990 |
Arterial baroreceptor control of peripheral vascular resistance in experimental heart failure.
Topics: Animals; Blood Pressure; Dogs; Heart Failure; Male; Nitroglycerin; Phenylephrine; Pressoreceptors; V | 1990 |
Effects of chronic glyceryl trinitrate on left ventricular haemodynamics in a rat model of congestive heart failure: demonstration of a simple animal model for the study of in vivo nitrate tolerance.
Topics: Animals; Blood Pressure; Disease Models, Animal; Drug Tolerance; Heart Failure; Heart Ventricles; Ma | 1990 |
Effects of chronic glyceryl trinitrate on left ventricular haemodynamics in a rat model of congestive heart failure: demonstration of a simple animal model for the study of in vivo nitrate tolerance.
Topics: Animals; Blood Pressure; Disease Models, Animal; Drug Tolerance; Heart Failure; Heart Ventricles; Ma | 1990 |
Experimental studies of the load reducing effects of nitroglycerin in heart failure.
Topics: Animals; Blood Pressure; Chordae Tendineae; Dogs; Female; Heart Failure; Male; Mitral Valve Insuffic | 1990 |
Experimental studies of the load reducing effects of nitroglycerin in heart failure.
Topics: Animals; Blood Pressure; Chordae Tendineae; Dogs; Female; Heart Failure; Male; Mitral Valve Insuffic | 1990 |
Nitrate tolerance in heart failure: differential venous, pulmonary and systemic arterial effects.
Topics: Adult; Aged; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Ma | 1990 |
Nitrate tolerance in heart failure: differential venous, pulmonary and systemic arterial effects.
Topics: Adult; Aged; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Ma | 1990 |
Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure.
Topics: Administration, Sublingual; Adult; Aerosols; Aged; Echocardiography; Female; Follow-Up Studies; Hear | 1990 |
Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure.
Topics: Administration, Sublingual; Adult; Aerosols; Aged; Echocardiography; Female; Follow-Up Studies; Hear | 1990 |
Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.
Topics: Adult; Aged; Aldosterone; Captopril; Coronary Disease; Drug Tolerance; Female; Heart Failure; Hemody | 1990 |
Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.
Topics: Adult; Aged; Aldosterone; Captopril; Coronary Disease; Drug Tolerance; Female; Heart Failure; Hemody | 1990 |
Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure.
Topics: Acetylcholine; Animals; Cardiac Pacing, Artificial; Coronary Vessels; Dinoprost; Dogs; Endothelium, | 1990 |
Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure.
Topics: Acetylcholine; Animals; Cardiac Pacing, Artificial; Coronary Vessels; Dinoprost; Dogs; Endothelium, | 1990 |
[Possibilities of the method of dilution of electro-impedance indicators in the assessment of volume dynamics of extravascular lung fluid in intensive care and resuscitation units].
Topics: Body Fluids; Furosemide; Heart Failure; Hemofiltration; Humans; Intensive Care Units; Lung; Models, | 1990 |
[Possibilities of the method of dilution of electro-impedance indicators in the assessment of volume dynamics of extravascular lung fluid in intensive care and resuscitation units].
Topics: Body Fluids; Furosemide; Heart Failure; Hemofiltration; Humans; Intensive Care Units; Lung; Models, | 1990 |
[Transcutaneous transport of trinitrin in children after application of nitroglycerin patches].
Topics: Administration, Cutaneous; Child; Child, Preschool; Heart Failure; Humans; Infant; Mass Spectrometry | 1990 |
[Transcutaneous transport of trinitrin in children after application of nitroglycerin patches].
Topics: Administration, Cutaneous; Child; Child, Preschool; Heart Failure; Humans; Infant; Mass Spectrometry | 1990 |
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
Topics: Aged; Captopril; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neuro | 1987 |
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
Topics: Aged; Captopril; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neuro | 1987 |
Nitrate therapy for left ventricular failure complicating acute myocardial infarction: a haemodynamic comparison of intravenous, buccal, and transdermal delivery systems.
Topics: Administration, Buccal; Administration, Cutaneous; Administration, Oral; Adult; Aged; Blood Pressure | 1989 |
Nitrate therapy for left ventricular failure complicating acute myocardial infarction: a haemodynamic comparison of intravenous, buccal, and transdermal delivery systems.
Topics: Administration, Buccal; Administration, Cutaneous; Administration, Oral; Adult; Aged; Blood Pressure | 1989 |
A one-sided affair? Myocardial infarction with pulmonary edema and forward failure.
Topics: Aged; Dobutamine; Female; Furosemide; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; P | 1989 |
A one-sided affair? Myocardial infarction with pulmonary edema and forward failure.
Topics: Aged; Dobutamine; Female; Furosemide; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; P | 1989 |
[Nitrate tolerance and its management by N-acetylcysteine (studies of patients with severe chronic heart failure)].
Topics: Acetylcysteine; Cardiomyopathy, Dilated; Coronary Disease; Drug Therapy, Combination; Drug Tolerance | 1989 |
[Nitrate tolerance and its management by N-acetylcysteine (studies of patients with severe chronic heart failure)].
Topics: Acetylcysteine; Cardiomyopathy, Dilated; Coronary Disease; Drug Therapy, Combination; Drug Tolerance | 1989 |
Effect of nitroglycerin-induced reduction of left ventricular filling pressure on diastolic filling in acute dilated heart failure.
Topics: Acute Disease; Animals; Cardiac Output; Diastole; Dogs; Echocardiography; Heart Failure; Myocardial | 1989 |
Effect of nitroglycerin-induced reduction of left ventricular filling pressure on diastolic filling in acute dilated heart failure.
Topics: Acute Disease; Animals; Cardiac Output; Diastole; Dogs; Echocardiography; Heart Failure; Myocardial | 1989 |
Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure.
Topics: Aged; Cardiac Catheterization; Cardiac Output; Dobutamine; Echocardiography, Doppler; Exercise; Fema | 1989 |
Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure.
Topics: Aged; Cardiac Catheterization; Cardiac Output; Dobutamine; Echocardiography, Doppler; Exercise; Fema | 1989 |
Follow-up the haemodynamic effect of nitroglycerin and determination of the optimal dose using the non-invasive and invasive methods in patients treated at the intensive care unit.
Topics: Aged; Aged, 80 and over; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Hemodynamics; H | 1989 |
Follow-up the haemodynamic effect of nitroglycerin and determination of the optimal dose using the non-invasive and invasive methods in patients treated at the intensive care unit.
Topics: Aged; Aged, 80 and over; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Hemodynamics; H | 1989 |
Interval therapy to avoid nitrate tolerance: paradise regained?
Topics: Administration, Cutaneous; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Heart Fail | 1989 |
Interval therapy to avoid nitrate tolerance: paradise regained?
Topics: Administration, Cutaneous; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Heart Fail | 1989 |
Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.
Topics: Aged; Blood Pressure; Captopril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitro | 1989 |
Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.
Topics: Aged; Blood Pressure; Captopril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitro | 1989 |
Changes in the haemodynamic responses to exercise, posture and nitrates after treatment of congestive heart failure with an arteriolar vasodilator.
Topics: Adult; Aged; Cardiac Output; Exercise; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nicar | 1989 |
Changes in the haemodynamic responses to exercise, posture and nitrates after treatment of congestive heart failure with an arteriolar vasodilator.
Topics: Adult; Aged; Cardiac Output; Exercise; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nicar | 1989 |
[New aspects of the action of nitroglycerin on the hemodynamics of the lesser circulation and heart rhythm disorder in patients with chronic heart failure].
Topics: Arrhythmias, Cardiac; Heart Failure; Hemodynamics; Humans; Nitroglycerin; Pulmonary Circulation | 1989 |
[New aspects of the action of nitroglycerin on the hemodynamics of the lesser circulation and heart rhythm disorder in patients with chronic heart failure].
Topics: Arrhythmias, Cardiac; Heart Failure; Hemodynamics; Humans; Nitroglycerin; Pulmonary Circulation | 1989 |
[Effects of nirmin on central hemodynamics in patients with heart failure in the acute period of myocardial infarct].
Topics: Adult; Aged; Central Venous Pressure; Female; Heart Failure; Hemodynamics; Humans; Injections, Intra | 1989 |
[Effects of nirmin on central hemodynamics in patients with heart failure in the acute period of myocardial infarct].
Topics: Adult; Aged; Central Venous Pressure; Female; Heart Failure; Hemodynamics; Humans; Injections, Intra | 1989 |
Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Female; | 1989 |
Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Female; | 1989 |
Lack of venodilative activity of alpha human atrial natriuretic polypeptide in patients with congestive heart failure.
Topics: Atrial Natriuretic Factor; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitroglycerin; | 1989 |
Lack of venodilative activity of alpha human atrial natriuretic polypeptide in patients with congestive heart failure.
Topics: Atrial Natriuretic Factor; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitroglycerin; | 1989 |
[Therapeutic tolerance with derivative nitrates].
Topics: Angina Pectoris; Animals; Drug Tolerance; Heart Failure; Humans; Nitrates; Nitroglycerin | 1989 |
[Therapeutic tolerance with derivative nitrates].
Topics: Angina Pectoris; Animals; Drug Tolerance; Heart Failure; Humans; Nitrates; Nitroglycerin | 1989 |
Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Diastole; Disease Models, Animal; Heart Failure; | 1989 |
Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Diastole; Disease Models, Animal; Heart Failure; | 1989 |
[New approaches to the study of the mechanism of action of nitrates].
Topics: Blood Platelets; Calcium; Calcium Channel Blockers; Calcium Channels; Cardiomegaly; Ferricyanides; H | 1988 |
[New approaches to the study of the mechanism of action of nitrates].
Topics: Blood Platelets; Calcium; Calcium Channel Blockers; Calcium Channels; Cardiomegaly; Ferricyanides; H | 1988 |
[Nitrates in the combined treatment of congestive heart failure patients in a mountainous location].
Topics: Adolescent; Adult; Altitude; Digoxin; Drug Evaluation; Drug Therapy, Combination; Female; Heart Fail | 1986 |
[Nitrates in the combined treatment of congestive heart failure patients in a mountainous location].
Topics: Adolescent; Adult; Altitude; Digoxin; Drug Evaluation; Drug Therapy, Combination; Female; Heart Fail | 1986 |
Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; | 1988 |
Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; | 1988 |
Effects of vasodilators on the coronary circulation in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cardiomegaly; Cilazapri | 1988 |
Effects of vasodilators on the coronary circulation in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cardiomegaly; Cilazapri | 1988 |
Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Fe | 1985 |
Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Fe | 1985 |
Guidelines for vasodilator therapy of congestive heart failure in infants and children.
Topics: Captopril; Child; Child, Preschool; Enalapril; Heart Diseases; Heart Failure; Heart Ventricles; Hemo | 1987 |
Guidelines for vasodilator therapy of congestive heart failure in infants and children.
Topics: Captopril; Child; Child, Preschool; Enalapril; Heart Diseases; Heart Failure; Heart Ventricles; Hemo | 1987 |
Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Blood Pressure; Cardiac Output; Dose-Res | 1986 |
Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Blood Pressure; Cardiac Output; Dose-Res | 1986 |
Treatment of cardiac failure in infants.
Topics: Alprostadil; Captopril; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; H | 1986 |
Treatment of cardiac failure in infants.
Topics: Alprostadil; Captopril; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; H | 1986 |
[Intravenous nitroglycerin infusion in patients with acute heart failure].
Topics: Acute Disease; Aged; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middl | 1986 |
[Intravenous nitroglycerin infusion in patients with acute heart failure].
Topics: Acute Disease; Aged; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middl | 1986 |
[Hemodynamic effects of intravenous nitroglycerin and of its combination with dopamine in experimental heart failure in the dog].
Topics: Animals; Dogs; Dopamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Infusions, Parenter | 1986 |
[Hemodynamic effects of intravenous nitroglycerin and of its combination with dopamine in experimental heart failure in the dog].
Topics: Animals; Dogs; Dopamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Infusions, Parenter | 1986 |
[Nitrate derivatives and congestive cardiac failure in infants. Pharmacological efficacy of transcutaneous administration devices].
Topics: Administration, Topical; Heart Failure; Humans; Infant; Nitroglycerin | 1986 |
[Nitrate derivatives and congestive cardiac failure in infants. Pharmacological efficacy of transcutaneous administration devices].
Topics: Administration, Topical; Heart Failure; Humans; Infant; Nitroglycerin | 1986 |
Buccal nitroglycerin tablets in heart failure.
Topics: Adult; Aged; Cheek; Heart Failure; Humans; Male; Middle Aged; Nitroglycerin; Tablets | 1986 |
Buccal nitroglycerin tablets in heart failure.
Topics: Adult; Aged; Cheek; Heart Failure; Humans; Male; Middle Aged; Nitroglycerin; Tablets | 1986 |
The role of transdermal nitroglycerin in the treatment of coronary heart disease.
Topics: Administration, Topical; Coronary Disease; Heart; Heart Failure; Humans; Muscle, Smooth, Vascular; N | 1986 |
The role of transdermal nitroglycerin in the treatment of coronary heart disease.
Topics: Administration, Topical; Coronary Disease; Heart; Heart Failure; Humans; Muscle, Smooth, Vascular; N | 1986 |
The use of impedance cardiography in heart failure.
Topics: Cardiography, Impedance; Heart Failure; Humans; Nitroglycerin; Plethysmography, Impedance; Stroke Vo | 1986 |
The use of impedance cardiography in heart failure.
Topics: Cardiography, Impedance; Heart Failure; Humans; Nitroglycerin; Plethysmography, Impedance; Stroke Vo | 1986 |
[Therapy of acute heart failure].
Topics: Acute Disease; Combined Modality Therapy; Digitalis Glycosides; Dobutamine; Dopamine; Drug Therapy, | 1986 |
[Therapy of acute heart failure].
Topics: Acute Disease; Combined Modality Therapy; Digitalis Glycosides; Dobutamine; Dopamine; Drug Therapy, | 1986 |
[Pharmacokinetics of glycerol trinitrate].
Topics: Animals; Biological Availability; Biotransformation; Dogs; Dose-Response Relationship, Drug; Heart F | 1986 |
[Pharmacokinetics of glycerol trinitrate].
Topics: Animals; Biological Availability; Biotransformation; Dogs; Dose-Response Relationship, Drug; Heart F | 1986 |
Dynamics of mitral regurgitation during nitroglycerin therapy: a Doppler echocardiographic study.
Topics: Aged; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve | 1986 |
Dynamics of mitral regurgitation during nitroglycerin therapy: a Doppler echocardiographic study.
Topics: Aged; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve | 1986 |
Use of nitroglycerin--1986.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Heart Failure; Humans; Nitroglycerin | 1986 |
Use of nitroglycerin--1986.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Heart Failure; Humans; Nitroglycerin | 1986 |
[Comparative efficacy of the long-term use of long-acting nitroglycerin (sustak) and molsidomine after myocardial infarct complicated by heart failure].
Topics: Adult; Aged; Delayed-Action Preparations; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Mi | 1986 |
[Comparative efficacy of the long-term use of long-acting nitroglycerin (sustak) and molsidomine after myocardial infarct complicated by heart failure].
Topics: Adult; Aged; Delayed-Action Preparations; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Mi | 1986 |
Determinants of cardiac failure after coronary bypass surgery within 30 days of acute myocardial infarction.
Topics: Coronary Artery Bypass; Coronary Disease; Heart Arrest, Induced; Heart Failure; Heart Ventricles; Hu | 1986 |
Determinants of cardiac failure after coronary bypass surgery within 30 days of acute myocardial infarction.
Topics: Coronary Artery Bypass; Coronary Disease; Heart Arrest, Induced; Heart Failure; Heart Ventricles; Hu | 1986 |
[Hemodynamic effect and duration of action of Deponit 10 in patients with congestive heart insufficiency].
Topics: Administration, Cutaneous; Aged; Blood Pressure; Cardiomyopathy, Dilated; Delayed-Action Preparation | 1986 |
[Hemodynamic effect and duration of action of Deponit 10 in patients with congestive heart insufficiency].
Topics: Administration, Cutaneous; Aged; Blood Pressure; Cardiomyopathy, Dilated; Delayed-Action Preparation | 1986 |
Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
Topics: Administration, Cutaneous; Adult; Aged; Biological Availability; Delayed-Action Preparations; Female | 1987 |
Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
Topics: Administration, Cutaneous; Adult; Aged; Biological Availability; Delayed-Action Preparations; Female | 1987 |
A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Nitroglycerin; Ren | 1987 |
A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Nitroglycerin; Ren | 1987 |
Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
Topics: Administration, Cutaneous; Adult; Aged; Delayed-Action Preparations; Drug Tolerance; Female; Heart F | 1987 |
Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
Topics: Administration, Cutaneous; Adult; Aged; Delayed-Action Preparations; Drug Tolerance; Female; Heart F | 1987 |
[Comparative evaluation of the efficacy of nitrosorbide and nitroglycerin in acute myocardial infarct patients].
Topics: Acute Disease; Angina Pectoris; Arrhythmias, Cardiac; Dyspnea, Paroxysmal; Electrocardiography; Fema | 1987 |
[Comparative evaluation of the efficacy of nitrosorbide and nitroglycerin in acute myocardial infarct patients].
Topics: Acute Disease; Angina Pectoris; Arrhythmias, Cardiac; Dyspnea, Paroxysmal; Electrocardiography; Fema | 1987 |
[Problems in acute therapy of coronary heart disease using drugs that reduce preload and afterload].
Topics: Coronary Disease; Heart Failure; Hemodynamics; Humans; Hypertension; Molsidomine; Nifedipine; Nitrog | 1987 |
[Problems in acute therapy of coronary heart disease using drugs that reduce preload and afterload].
Topics: Coronary Disease; Heart Failure; Hemodynamics; Humans; Hypertension; Molsidomine; Nifedipine; Nitrog | 1987 |
Use of nitroglycerin in the treatment of acute heart failure and cardiogenic shock in patients with myocardial infarction.
Topics: Acute Disease; Adult; Aged; Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Female; Heart | 1987 |
Use of nitroglycerin in the treatment of acute heart failure and cardiogenic shock in patients with myocardial infarction.
Topics: Acute Disease; Adult; Aged; Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Female; Heart | 1987 |
Hemodynamic effects of transdermal nitroglycerin in subjects with angina and without congestive heart failure: comparison between never treated and chronically treated subjects.
Topics: Administration, Cutaneous; Angina Pectoris; Female; Heart Failure; Hemodynamics; Humans; Male; Middl | 1987 |
Hemodynamic effects of transdermal nitroglycerin in subjects with angina and without congestive heart failure: comparison between never treated and chronically treated subjects.
Topics: Administration, Cutaneous; Angina Pectoris; Female; Heart Failure; Hemodynamics; Humans; Male; Middl | 1987 |
Application of a combination of sublingually administered vasodilating drugs for rapid action on pulmonary hypertension in patients with cardiac asthma and with pulmonary oedema.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Dyspnea, Paroxysmal; Female; Heart Fai | 1987 |
Application of a combination of sublingually administered vasodilating drugs for rapid action on pulmonary hypertension in patients with cardiac asthma and with pulmonary oedema.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Dyspnea, Paroxysmal; Female; Heart Fai | 1987 |
Dependence of oxygen consumption on oxygen delivery in patients with chronic congestive heart failure.
Topics: Blood Gas Analysis; Heart Failure; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Nitroglycerin; | 1987 |
Dependence of oxygen consumption on oxygen delivery in patients with chronic congestive heart failure.
Topics: Blood Gas Analysis; Heart Failure; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Nitroglycerin; | 1987 |
Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Drug Tolerance; Female; Heart Failure; Hemodynami | 1987 |
Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Drug Tolerance; Female; Heart Failure; Hemodynami | 1987 |
Role of nitrates in congestive heart failure.
Topics: Dosage Forms; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbid | 1987 |
Role of nitrates in congestive heart failure.
Topics: Dosage Forms; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbid | 1987 |
The influence of transdermal glyceryl trinitrate on peripheral circulation in healthy subjects and in patients with congestive cardiac failure.
Topics: Administration, Cutaneous; Blood Circulation; Blood Pressure; Female; Heart Failure; Heart Rate; Hum | 1987 |
The influence of transdermal glyceryl trinitrate on peripheral circulation in healthy subjects and in patients with congestive cardiac failure.
Topics: Administration, Cutaneous; Blood Circulation; Blood Pressure; Female; Heart Failure; Heart Rate; Hum | 1987 |
[Hemodynamic effect of unloading therapy in acute myocardial infarction with congestive heart failure].
Topics: Age Factors; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Infusions, Intravenou | 1987 |
[Hemodynamic effect of unloading therapy in acute myocardial infarction with congestive heart failure].
Topics: Age Factors; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Infusions, Intravenou | 1987 |
Prenalterol in severe congestive heart failure. I. The immediate haemodynamic effects as compared to nitroglycerine.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Huma | 1988 |
Prenalterol in severe congestive heart failure. I. The immediate haemodynamic effects as compared to nitroglycerine.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Huma | 1988 |
Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
Topics: Aged; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Nitro | 1988 |
Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
Topics: Aged; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Nitro | 1988 |
Transdermal nitroglycerin patches in congestive heart failure: evaluation by continuous hemodynamic monitoring for 72 hours.
Topics: Administration, Cutaneous; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mon | 1988 |
Transdermal nitroglycerin patches in congestive heart failure: evaluation by continuous hemodynamic monitoring for 72 hours.
Topics: Administration, Cutaneous; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mon | 1988 |
[Hemodynamic effects of nitroglycerin in oral form (Nitrilex Spray)].
Topics: Administration, Sublingual; Adult; Aerosols; Aged; Female; Heart Failure; Hemodynamics; Humans; Male | 1988 |
[Hemodynamic effects of nitroglycerin in oral form (Nitrilex Spray)].
Topics: Administration, Sublingual; Adult; Aerosols; Aged; Female; Heart Failure; Hemodynamics; Humans; Male | 1988 |
[Transdermal therapeutic systems. Possibilities and limitations].
Topics: Administration, Cutaneous; Angina Pectoris; Estradiol; Evaluation Studies as Topic; Female; Heart Fa | 1988 |
[Transdermal therapeutic systems. Possibilities and limitations].
Topics: Administration, Cutaneous; Angina Pectoris; Estradiol; Evaluation Studies as Topic; Female; Heart Fa | 1988 |
Resting and exertional haemodynamic effects of buccal nitroglycerin: acute and chronic discontinuous treatment in post-myocardial infarction patients with heart failure.
Topics: Administration, Buccal; Drug Administration Schedule; Exercise Test; Heart Failure; Hemodynamics; Hu | 1988 |
Resting and exertional haemodynamic effects of buccal nitroglycerin: acute and chronic discontinuous treatment in post-myocardial infarction patients with heart failure.
Topics: Administration, Buccal; Drug Administration Schedule; Exercise Test; Heart Failure; Hemodynamics; Hu | 1988 |
Sustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Ma | 1988 |
Sustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Ma | 1988 |
The correlation between CK MB curve type and the clinical course of recent myocardial infarction.
Topics: Adult; Aged; Creatine Kinase; Heart Failure; Humans; Isoenzymes; Middle Aged; Myocardial Infarction; | 1988 |
The correlation between CK MB curve type and the clinical course of recent myocardial infarction.
Topics: Adult; Aged; Creatine Kinase; Heart Failure; Humans; Isoenzymes; Middle Aged; Myocardial Infarction; | 1988 |
Nitrates: the problem of tolerance.
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglyceri | 1988 |
Nitrates: the problem of tolerance.
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglyceri | 1988 |
[The advantageous effects of a prolonged intravenous load with a nitroglycerin solution on the lesser circulation in patients with chronic heart failure].
Topics: Chronic Disease; Drug Evaluation; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infus | 1988 |
[The advantageous effects of a prolonged intravenous load with a nitroglycerin solution on the lesser circulation in patients with chronic heart failure].
Topics: Chronic Disease; Drug Evaluation; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infus | 1988 |
[Significance of nitrates in acute therapy of heart failure with and without lung edema].
Topics: Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; | 1985 |
[Significance of nitrates in acute therapy of heart failure with and without lung edema].
Topics: Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; | 1985 |
Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Heart; Heart Failure; Heart Ventricles; Humans; Male; M | 1985 |
Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Heart; Heart Failure; Heart Ventricles; Humans; Male; M | 1985 |
Treatment of congestive heart failure by altering loading conditions of the heart.
Topics: Captopril; Cardiac Output; Child; Digoxin; Dopamine; Drug Therapy, Combination; Heart; Heart Failure | 1985 |
Treatment of congestive heart failure by altering loading conditions of the heart.
Topics: Captopril; Cardiac Output; Child; Digoxin; Dopamine; Drug Therapy, Combination; Heart; Heart Failure | 1985 |
Hypotensive acute cardiopulmonary edema.
Topics: Aged; Blood Proteins; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; | 1985 |
Hypotensive acute cardiopulmonary edema.
Topics: Aged; Blood Proteins; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; | 1985 |
[Comparative evaluation of the effectiveness of various peripheral vasodilators in the treatment of cardiac insufficiency].
Topics: Administration, Oral; Adolescent; Adult; Captopril; Chronic Disease; Female; Heart Failure; Hemodyna | 1985 |
[Comparative evaluation of the effectiveness of various peripheral vasodilators in the treatment of cardiac insufficiency].
Topics: Administration, Oral; Adolescent; Adult; Captopril; Chronic Disease; Female; Heart Failure; Hemodyna | 1985 |
[Classification and principles of the use of vasodilators in the treatment of left ventricular insufficiency].
Topics: Calcium Channel Blockers; Captopril; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Kinetics | 1985 |
[Classification and principles of the use of vasodilators in the treatment of left ventricular insufficiency].
Topics: Calcium Channel Blockers; Captopril; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Kinetics | 1985 |
The effects of sublingually administered nitroglycerin on forearm vascular resistance in patients with heart failure and in normal subjects.
Topics: Adult; Animals; Arm; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mouth Floor; Mu | 1985 |
The effects of sublingually administered nitroglycerin on forearm vascular resistance in patients with heart failure and in normal subjects.
Topics: Adult; Animals; Arm; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mouth Floor; Mu | 1985 |
[Nitro plaster in coronary heart disease and severe left heart insufficiency].
Topics: Administration, Topical; Bandages; Coronary Disease; Drug Tolerance; Heart Failure; Humans; Nitrogly | 1985 |
[Nitro plaster in coronary heart disease and severe left heart insufficiency].
Topics: Administration, Topical; Bandages; Coronary Disease; Drug Tolerance; Heart Failure; Humans; Nitrogly | 1985 |
Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
Topics: Administration, Topical; Adult; Blood Pressure; Cardiac Output; Catecholamines; Female; Heart Failur | 1985 |
Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
Topics: Administration, Topical; Adult; Blood Pressure; Cardiac Output; Catecholamines; Female; Heart Failur | 1985 |
Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Heart Failure; Hemodynamics; Humans; Infusions, Parente | 1985 |
Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Heart Failure; Hemodynamics; Humans; Infusions, Parente | 1985 |
Vasodilator therapy for chronic congestive heart failure.
Topics: Captopril; Cardiac Catheterization; Heart Failure; Hospitalization; Humans; Hydralazine; Myocardial | 1985 |
Vasodilator therapy for chronic congestive heart failure.
Topics: Captopril; Cardiac Catheterization; Heart Failure; Hospitalization; Humans; Hydralazine; Myocardial | 1985 |
[Nitrates in the complex treatment of circulatory failure].
Topics: Adult; Aged; Cardiac Glycosides; Drug Therapy, Combination; Female; Heart Failure; Humans; Isosorbid | 1985 |
[Nitrates in the complex treatment of circulatory failure].
Topics: Adult; Aged; Cardiac Glycosides; Drug Therapy, Combination; Female; Heart Failure; Humans; Isosorbid | 1985 |
[Digoxin and nitroglycerin in the treatment of heart failure in myocardial infarction].
Topics: Digoxin; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myoc | 1985 |
[Digoxin and nitroglycerin in the treatment of heart failure in myocardial infarction].
Topics: Digoxin; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myoc | 1985 |
Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Heart Failure; Heart Rate; H | 1985 |
Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Heart Failure; Heart Rate; H | 1985 |
Vasodilator drugs in patients with chronic ischaemic heart failure.
Topics: Aged; Coronary Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; | 1985 |
Vasodilator drugs in patients with chronic ischaemic heart failure.
Topics: Aged; Coronary Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; | 1985 |
[Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
Topics: Arterial Occlusive Diseases; Brain Ischemia; Cardiovascular Diseases; Coronary Disease; Drug Therapy | 1985 |
[Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
Topics: Arterial Occlusive Diseases; Brain Ischemia; Cardiovascular Diseases; Coronary Disease; Drug Therapy | 1985 |
[Nitroglycerin treatment of acute left heart failure in myocardial infarct patients].
Topics: Acute Disease; Adult; Aged; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Nitroglycerin | 1985 |
[Nitroglycerin treatment of acute left heart failure in myocardial infarct patients].
Topics: Acute Disease; Adult; Aged; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Nitroglycerin | 1985 |
Buccal nitroglycerin in elderly patients with congestive cardiac failure.
Topics: Administration, Oral; Aged; Female; Heart Failure; Humans; Male; Nitroglycerin | 1985 |
Buccal nitroglycerin in elderly patients with congestive cardiac failure.
Topics: Administration, Oral; Aged; Female; Heart Failure; Humans; Male; Nitroglycerin | 1985 |
[Treatment of circulatory insufficiency with nitrates].
Topics: Coronary Disease; Dyspnea, Paroxysmal; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; | 1985 |
[Treatment of circulatory insufficiency with nitrates].
Topics: Coronary Disease; Dyspnea, Paroxysmal; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; | 1985 |
[Criteria for acute heart failure in myocardial infarction and its differentiated treatment with nitroglycerin].
Topics: Acute Disease; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardi | 1985 |
[Criteria for acute heart failure in myocardial infarction and its differentiated treatment with nitroglycerin].
Topics: Acute Disease; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardi | 1985 |
[Nitroglycerin by transdermal route in chronic congestive heart failure].
Topics: Administration, Cutaneous; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Ag | 1985 |
[Nitroglycerin by transdermal route in chronic congestive heart failure].
Topics: Administration, Cutaneous; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Ag | 1985 |
A practical approach to the management of angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arm; Arrhythmias, Cardiac; Digitalis Glycosides; Diure | 1974 |
A practical approach to the management of angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arm; Arrhythmias, Cardiac; Digitalis Glycosides; Diure | 1974 |
Sympathetic and parasympathetic components of reflex tachycardia induced by hypotension in conscious dogs with and without heart failure.
Topics: Animals; Atropine; Blood Pressure; Depression, Chemical; Dogs; Heart Failure; Heart Rate; Hypotensio | 1974 |
Sympathetic and parasympathetic components of reflex tachycardia induced by hypotension in conscious dogs with and without heart failure.
Topics: Animals; Atropine; Blood Pressure; Depression, Chemical; Dogs; Heart Failure; Heart Rate; Hypotensio | 1974 |
Coronary bypass grafts.
Topics: Angina Pectoris; Angiography; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; He | 1974 |
Coronary bypass grafts.
Topics: Angina Pectoris; Angiography; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; He | 1974 |
[Proceedings: Effect of nitroglycerin in acute myocardial infarct].
Topics: Blood Pressure; Cardiac Output; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Nitrogly | 1974 |
[Proceedings: Effect of nitroglycerin in acute myocardial infarct].
Topics: Blood Pressure; Cardiac Output; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Nitrogly | 1974 |
[Proceedings: Oral nitroglycerin preparations in the therapy of left heart failure in acute myocardial infarct].
Topics: Administration, Oral; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglyce | 1974 |
[Proceedings: Oral nitroglycerin preparations in the therapy of left heart failure in acute myocardial infarct].
Topics: Administration, Oral; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglyce | 1974 |
[Combined administration of obzidan and sustak in the treatment of patients with chronic coronary insufficiency].
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Female; Heart; Heart Failure; Humans; Male; | 1974 |
[Combined administration of obzidan and sustak in the treatment of patients with chronic coronary insufficiency].
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Female; Heart; Heart Failure; Humans; Male; | 1974 |
The "natural" history of severe angina pectoris with intensive medical therapy alone: a five year prospective study of 133 patients.
Topics: Adult; Aged; Aging; Angina Pectoris; Atrial Fibrillation; Cardiomegaly; Cerebrovascular Disorders; D | 1974 |
The "natural" history of severe angina pectoris with intensive medical therapy alone: a five year prospective study of 133 patients.
Topics: Adult; Aged; Aging; Angina Pectoris; Atrial Fibrillation; Cardiomegaly; Cerebrovascular Disorders; D | 1974 |
[Physiology of the coronary circulation as a basis for evaluating coronary dilators].
Topics: Animals; Blood Pressure; Carbon Dioxide; Coronary Circulation; Coronary Vessels; Disease Models, Ani | 1972 |
[Physiology of the coronary circulation as a basis for evaluating coronary dilators].
Topics: Animals; Blood Pressure; Carbon Dioxide; Coronary Circulation; Coronary Vessels; Disease Models, Ani | 1972 |
When "refractory" angina has an unsuspected cause.
Topics: Aged; Angina Pectoris; Angiography; Coronary Disease; Extracorporeal Circulation; Female; Heart Fail | 1972 |
When "refractory" angina has an unsuspected cause.
Topics: Aged; Angina Pectoris; Angiography; Coronary Disease; Extracorporeal Circulation; Female; Heart Fail | 1972 |
Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Blood Pressure; Carbon Monoxide; Cardiac Output; Electrocardiog | 1972 |
Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Blood Pressure; Carbon Monoxide; Cardiac Output; Electrocardiog | 1972 |
Divergent effects of antihypertensive therapy on cardiovascular responses and left ventricular function during upright exercise.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Catheterization; Cardiac Output; Electrocard | 1972 |
Divergent effects of antihypertensive therapy on cardiovascular responses and left ventricular function during upright exercise.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Catheterization; Cardiac Output; Electrocard | 1972 |
[Myocardial asynergy in ischemic heart disease and the effect of nitroglycerine].
Topics: Adult; Aged; Coronary Disease; Electrokymography; Female; Heart Failure; Humans; Male; Middle Aged; | 1972 |
[Myocardial asynergy in ischemic heart disease and the effect of nitroglycerine].
Topics: Adult; Aged; Coronary Disease; Electrokymography; Female; Heart Failure; Humans; Male; Middle Aged; | 1972 |
Medical Grand Rounds from the University of Alabama Medical Center. Panel discussion on complications of acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Aged; Diabetes Complications; Digoxin; Female; Heart Failure; Humans; Male; | 1966 |
Medical Grand Rounds from the University of Alabama Medical Center. Panel discussion on complications of acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Aged; Diabetes Complications; Digoxin; Female; Heart Failure; Humans; Male; | 1966 |
[The fourth heart sound, a sign of latent left ventricular insufficiency in myocardial ischemia].
Topics: Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; Phonocardiography | 1966 |
[The fourth heart sound, a sign of latent left ventricular insufficiency in myocardial ischemia].
Topics: Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; Phonocardiography | 1966 |
[Basic surgical problems in congenital heart defects].
Topics: Age Factors; Aortic Coarctation; Aortic Valve Stenosis; Child; Child, Preschool; Heart Defects, Cong | 1969 |
[Basic surgical problems in congenital heart defects].
Topics: Age Factors; Aortic Coarctation; Aortic Valve Stenosis; Child; Child, Preschool; Heart Defects, Cong | 1969 |
Effects of nitroglycerin upon the presystolic gallop.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Female; H | 1969 |
Effects of nitroglycerin upon the presystolic gallop.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Female; H | 1969 |
Severe bradycardia induced by caloric test in cardiac patients.
Topics: Acute Disease; Bradycardia; Digoxin; Female; Hearing Disorders; Heart Diseases; Heart Failure; Human | 1970 |
Severe bradycardia induced by caloric test in cardiac patients.
Topics: Acute Disease; Bradycardia; Digoxin; Female; Hearing Disorders; Heart Diseases; Heart Failure; Human | 1970 |
[Conservative therapy of angina pectoris].
Topics: Acute Disease; Amyl Nitrite; Angina Pectoris; Anticoagulants; Coronary Disease; Digitalis Glycosides | 1970 |
[Conservative therapy of angina pectoris].
Topics: Acute Disease; Amyl Nitrite; Angina Pectoris; Anticoagulants; Coronary Disease; Digitalis Glycosides | 1970 |
Problems with prosthetic valve surgery.
Topics: Adult; Anemia, Hemolytic; Angina Pectoris; Aortic Valve Insufficiency; Aortic Valve Stenosis; Cardia | 1971 |
Problems with prosthetic valve surgery.
Topics: Adult; Anemia, Hemolytic; Angina Pectoris; Aortic Valve Insufficiency; Aortic Valve Stenosis; Cardia | 1971 |